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Preface 
Thc initial idca to compilc a book on marker substances useful for characte-
rising ncurons and endocrine cclls was conceived at a mccting hcld in thc 
autumn of 1988 at Gargel lcn in the Austr ian A lps undcr the aiispiccs of the 
"Gesellschaft für His tochemie" (International Association of Histocliemists). 
Informal disciissions that took pIacc between fundamental research workers 
and clinicians, botli in that bcautiful and isolated congrcss location and 
subsequently at othcr mcetings and through personal eontact pointed out thc 
value of ccUtypc markers in clinical practicc and the constant necd to test 
potentially new markers. They also made us aware of the nccd for an 
authoritativc volumc on the one hand reviewing the latcst data on the 
molecular biology. biochemistry and cell biology of these marker molecules and 
on the other explaining how these molecules are employed clinieally. This 
book represcnts the fruits of these discussions. In it we attcmpt to bridge the 
gap between fundamental research and clinical practice and hopc that it wi l l 
hclp to stimulate future dialogue between the basic discipliiies and applied 
research. 
The clinical aspects on which we chose to concentrate in tIiis book principally 
conccrn abnormalities of the nervous and endocrine systems. Prcsent day 
concepts on the relationships existing between thcse two systems owe a 
enormous debt to the eminent pathologist E . Feyrtcr and Iiis pioneering work 
carly this century. which culminated in his book " Ü b e r diffuse endokrine 
epitheliale Organe*' published in Leipz ig in 1938. and also to the renowned 
histocliemists and cytochemists A . G . E . Pearse and T Fujita in thc 196()s and 
197()s. Dcvelopmenta l aspects of neural and endocrine cclls Iiave siiice been 
studied in deptl i by Nicole L e Douar in and her colleagues and constitute thc 
tlieme of the first chapter in this book. 
Whi le ncurons and endocrine cclls share many propcrties tliey also differ in 
important respects.The most striking differcnces include tlieir basic morplio-
logy: neiirons extend Iong processes (axons and dentrites) in contrast to the 
absencc of such structures in endocrine cells. Neurons arc also remarkable for 
theircapacity to separate sitcs of synthesis of ncurotransmitters from their sites 
of storage and release. while such separation is spatially very limited in 
endocrine eells. Neurotransmitter release occurs from neuroiis at specializcd 
junctions (synapses. neuroniuscular junctions) while endocrine cclls secrete 
their hormones into the extraccllular space, from where tlicy may be 
transportcd in thc b lood to affect remote targets in thc body. Exccptions to 
these general principles cx is t .Thus the hypothalamic/neurohypophyscal sys-
tem bridges the gap between the neural and endocrine systems in that their cell 
bodies are part of the central nervous system while their distaiit cndings release 
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Iiormones in thc vicinity ofb lood vesscls. Ot l ie r examples wli icl i do not liappily 
fit into thcsc broad divisions may be found (e.g. endocrine cclls whicli affecl 
their immcdiate neighbors in a paracrine fasliion). 
Apar t from the devclopmcntal relationships reviewcd in the first cliapter. 
ncurons and endocrine cells sharc many common proteins which may in part 
COiistitutc clcmcnts of the secrctory machinery. Chapters 2 and 3 concentrate 
on clcar synaptic vcsiclcs and secretory granulcs, respectivcly and focus 
attention in particular on either membranc constituents or protcins contained 
vvithin granules. A class of molecules which profouiidly affccts both develop-
mental cvcnts and patliological processes, the N C A M family, dcalt with in 
chapter 4, is representative of cell surface membranc constituents common to 
neural and endoerinc cells. 
One of thc first marker protcins used for ideiitifying ncurons and endocrine 
cells, thc cytosolic enzymc neuron specific cnolasc, N S E , was also one of the 
first to attain the status of a clinically useful diagnostic tool (chapter 5). 
Sccrctory proteins contained in granules. such as chromogranin A , C G A , w h i c h 
are releascd from actively secreting cclls arc also now employcd in clinical 
practicc (chapter 6). Synaptophysin is a recent addition to thc clinicians' 
battcry of markcr substanccs reviewed in chapter 7. which also discusscs the 
value of gcncral cell markcrs (including intermediate filamcnt protcins) and 
specific peptide Iiormonc markcrs. Different Ibrms of N C A M . including 
post-translationally modified forms represent examples of molecules the 
potcntial applicatioiis ofwhich haveyet tobe fu l lyexplo ied . though promissing 
iiidications are already publisl icd. Other adhesion molecules as yct unexplored 
in this context may also sharc this potential. 
Ifthis book stiniulates future contact between those who study the molecular 
biology, biochemistry or cell biology of given molecules and those who are 
seeking for bcttcr ways of diagnosing thc condition of their patients, we wi l l 
have achicvcd one ofour principal aims.Without thc aid and cooperation ofthe 
experts who contributcd thc different chaptcrs. this would not have becii 
possible. 
July L990, 
Strasbourg and U l m Kei th Langley and Manfred Gratz l 
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Part I 
Ontogenetic Relationships 

1 Embryonic Origin of Polypeptide 
Hormone Producing Cells 
NicoIc M. Le Doiuirin and Josiane Fontciine-Perus 
1.1 Introduction 
Since the discovcry that all eells of the peripheral ganglia and nerves originate 
from the neural crest. the dogma that the nervous system of vertebrates is 
entirely of ectodermal origin has becn universally aecepted (sec Le Douar in , 
1982 for a revicw). It has long becn known that the ectodermal germ layer 
produces the endocrine cells of the adenohypophysis through the Rathke"s 
pouch and that the adrcncrgie autonomic ncurons, the small intcnsely 
fluorescent (SIF) cells ofthe sympathetic ganglia and the chromaffin endocrine 
cclls of the suprarenal gland and various adrcnergic paraganglia belong to a 
common cell lineage (Landis and Patterson. 1981). It is thercfore obvious that 
close developmental and functional relationshipsexist between ncurons. either 
displaying or not a neurocndoerine activity. and certain endocrine cclls, 
cssentially thosc rcsponsible for polypeptide hormone production. 
Endocr inology and one of its clinical cornerstones. diabetology. originated 
from the interest that certain renowned physioIogists ofthe nineteenth century 
took in the pancreas. It was by examining the postulate o fClaude Bernard that 
this organ is necessary for survival (C. Bernard, 1856). that Mer ing and 
M i n k o w s k i (1889) discovered that diabetes mellitus was due to a disfunction of 
the pancreas. The concept of "blood borne chemical messcngers" was 
thereafter proposed by Bayliss and Starling (1902) with the discovery of 
secretin. the first of what turncd out to be a Iong Iist of hormones produccd by 
the gut ep i thc l ium. 
Al though endocrinology began with the discovery o fa hormone produced by 
the digestive ep i thc l ium. it is only considcrably latcr that thc gastrointestinal 
tract. became l'ully recognized as an endocrine organ. In 1938 Friedrich Feyrter 
described a system o f c l c a r c c l l s (helle Zellen) dispersed in the gut epithclium 
and in various other parts ofthe body. He considered that at Ieast some ofthcse 
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cclls wcrc actingon their immediate neighboiirs and were thcrefore paracrine in 
natLire. ratherthan endocrine. He thought that they arosc from the enterocytes 
by a process called endophytie and are thcrefore of endodermal origin. 
The fact that gut endocrinology progrcssed so slovvly and that "most gut 
hormones rested unknown in the darkness of the bowel" 1 is due to sevcral 
reasons. mainly bccausc they are not concentrated in glands Iike steroid, or 
thyroid and pituitary hormones for example, the knowledge of which 
progrcssed so rapidly during the first half of this century. Such a dispersion of 
the sccrctory cells hampered the eolleetion of materials for chemieal purifica-
tion and physiological investigation. 
However. their identifieation has dramatically progrcssed sincc thc sixties. 
wheii efficient purification procedures wcre used to isolatc and then scquencc 
scveral polypeptidic hormones from thc digestive tract. The first of these 
followcd by maiiy others. were mammalian gastrins by Gregory and Tracy 
( l % 4 ) and secretin by V i k t o r Mut t and his collaborators (197()). 
A t thc same time the embryonic origin of the "system of clear cells" as 
described by Feyrter was qucstioned and the initial conception of a diffuse 
endocrine organ was rcinvestigated and devclopcd with new expcrimental 
methods by A . G . E . Pca r sc 
Peaise emphasized the l'act that a number oI' polypeptide-hormone-
producing cells. Iocated mainly in the gut and its appcndages but also in other 
parts of thc body, posscss a common set of cytochemical and ultrastructural 
characteristics(Pearse, l%<S. L969)Tab. 1-1. 
Tiil). 1-1 Cytochemical characteristics of polypeptide-hormone-secreting cclls of the 
A P U D series(from Pcarsc L969). 
(A) 1. Fluorogeiiic amine content (catecholamincs. 5 HTorothcrs) 
(a) primary: (h). secondary uptake 
(I') 2. Amine precursor uptake (>HTP. DÜPA) 
(U) 
(D) 3. Amino acid decarboxylase 
4. High side-chain carboxyl or carboxyamide (masked metachromasia) 
5. Uigh non-specific esterase or cholinesterase (or both) 
Cn High (<-CiPD (a-glycerophosphate mciiadioiie reductase) 
7. Specific immunofluorescence 
5-HT. 5-liydroxytryptamine; >HTP. hydroxytryptoplian: D O P A . 3.4-dihydroxyphe-
iiylalaiiine: c.-(iPD. a-glycerophosphate dehydrogenase 
quoted Irom Rehfeld, J.F. ( IWl) ln: (,"/// Hormones, (S.R. Bloom cv .I.M. Polak. 
eds.), Cliurcliill Livingstone, p. 10. 
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Pcarsc groiiped these eells in the so-eallcd A P U D series. an acronym derived 
Irom the initial Iet tersol their thrce moreconstant and important cytochemical 
properties: A min e content and/or Amine Preciirsor Uptake and Decarboxy-
lation. 
For Pearse. these features indicated closely related metabolic mechanisms 
and common synthetie storagc and seeretion propcrties. O n that account he 
proposcd that thc A P U D cells share a common embryological preciirsor vvhich 
arises from the neural crest. The Iist of cells belonging to the A P U D series, 
limited to 14 cell typcs (including pituitary corticotrophs and melanotrophs, 
pancreatic islet eells. ealcitonin producing cells. earotid body type I cells. 
adrenal medulla and various endocrine cclls of the gut epithclium) in L969, had 
increased to 40 Iess than 10 years later. By then Pearse had included the 
parathyroid and a iuimber ofcells in the gut. Iiing and skin that had been shown 
to produce peptidcs or neuropeptides (Pearsc. L976, 1977). 
In all these cclls thc most characteristic propcrties can bc dcmonstrated by a 
simple cytocheniical test.The L- i somcrof eitlier ofthe two principal aminoacid 
precursors of the fluorogenic monoamines (3,4-dihydroxyphenylalanine 
( D O P A ) forcatecholaniii iesor5-hydroxytrypoptophan (5 -HTP) forserotonin) 
administered intravenously is taken up and decarboxylatcd by A P U D cells. 
Some ultrastructural characteristics arc shared by the A P U D cclls (Pearse. 
L968): 
1. Iow Ievels of rougli (granular) cndoplasmic reticiiluni; 
2. high Ievels of smooth cndoplasmic reticuliim in the form of vesicles; 
3. high content of free ribosomes: 
4. electron-dense, l'ixation-labile mitochondria; 
5. membrane-bound seeretion vesicles with osmiophilic contents (average 
diameter 100-200 um). 
The first test case Ibrt l ic A P U D c o n c e p t was the cell type reportcd by Pearse 
(I96<X) responsible Ior the production of the calcium-regulating l iormone. 
ealcitonin. a Iiormone discovered by Copp and Iiis associates (Copp et a l . . 
1962). The source of calcitonin in the thyroid gland was ideiitified as the 
parafollicular cells which werc then rcnamed C-cells (C Ior calcitonin). 
Fiiially. Pearse's tlieory was that cells of the A P U D series eonstituteil a 
"diffuse neurocndocrine systeni" ( D N E S ) which Iie viewed as a tliird brauch of 
the iiervoiissysteni. "acting with the second. aiitonomic divis ioi i . in thc control 
of the function of all the intestinal organs". (Pearse. 19X0). 
One ofthe implications of the A P U D cell concept was that a common origii i 
Ior a varicty of endocrine cells could account Ibr a niimbcr of associated 
endocrine disorders such as mediillary thyroid carcinomas coneoniitaiit with 
the plieochromocytonie syndrome (Ljimgberg et a l . . 1967). the Zol l inger-
Ell ison syndrome (Zoll inger and El l i son . 1955) and other fornis ofthe so-called 
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multiple endocrine tumors. This cxplains vvhy. although hased only on ver\ 
circumstancial evidence. the A P U D cell concept was widely accepted. 
The neuroectodermal origin of the endocrine cells of the gut epithclium and 
of the endocrine glands (pancreatic islet cells) associatcd with the digestive 
tract is, howcver, a very controversial subjeet. O n thc one hand an impressive 
number of molecular markers have been shown to be sharcd by ncurons and a 
varicty of thcsc polypcptide hormone producing cells. thus pleading for thc 
existence of a common embryological anccstor. from vvhich. in a terminal 
differentiation state, sevcral cell types would have emerged. O n thc other 
hand. precise cell tracing tcchniques applied on the avian embryo, an 
experimental model particularly favourable for this type ofanalysis, have failed 
to confirm the implication ofectodermal cells in histogenesis ofthe gut related 
endocrine organs.These two sets of data wil l be briefly analyzed in this chapter 
from a devclopmental vicw point. 
1.2 The Use of Molecular Markers to Study Cell 
Lineages 
It is often assumed that whcn different ccll types divergc Irom a common 
progenitor cel l , ecrtain metabolic characteristics are eonserved and therefore 
can be considcrcd as markers of their kinship.This may or may not be true and 
should regarded only as an indication o fa possiblc common origin essentially 
.iecau: when carefully examined. most of thc markers do not show the strict 
eell-typ specificity that one should expect in such a case. 
For exampie, the most characteristic common property of A P U D cells, i.e. 
decarboxylation of the aminoacid precursors of Iluorogcnic monoamincs 
' D O P A and 5 H T P ) is due to the prescnce in these cells of an L-aminoacid 
decarboxylase ( A A D C ) . T h i s enzymc is prcscnt in thc ncuroepilhelium of the 
basal plate of brain and spinal cord of young rat cmbryos. Howcver. during 
development, it is not restricted to neural and endocrine cells since it is also 
transiently expressed by othcr tissues of mesodcrmal origin such as notochord 
and musclcs as well as in pancreatic acinarcclls . the endodermic origin o l w h i c h 
is univcrsally aecepted (Teitclman et a l . . I cASl). 
Another proposed marker for A P U D cells is a Cholinesterase. In chick 
embryos. a specific acetylcholinesterase ( A C h E ) is found in developing 
pancreatic endocrine cells. in some unidentified cells in the gut groove (Drews 
et a l . . 1967). in the ncuroepithclium ofthe basal plate ofthe neural tube. and in 
thc neural crcst (Cochard and Coltey. 1983). A t Iater stagcs. howcver. A C h E 
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does not rcmain confincd to neural and neuroendocrine cclls; tlius its status as a 
molecular marker for thc D N E S is doubtful. 
Ncuron-specific enolase ( N S E ) , an enzyme prescnt in nervc cells ( Marangos 
et a l . . 1978), is also found in some cclls of the diffuse endocrine system 
including entcro-chromaffin cclls and the pancreatic islct cclls (Schmechcl ct 
a l . . 1978; Falkmeret a l . , 1984). Hovvevcr, N S E has been dctcctcd in othercel l 
types, such as mcgakaryocytcs and platelets (Marangos et a l . , 1980). 
Thcre are howcver other molecular features strikingly common to ncurons 
and endocrine cc l l s .This is thc case for synaptophysin, an integral mcmbrane 
glycoprotcin localized in presynaptic vesicles of ncurons and in similar vcsicles 
ofthc adrenal mcdulla. It wasalso repor tedtobc prescnt in pancreaticislet cells 
and in a variety c>f epithelial tumors including islet-cell adenomas. neuroendo-
crine carcinomas of thc gastrointcstinal and bronchial tracts. and medullary 
carcinomas of the thyroid (Wiedcnmann ct a l . . 1986). 
Reccptors for tctanus toxin and for the monoclonal antibody A 2 B 5 . which 
identify specific gangliosides present on nerve cclls and astrocytes, have also 
been found in the endocrine pancrcas (Eisenbarth et a l . . 1982). 
SimilarlyTeitelman and Lec (1987) reported that tyrosine hydroxylase ( T H ) 
the first enzyme in the catccholamine ( C A ) biosynthetic pathway. is transicntly 
produccd by all pancreatic islet cclls but nevcr in acinar cxocrine cells. 
Moreovcr . a detailcd Iineage analysis of the endocrine cclls of thc pancreas 
has been performcd during ontogeny of transgcnie mice earrying hybrid genes 
in which the 5* regulatory scqucnce of the rat insulin gene was Iinked to the 
coding sequence of simian virus (SV40) l a rgeTant igen (Tag) (Alpert ct al. 
1988). 
Alpert et al. found that islct cells syn thcs iz ingTH plus glucagon, somatos-
tatin, or pancreatic polypeptide coexpressed thc transgene when they first 
arose. A dcvelopmcntal lineage is proposed for the pancreatic islct cclls on thc 
basis of coexpression at an carly stage of genes, the aetivity of which is Iatcr 
rcstricted to distinct eell types. A prccise chronological sequence is established 
for the diffcrcntiation o fa l l dcfincd islet ccll types from a common pluripotent 
ancestor. able to transcribe not only thc glucagon and insulin gcnes but also the 
T H gene. 
Surprisingly, lhese authors also found that Tag was present transiently in thc 
developing ncrvous system specifically. in some neural crest cells and in thc 
basal plate of the neural tubc. the rhombcncephalon. rostral mescncephalon 
and diencephalon. It is noteworthy that monoaminergic systems, producing 
serotonin and eatecholamines. subsequently dcvclop in some of thcse loca-
tions.Thesc obscrvations rcinforce the long-standing suggestion that the isIct 
cells may be derived from neurectodermal precursors rathcr than from thc 
endoderm. 
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However, although tIic Iist of molccular markers common to the nervous 
system and thc polypeptidc-hormone-producing cclls of thc A P U D scries is 
imprcssivc and may be suggestive that these cells share a common ancestor, this 
cannot be taken as proof sincc therc is no obligatory anccstral relationship 
between cells expressing the same structural gcnes. 
Definitive evidcnee for kinship within a common Iineage for diverging 
histiotypes can come only from either clonal analysis. if the developmental 
potcntialitics of embryonic cells are evaluated in single cell-dcrived colonics in 
vitro (e.g. Baroffio et a l . , L988; Dupin et a l . . IWO for the neural crcst, sec also 
/// vivo stLiclies. Bronner-Fraser and Frascr. 19<S<S, 1989), or from the use of 
embryological cell tracing techniques. 
1.3 Cell Tracing Methods Applied to the Problem 
of the Origin of the DNES 
In the 197()s, using thc newly developed quail-chick marker systcm.wc havc 
carried out studies to determine which, if any. of the A P U D cells could be 
derivcd from precursors in the neural crcst. No doubt remained about the 
ectodermal origin of thc adrenal medulla, or of the pituitary gland, since the 
hypophyscal placodc (which latcr bccomes the Rathke's pouch) appeared 
closely related in its mode of formation to thc neural anlage. Recently. its 
presumptivc territory at carly somitic stagcs has becn vcry prceiscly Ioealized to 
the most anterior rcgioii ofthe neural fold, in continuity with the neural plate 
area destincd to form the hypothalamus (Couly and Le Douar in , 19<S5. 
I9,S7). 
By using the quail-chick chimera system. the neurectodermal origin of 
carotid body cells and ofthe glandularcomponents ofthe ultimobranchial body 
( U B ) . the rolc of which is to produce ealcitonin (C-cclls) , proposed by Pearse. 
nnnnnnnn 
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Fig. 1-1 Chimeric emhryos were constructecl by substituting the rhombencephalon of a 
chick by its counterpart at stage 6- to lO-somites. 
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was confirmed. C o n v c i g c i i l data from our group and A n n Andrew 's Iaboratory 
liowever. invalidated the Iiypotliesis of a possiblc derivation of the pancreatic 
islets and of thc Iiormone prodiieing cclls of the gut epithelium from the neural 
crest. 
The carotid body which plays a role as chemorcceptor is a paired glandulär 
Structure Iocated close to the carotid artcry and parathyroid glands. Investi-
S-
... •,» 
2 b 
Fig. 1-2 Carotid body of a L4-day-old chick embryo which Iiad received at the IOsomite 
stage a graft of a quail rhombencephalon. a. FIF technique shows a bright greenish 
fluorescence in the gland. b.The Feulgen and Rossenbeck stainiiig shows that all the 
Iluoreseent cells Iiavc thc quail nuclear marker. 
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gations on thc origin of thc carotid body bascd mainly on thc classical 
techniques of descriptive embryology had produced iintil thc sixties contro-
vcrsial results. Accord ing to Rogers (1965) the first visible sign of the 
developing carotid body is a "primary condensation ofcel ls"of unknown origin 
"on the third aortic arch". 
Type I cells that contain dcnse core granules. vvhcn subjected to the 
A P U D - F I F proccdurc, show positive fluorescence essentially duc to 5 H T in 
chicken (with a yellowish colour) and dopamine in the quail (grecn fluores-
cence) as shown by Pcarse et al . (1973). 
Chimeric embryos were constructed by substitutingthc rhombencephalon of 
a chick by its quail countcrpart at stage 6 to lO-somites (Fig. l - l ) . T h c neural 
crest cells migrating from the graft invaded the branchial and g landulär 
structurcs(Lc Douar in ct a l . . 1974; L e L iev rcand Le Douar in . 1975; L e Lievre . 
1974). Under thcse cxperimental conditions the carotid bodies (cxcept for 
endothelial cells) wcre entirely derived from the graftcd neural c rcs t .When 
trcated consccutivcly for F I F and for Feulgcn nuclcar Staining proeedures, thc 
carotid body cells of such chimaeras exhibitcd a bright grecnish fluorescence 
eharacteristic of quail type I cclls and thc hctcrochromatin rieh nueleoli of the 
quail nuelci (Le Douar in et al . 1972; Pearse et al. 1973) (Fig. 1-2). 
Microspectrofluoromctric analysis of thc biogcnic amine content of the carotid 
body type I cells of thc chimaeras revealed the prescnce of dopamine as in the 
normal quail carotid body. A t the clectron microscope lcvel , thc type I cclls 
contained small dcnse corc granules and had the quail nuclear marker 
indicating that these cclls originatcd from the neural crest. 
Similar results wcrc obtaincd for the C cells ofthe U B in these expcriments. 
Thc C cells of the grafted embryos were charactcrizcd by 1) the observation of 
formol induecd fluorescence rcsulting from thc prcscncc of fluorogcnic amincs 
2) the prescnce at thc elcetron mieroscopic lcvel ofclcctron dcnse corc granules 
and 3) a positive immunocytochemical reaction to anti-calcitonin antibody 
along with the quail nuclear marker attesting their origin Ironi the neural 
crest. 
In manimals. a differeiit stratcgy was used to trace the parafoIlicular cells of 
thc thyroid glaiids back to their origin from thc branchial arcli mesectoderm 
derived from the neural crest. In mammals. the U B joins thc thyroid gland 
when its rudimeiit migratcs caudally during neck morpliogcnesis (Pearsc and 
Carvall ieira. 1967; Stocekcl and Porte. 1970). Ult imobrancl i ia l cclls then 
invade the thyroid and beeomc distributed mainly between the folliclcs.where 
they are ternied parafol l ieularorclearcel ls , although they are sometimes also 
insertcd into the follicular epithclium itself. 
Cells with A P U D cliaracteristics havc bcen described in thc early niouse 
enibryo in the vicinity ofthe fourth pharyngeal pouch and have been claimcd to 
be C-ccl l precursors on thcir way to thc ultimobrancliial body endoderm 
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(Pcarsc and Polak. 1971 ).without proof, howevcr, oftheir neural crcst origin or 
ulterior fatc. One of us (Fontaine, 1979) reinvestigated tIiis question. The 
pharyngeal region of 18- to 45-somite mouse embryos was dissccted, in order to 
isolate the thyroid rudiment (Tab. I-IF scries A ) . 
In a separate series ofanimals , the thyroid rudiment remains associated with 
the last pharyngeal pouches (Tab. l - I I . scries B , C . D ) . In both cases. the 
pharyngeal regions so defined were transplanted for about 14 days on the 
chorioallantoic membranc of chick embryos used as a eulturc "medium". In 
scrics B (Tab. l-II) the endoderm and the mescnchyme of the thyroid and 
branchial pouches were ineluded in the explants, while in series C the 
mesenchyme was rcmoved at the level ofthe branchial pouches; finally in series 
I) the mesenchyme was present but the endoderm of the last pouch was 
rcmovcd. 
C-cc l l differentiation was dctected in the cxplants by application of the FIF 
technique aftcr L - D O P A injection and also by elcctron microscopic observa-
tion of the tissucs. N o C-cclls developed in the thyroid rudiment cxplantcd 
lab. 1-2 Ditlerent types of explants and the presencc of C-cells in the thyroid gland 
after 14 days in graft on the chorioallantoic membrane of 6-day-old chick embryos. 
Type of explant 
Sene< 
Siages of operation 
From 11 
IO 25 
somites 
Ffom 25 
lo 28 
somites 
F rom 30 
Io 45 
somites 
Rerults 
C c e l l differentiation 
0 L 0 J 1 = ö L " J v ; o <x7 
BP Ist 
2nd 
3rd 
y 4th 
V , t f 
O i 0 , 0 =^= 10 23 (100',.) 
^r-V? 
°:o;= M r = ^
3 
1 7 4 
l24",,l 
39 
39 
1100',.l 
?jO'lP_ 
48 _-_ 
•r 
l86%l 
5 
l49",.l 
Endoderm Mesenchyme P J BP1 hranchial pouch 
' Nurnerals indicate number of cases throuqhout 
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alonc (Fig . 1-3). whercas thcy wcrc prcscnt in evcry case whcn the completc 
Lil t imobranehia l body primordium was included in the graft (Fig. 1-4). Series ( ' 
and D indieated in addition that the preeursorC-eellswere mainlydistributed in 
thc mesenchymal component of the branchial arch iintil the 28- somite stagc. 
Thercaf'ter. and during a short per iod of time corresponding to 28- to 30-somite 
Fig. 1-3 Thyroid tissLie resulting from the evolution ol' the median thyroid bud 
(endoderm + mescnchymc) of a 25-somite mouse embryo grafted during 14 days on 
chorioallantoic membranc ot'a 6-day-old chick embryo.Treatmcnt bv the FIF technique 
alter injection of F-D()PA. No Iluorescent cells are present in the gland. 
Fig. 1-4 Resultofthegraftofthemedianthyroid(endoderm ( mesenchyme)togethcr 
with the Iast pharingeal pouches (endoderm t mesenchyme) Irom a 25-somite stage 
mouse embryo. Numerous fluoreseent C cells are prescnt in the thyroid. FIF tccliniqiic 
alter injection of F -DOPA. 
Fig. 1-5 Thyroid developed in graft from an explant comprisingthe median thyroid Innl • 
(endoderm I mesenchyme) and the endoderm of the tliird and Iourth branchial 
pouches ol' a 2()-somite mouse embryo. The rudiment was grafted Ior 14 days on Ihe 
chorioallantoic membranc ol'a 6-day-old chick embryo. (a) The glandulär lissue was 
totally deprived ofcells containing fIuorogenic amines. FIF technique aller injection of 
L-I)()PA. (b) Ihe same section stained with PAS-hemato.xylin showed iiumerous 
colloid-containing follicles. 
Fig. 1-6 Same experiment as in Fig. 1-5 carried out at 3l-somite stage. (a) The thyroid 
gland contained Iluorescent cells. (b) Same section stained with PAS-hematoxylin. A 
Iew thyroid follicles havc diffeientiated. 
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stagcs, the presumptive C-cclls invaded the endoderm of the last pouch vvhere 
they remaincd imtil the U B bccamc confliicnt with the thyroid (Figs. 1-5. l-6, 
1-7. l-cS). Sincc the branchial arch mesenchyme has bcen shown to originate 
mostly from the neural crcst in mammals as well as in birds (.lohnston. 1966). 
one can conclude from thcse cxperimcnts that thc final Iocalization ofC-eells in 
the thyroid gland involves a multistep migration, first from thc neural 
primordium to the branchial arch mesenchyme. then from the latter to the 
endoderm of the ultimobranchial rudiment, and finally from the ultimobran-
chial body itsclf to the developing thyroid. 
These results support Pearse's hypothesis of the non-endodermal but neural 
crcst origin of the C-cclls in mammalian as well as in bird embryos. 
Interestingly. Barash ct al . (19<S7) havc reccntly shown that ciiltured C-cells 
from aduIt shccp thyroid respond to the ß subunit of nerve growth factor by 
cxtending neurites and switching expression from ealcitonin to calcitonin-
genc-related pcptide ( C G R P ) . a peptidc also found in a number of neuronal 
cell types in both thc central and peripheral nervous systems. C-cclls thcrefore 
share with adrenomedullary cells a common origin from thc neural crest and a 
common response to nervc growth factor. 
In contrast with the above mentioned ccll typcs (carotid body type I cells and 
C-cclls) . the hypothesis o f a neural crest origin has bcen shown to be untenable 
for the endocrine cells of the panercas and of the gastrointcstinal mucosa that 
secretc polypeptide hormones or ncuropeptides. 
From descriptive studics,which can only yield ineonclusive data, endocrine 
cells werc claimed to bc derived from ganglion cclls of thc autonomic system 
(Danisch. 1924; Chung, 1934). But Simard and Van Campcnhout (1932) 
observcd that no nervous cIements arc prcsent in thc intcstine ofehick embryos 
pr ior to 32 hours ofincubation,whcreas intestinal endocrine cells differentiated 
in ehorioallantoic grafts ofgut primordia taken from 82 hour embryos. Andrew 
(1963. 1974) isolated from the head-process- to thc 22-somitc-stage cliick 
embryos, embryonic territorics with gut potcncics plus or minus the neural 
crcst arca. Aftcrcul ture on thc ehorioallantoic membranc, most ofthe cxplants 
Fig. 1-7 Thyroid developed in graft from an explant coniprising Ihe median thyroid bud • 
(endoderm + mesenchyme) and the mesenchyme ofthe third and fourtli pharyngeal 
pouches of a 22-somite mouse embryo (14 days in ehorioallantoic membranc graft). (a) 
The thyroid shows fluorescent C-cells. some of which were iiisertcd in the follicle 
epithclium. I7IF technique after injection of I .-DOPA. (b) Thc same section stained 
with PAS-hematoxylin reveals that the glandulär tissue differentiated normaIly. 
Fig. 1-8 Sameexperiment asiii Fig. l-7carriedout a30-somitestage. (a)Theglandular 
tissue does not contain fluorescent cells. FIF technique after injection of F -DOPA. (b) 
The same section stained with PAS-hematoxylin. 
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exhibited well-developed intestinal structurcs, all showing enterochromaffin 
ccl ls ,whilc enteric ganglia,were prescnt only in explants that ineliided the crest. 
Thcse experiments strongly siiggcsted that the neural crest is not the sourcc of 
c n t e roc h ro ni a ffi n cc 11 s. 
<t 
* 
10 
Fig. 1-9 Intestinal structurcs whieh developed in the explants composed of chiek 
endomesoderm and quail ectoblast ofquail.The association ofthe two germ laycrs was 
performed at stage 6 of Hamburger and Hamilton and the explant was cultured for 14 
days. Ouail cells originatiiig Irom the neurectoderm have migrated iiito the gut 
structures and have given rise to the enteric ganglia (EG) , but no quail cells are seen in 
the gut epithclium. Feulgen-Rossenbeck staining. 
Fig. I-IO Immunoeytoehemical Iocalization of somatostatin. Samc cxperiment as in 
Fig. L-9.The gut epithclium contains immunoreactivc endocrine cells. 
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By mcans of isotopic and isochronic transplantations of fragmcnts of thc 
quail neural primordiuni into chick embryos (or vicc vcrsa). at all thc levcls of 
thc neural a.xis Le Douar in and Teillct (1973) showed that, although cells do 
niigrate into the gut from the neural crest (two privileged rcgions. the "vagal" 
level locatcd bctwccn somitcs 1 to 7. and the "lumbosacral" arca caudal to the 
level of somite 28 give risc to thcse gut-seeking cells). none reaches the 
endodermal epithclium. Rathcr the invading crest cclls differentiate into the 
enteric ganglia of Auerbach's and Meissncr"s plexuses; they do not colonize thc 
endoderm,which nevertheless contains cclls with A P U D charaetcristics (Figs. 
1-9. 1-10). 
The possibility that these cells might be derivcd from the neurectoderm at a 
stage prececding the onset of the neural crest structure was thereafter tcsted 
expcrimentally (Fontaine and Le Douar in , 1977).Thc endomesoderm ofchick 
embryos was associated with the ectodcrmal germ Iayer ofquai l blastoderms at 
various stagcs including the formation ofthe primitive streak. the head-process 
and the neural plate, ranging from 12 to 24 hours of incubation. The 
recombined embryos were eitlier cultured in viir<> or on the ehorioallantoic 
membrane and the intestinal structure which developed in the explants was 
analyzed forchimaerism usingvariouscytochemical techniques: FIFtcehniquc 
after L - D O P A injection. Icad haematoxylin, silver staiiiing to indieate 
argentaffinity and argyrophily, all combined with the Fculgen-Rossenbeck 
reaction. 
In all cases enteric ganglia originatcd from thc quail ectoderm. but the 
enterochromaffin as well asotlier A P U D c e l l s . w h i c h developed normally in the 
epithelium,were always ofchick type.Therefore. iio niigration ofcells from the 
ectoderm into the endoderm appeared to occur before formation ofthe neural 
crest.Thus a neureetodernial origin for the endocrine or paracrinc cells of the 
gastrointcstinal tract epithclium iiiust be cxcluded. 
The Iiypothcsis o fa neural crest origin Ior the pancreatic endocrine cells Iias 
also been tested in avian embryos subjected to isotopic and isochronic 
transplantations of the neural pr imordium. Such grafts were niade from quail 
into chick embryos at the vagal Ievel ofthe neuraxis. Subsequently small groups 
ofqua i l cells were found in the pancreatic tissue but did not correspond to thc 
islets of Langcrhans (l.e Douarin and Tcillet . 1973). Fontaine et al. (1977) 
studied the type of dilfercntiation expressed by these cells and observcd that 
the clusters of quail cclls were always separate Ironi both exocrine and 
endocrine structures.They were subjected to the F IF technique alter L - D O P A 
injection. and their affinity for Iead haematoxylin was investigatcd.The cells 
originating from the neural erest. identified by the nuelear marker, did not 
exhibit the cytochcmical propcrties of pancreatic endocrine cclls. In fact. the 
crest cells that Iiad migrated into thc pancreas. differentiated into parasyiiipa-
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thctic ganglia, as demonstrated by silver impregnation lecliniqiies (Fig. 
1-11). ' 
Antisera directed against glucagon. iiisiilin and somatostatiii. niarking 
rcspectively A - . B - and D-eells. were applied to the chimaeric panereas. A s in 
prcvious assays. the endocrine cells so identified never carricd the quail marker 
(Fontaine-Perus et a l . . 198()).The samc type ofexperiment was perfornied by 
Andrew (1976). who grafted labelled neural crest cells in chick-quail embryo 
chimeras and followed their fate in thc panercatie rudiment in 3—l-day hosts. 
Although pancreatic differentiation is not yct fullyexpresscd at this stagc. some 
cells with A P U D characteristiescan alrcady be distinguislicd (Andrew, 1974) in 
the pancreatic bud, and iionc of them was ever labelled with the crest cell 
marker. 
Dietcr lcn-Lievre and Bcaupain (1976) reached similar conclusions througli 
anotlicr cxperimcntal approach in which fragments of the splaiicliiiopleurc 
Fig.l-11 Application of silver impregnation technique on the chimeric pancreas 
showing that the neural crcst cells which migrate into thisorgan differentiate into nerve 
cclls. Section throught the panereas of a 14-day-old cliick which had received at the 
7-somite stage an isotopic graft of quail neural tiibe at thc lcvel of thc Isl to thc 7th 
somite.The group ofquail cclls is associated with a Iarge bundle of nerve fibers. 
I.."> Rcfcrciiccs \{) 
(endoderm plus mesoderm takcn at thc prcsumptivc pancreatic lcvcl from 
embryos with from 8 to 15 pairsof somites) werc transplanted into the coclomic 
cavity of 3-day chick embryos. Immunocytochcmical loealization of insulin-
and glucagon-producing cclls was performed in the cxplants, showing that 
these cell types devclop in thc abscnce of ncurectodcrmal cells. 
A simiIar stategy was uscd in the mammalian embryo by Pictet et al . (1976). 
Nine-day rat embryos (prior to the 4-somite stage) were trcated with a solution 
of trypsin-pancreatin: thus the wholc ectodcrmal shcct was pecled off. A t this 
time thc neural groove has not closcd and the neural crcst is not yct formed.The 
mesendoderm was then cultured for 11 days; in cvery casc with a devcIopcd 
pancreas, insulin was dctcetcd and B-cells were idcntificd. Thercforc, as in 
other experimcnts reportcd abovc. a neural crcst origin of pancreatic islet 
B-cells is disproven. 
1.4 Concluding Remarks 
In conclusion, onc can say that. in contrast to thc unifying hypothesis proposcd 
by Pcarsc. as tempting as it may be, the polypeptide hormone producing cells 
distributed in dispcrscd Iocations throughout the body do not all share a 
common cmbryological origin from the ectodermal germ laycr. Certain ofthese 
cclls arc indeed derived from the ridgcs of the initial neural primordium i.e. 
from thc neural folds either anterior for the pituitary or lateral for thosc 
originating from migratory neural crest cells. Howcver. the endocrine cells 
associatcd with the digestive tract including the gut epithclium and thc 
pancreas. could not be traccd back to the ectoderm as it exists when 
gastrulation is eompleted. 
Such convcrgencc ofdifferentiation phenotypes arising from diffcrcnt germ 
Iayers in fact is not cxccptional in embryonic developmcnt. One other striking 
case concerns some boncs of the face (e.g. thc frontal) that is Iormcd by cells 
arising both from ectoderm and mesoderm ( L c L icvre . 1971). 
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2 Membrane Proteins of Synaptic 
Vesicles: 
Markers for Neurons and Endocrine 
Cells; Tools for the Study of 
Neurosecretion 
ReinhardJahn and Pietro De Caniilli 
2.1 Introduction 
Interccllular signalling in thc ncrvous system is mediated Iargcly by hydrophilic 
molecules, the neurotransmitters, which are released from presynaptic nerve 
endings upon Stimulation. Two classes of neurotransmitters can be distin-
guished: small , non-peptide molecules (often referred to as classical neuro-
transmitters. e.g. acetylcholine, catecholamines and certain amino acids). and 
thc peptides. It was formerly bclieved that non-pcptide ncurotransmitterswere 
thc onlv transmitters in most synaptic terminals of thc central and periphcral 
nervous system and that peptides werc confined to a small number of 
specializcd ncurons. Rcccntly, evidence has accumulated showing that most. 
and perhaps a l l . nerve terminals are capable of secreting a variable cocktail of 
molecules including botli classical and peptide neurotransmitters (Hökfel t et. 
a l . , 1986). 
It is well establishcd that neurotransmitters are stored in sccrctory vcsiclcs 
which undcrgo calcium-dependent exocytosis upon stimulation. A t lcast two 
types of morphologically distinct secrctory vesicles exist in ncrve terminals. 
O n c typc is reprcsented by small . highly homogeneous vesicles.with an average 
d iamete rof50 nm in the mammalian nervoussystem (Peterset a l . . 1976).They 
are referred to as SSVs (small synaptic vesicles) and are thought to be involved 
only in the storage and secretion of classical neurotransmitters. They are 
translucent when observcd in thc electron microscope. Howevcr. catecholam-
ine-containing SSVs acequirc a dcnse corc under certain fixation conditions 
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(Kle in et a l . , 1982; Hökfel t et a l . , l986) .The sceond type is rcprcscnted by 
Iarger vesicles (70-200 nm diameter) whieh contain an clcctron-densc corc. 
Thcsc vesicles, rcfcrred to as L D C V s (large dcnsc corc vesicles), are the storage 
organelles ot' neiiropcptides but may in additioii also contain classical 
neurotransmitters. L D C V s arc particularly coneentrated in nerve terminals of 
certain parts of the brain (e.g. the hypothalanius) but are prcscnt in variable 
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Fig. 2-1 Proteins l'roni mammalian SSVs. separatetl by SDS-polyacrylamide gel 
electrophorcsis (9-13% graüient gel) and visualizetl by staining with Cooniassie Hlue. 
I.ane A shows thc profile of IiighIy purified SSVs (method of Nagy ct al. (1976) with the 
modifications by Huttner el al.. 1983; see also Fig. 2-2). This was followed by Ihe 
separation ofdetergent-binding protcins (lane B. mostly integral membranc protcins) 
from mcmbrane-associated proteins (lane C) using tlieTriton X-114 procedure.The 
protcins were identified with the aid of monospecific antibodies or by N-terminal 
sequencing (only glutaraldehyde-3-phosphate dehydrogenase [GAP-DH]) .The bands 
corresponding to the positions of synapsin IIa and tubuIin/synapsin IIb contain 
additional unidentified proteins. Note that thc G-protcin. rab3, codistributes with the 
integral membranc proteins despite the Iack of a membrane-spanning domain which is 
probably due to a Iiydrophohie posttranslational modification. See text fordetails. For 
methods sec Baumert et al. (1989). 
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i H i m b c r at most synapses of the central and peripheral nervous system and may 
be prcsent in cvcry ncrvc cell (for review see Peters et a l . . 1976; K l c i n et a l . , 
1982; Hökfel t et a l . . l 986 ;Thureson-Kle in and K l e i n . 1990). 
In thc last fcw ycars, significant progress has bccn madc in elucidating the 
molecular composition of SSVs. Prcsently. the membranc composition of SSVs 
is better characterized than that of any other secrctory organelle.This is due to 
the application of modern techniques of immunochemistry and molecular 
biology. SSVs share a group of abundant membrane proteins with unique 
structural propcrties which are highly specific for these organelles (Fig. 2-1). 
Al though the function of none of these protcins is conclusively established, 
their idcntification and charactcrization allow ncw expcrimental approaches 
for the solution of problems not acccssible bcfore. For example. thc pathways 
for vesicle biogencsis. recycling and dcgradation arc being studied using thcsc 
proteins as markers. Some of thcse studics have Ied to new conccpts concerning 
the membranc dynamics involved in thesc processcs. In contrast. the data 
concerningthe membranes of L D C V s are still l imited and mainly restricted to a 
few acccssible. highly specialized. model systcms. 
In this rcvicw,wc wil l summarize thc current information about structurally 
identified protcins of synaptic vesicles focussing on thosc prescnt in mammal-
ian SSVs. 
2.2 Membrane Proteins of Small Synaptic Vesicles 
(SSVs) 
2.2.1 Preliminary Remarks 
A n cssential prercquisite for the study of synaptic vesicle proteins is thc 
availability of synaptic vesicle Iractions in suffieient quantities for biochemical 
analysis. Purification protocols wcre first developed for mammalian brain (De 
Robcrtis et a l . . 1963; Whit taker ct a l . . 1963. 1964). Later, synaptic vesicles 
from the electric organ of electric rays. which are piircly cholinergic. were 
established as a model system and studied in detail (for revicw see Kel ly et a l . , 
1979; Whittaker. 1984; Z immermann . 1988; Whit takcr. 1988). Majorefforts 
werc made to evaluate thc dcgrcc of contamination of thcse vesicle prepara-
tions by other membranes. using acetylcholine content as a marker for SSVs. 
Acctylchol inc storage appears to survive prolonged isolation procedures 
(Whit takcr et a l . . 1964; Z immermann . 1982; Whittaker. 1988), in contrast to 
that of amino acid transmitters (Burger et a l . , l989).These studics resultcd in 
csscntially pure and homogeneous vesicle preparations (for revicw sce 
Fig. 2-2 Electron micrograph illustrating the morphologieal homogeneity of mammal-
ian SSVs purified as in Fig. 2-1. Although many other purilieation protocols are 
available. this preparation is thoroughly characterizetl and remains a reference standard 
for the purity of mammalian brain SSV preparations. Reprodueed from Huttner et al. 
(1983) by eopyright permission of the Rockefeller University Press. 
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Zimmermann, L982). Preparations of similar purity arc also available from 
mammal ianbra in (c .g .Nagye t a l . , 1976;Huttncret a l . , L 9 8 3 ; H e l l e t a l . , 1988; 
Burgcr et a l . . 1989; sce Figs. 2-2 and 2-3) althougli these vesieles arc probably 
heterogencous with rcspect to thcir neurotransmittcr content. 
Two different approaehcs have bccn adopted to study synaptic vesicle 
protcins. First, functional propcrt icsofisolated vesicles werc investigatcd using 
cnzyme or transport assays.Thcsc studies Ied to thc identification of various 
activities which arc associated mostly with thc uptake and storage of 
•., > 
>. 
Kig. 2-3 Electron micrograph showing the morphology of SSVs which were isolated by 
immunoadsorption. Methacrylate microbeads were used as immunosorbent which 
contained covalently-bound monoclonal antibodies directed against synaptophysin on 
their surface.This procedure allows the rapid purification ol' small amounts of SSVs 
under mild conditions in a fraction of the time required by conventional protocols 
(Burger et al.. 1989).The purity is comparable to that of the preparation of Huttner ct 
al. (1983). Reproduced Irom Burger et al. (1989) by copyright permission of Cell 
Press. 
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neurotransmitters. It was shown that isolated synaptic vesicles contain uptake 
systems for acetylcholine (Koenigsbcrger and Parsons, 1980; Giompres and 
Luqmani , 1980; Diebler and Morot-Gaudry, 1981), monoamines (for revicw 
sce Phil ippu and Matthaei , 1988), glutamatc (Disbrow et a l . , 1982; Nai to and 
Ueda . 1983). G A B A (Hel l et a l . , 1988; Fykse and Fonnum. 1988) and glycinc 
(Kish et a l . , 1989) which are cnergized by an electrochemical proton gradient 
(for rcview see Njus et a l . , 1986; Marshal l and Parsons. 1987; Phi l ippu and 
Matthaei , 1988;Johnson. 1988 ;Maycoxe ta l . , 199()).Thisgradicnt isgencratcd 
by a proton pump of thc vacuolar type present in thc vesicle membranc (see 
section 2.2.9). In addition, catecholamine containing SSVs appcar to contain 
proteins involved in thcir biosynthesis, notably cytochrome b~,M and dopamine 
ß-hydroxylasc (see section 2.3.2). Cholinergic vesicles were studied in more 
detail and possess, in addition to the proton pump and thc acetylcholinc carrier. 
a transport system for A T P which is atractylosidc sensitive (Luqmani . 1981). 
Furthermore, an ATP-dcpendcnt C a f l uptake system (Israel et a l . . 1980; 
Michaclson ct a l . , 1980), ion channels (Rahamimoffet a l . , 1988) and various 
ATPase activities havc been reported in studies on SSVs. It is unclear.whether 
these activities rcprcscnt vesicular enzymes or are due to contamination by 
other subcellular fractions (see e.g. Whit takcr , 1988) or. in the easc of the 
ATPases . reprcsent atypical states of the vesicular proton pump (sce section 
2.2.9). Most ofthis work was covcred exhaustivcly in scveral rccent rcvicws to 
whieh the readcr is refcrred (Ke l ly et a l . . 1979; K l c i n ct a l . , 1982; Whittaker, 
1982; Rcichardt and Kel ly , 1983; Z immermann , 1988; Whittaker. 1988).With 
cxccption ofthe proton pump (section 2.2.9), cytochrome b%| (section 2.3.2), 
dopamine ß-hydroxylase (section 2.3.2) and candidates for the monoaminc 
carrier (section 2.3.2) and the ATP-transporter (section 2.2.10.2). nonc of the 
protcins responsiblc for these transport activities has becn identified. 
Second, major proteins of S S V membranes werc characterized in order to 
identify molecules of functional significance. It is elcar that all specific 
interactions of SSVs with other eellular components during exo-endocytotic 
membrane cycling must bc mediated by specific protcins present on thcir 
sLirfacc or in their membranc. Such protcins may therefore possess specific 
fcatures rcsponsible for binding of calcium, interaction with the synaptic 
cytoskeleton. recognition of the plasma membrane, membranc fusion etc.. 
Howcver, none of the proteins responsible for such activitics havc bccn 
identified with certainty. For these reasons. structiiral characterization of thc 
major SSV membranc proteins shoiild allovv the development of improvcd tools 
for functional studies. 
The structural characterization of S S V proteins was largely based on the 
biochemical analysis of purified S S V fractions. In addition. some S S V protcins 
were discovercd by sercndipidy in primarily unrclated studies (e.g. synapsin I or 
p65). In a varicty of studies. synaptic vesicle proteins wcre analyzcd by one and 
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tvvo-dimcnsional electrophoresis or lcctin binding to idcntify their main 
eonstitucnts (e.g. Stadler and Tashiro, 1979; Zisapel and Z i i r g i l , 1979; Zanetta 
et a l . . 1981; Smith and L o h . 1981; March et a l . . 1987). Al though these studies 
provided usefiil information about some major proteins. thcy are difficult to 
compare with each other. In addit ion, the concliisions in somc of these studies 
were compromised by inhcrent problems of vesicle purity, by artificial 
adsorption of proteins di ir ing S S V isolation (e.g. proteins of thc cytoskeleton: 
Zisapcl et a l . , 1980; scc F ig . 2-1) and by difficiiltics in identifying individual 
componcnts in impiire fractions. Wc wil l thcrcfore restrict our discussion to 
identified proteins which mcet at lcast some of the following critcria: 
- monospecific antibodies or other specific probes are availablc for their 
study 
- their presence on SSVs is demonstrated by immunocytochcmistry at the 
electron microscopical level 
- their interaction with thc vesicle membrane is sufficiently specific to rule out 
artificial association 
- they copiirify with other synaptic vesicle markcrs using statc-of-the-art 
vesicle purification protoeols 
- structural data arc availablc from peptidc or c D N A scc|uencing. 
2.2.2 Synapsins 
Thc synapsins are representcd by a family of foiir homologous proteins, 
synapsin Ia and Ib and synapsin IIa and IIb (previoiisly refcrrcd to as protein 
IIIa and IIIb) which are associated with the cytoplasmic surface of SSVs .They 
wcre first identified as major substratcs for cndogenoiis phosphorylation 
activity in thc mammalian brain (Johnson et a l . , 1972; Ueda et a l . , 1973; Forn 
and Greengard. 1978; Huang et a l . , 1982). Subsequent studies Ied to thc 
conccpt that they aet as a link between SSVs and an actin-bascd cytomatrix of 
ncrve terminals, thus controlling the availability of SSVs Ior exocytosis (for 
rcview of thc oldcr Iitcraturc sce Nestlcr and Greengard. 1984; Dc Camil l i and 
Grcengard. 1986). 
2.2.2.1 Structural Properties 
Svnapsin Ia and Ib (collectively rcfcrred to as synapsin I) are major protcins of 
SSVs. rcprescnting approximatcly 6% of vesicle protcin and 0.4 % of total 
p r o t e i n o f r a t c c r c b r a l c o r t c x ( G o e l z e t a l . . 1981; H u t t n c r e t a l . . 1983).Theyare 
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two Iiighly homologoiis. cxtrcmcly basic (pI > 10). acid solublc and clongated 
protcins with apparcnt molecular wcights of 86.000 and 80.000 daltons, 
rcspcctivcly (Ucda and Grccngard , f977) .Thcy consist of a hcad rcgion and a 
collagcnasc-scnsitivc tail region rcsponsiblc for thc basic pI of thc molcci i lc 
(Ucda and Grccngard , 1977). Synapsin I is phosphorylated by thrcc diffcrcnt 
protein kinascs at multiple si tcs.The head region contains a scrine rcsiduc that 
is phosphorylated both by cAMP-dependcn t protcin kiiiasc and by C a ' 
calmodulin dependent protcin kinase typc 1 (Hut t i ierc t a l . . 1981; Kennedy and 
Grecngard, 1981; Nairn and Grecngard, 1987).Thc sequencc prccceding this 
site (Arg -Arg -Arg -Lcu -Sc r (P ) ) conforms well with that of the consensus-
sequence fo rcAMP-dcpendent protein kinase (Czernik et a l . , 1987).Thc tail of 
the molecule contains two additional phosphorylation sites which are phos-
phorylated cxclusively by Ca + + -ca lmodul in-dependent protcin kinase typc II 
(Hut tneret a l . . 1981; K e n n e d y a n d G r e e n g a r d . 1981; K e n n e d y e t a l . . 1983). 
The amiiio acids around thcse sites havc bcen deterniined ( A l a - T l i r - A r g -
Gln-Ala -Ser (P) , and Pro- I l e -Arg-Gln-Ala -Scr (P) ) and corrcspond to thc 
minimal requircmcnts for this kinase (Pearson ct a l . . 1985; Czernik et a l . , 
1987). 
Synapsin IIa and IIb (previously protein IIIa and IIIb; eollcctively referrcd to 
as synapsin II) are two closely related polypeptides with apparent molecular 
weights of 74,000 and 55.000 daltons. respectively (Huang ct a l . . 1982; 
Browning et a l . , 1987). L i k e synapsin I, thc synapsin II molecules are elongated 
and acid-solublc, but their isoclectric point is neutral (around 7) and they Iack 
the collagenasc-sensitivc tail . Synapsin II is phosphorylated by c A M P dcpeii-
dent protcin kinase and Ca + + -ca lmodul in-dependent protein kinase typc I 
(Huang et a l . , 1982) at a serine rcsiduc corrcsponding to the phosphorylated 
scrinc in thc head rcgion of synapsin I. Synapsin II shares with synapsin I thc 
sequence surrounding this scrine ( S ü d h o f e t a l . . 1989a, scc bclow). In contrast. 
both synapsin IIa and IIb are not phosphorylated by C a + + - c a l m o d u l i n -
depciident protcin kinase typc II (Browni i ige t a l . . 1987; S ü d h o f e t a l . , 1989a). 
Recently, the primary structurc of the four synapsins Iias been elucidated 
( S ü d h o f e t a l . . 1989a). Synapsin Ia and Ib arc encoded by two n i R N A s that are 
dcrivcd from thc same primary transcript by alternative splieing. In accordance 
with this, synapsiii Ia and Ib arc encoded by a single eopy gcnc ( S ü d h o f c t a l . , 
1989a) which is probably Iocatcd on the X-chromosomc (Yang-Feng ct a l . . 
l986).The m R N A s e n c o d e for two protcins of704 (rat synapsin Ia) and 668 (rat 
Ib) amino acids which are idcntical in thcir first 659 amino acid rcsidues.The 
C-terminus is divergent which is due to a 38 nucleotide iiisertion present in thc 
synapsin Ia m R N A rcsultiiig in a frameshift of the remaining common 
nucleotide sequencc. Both proteins are Iiighly conscrvcd within iiiammalian 
spccies.with 96% identical amino aeid residucs bctwccn rat and cow ( S ü d h o f e t 
a l . . 1989a). 
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Synapsin IIa and IIb arc also idcntical in Uieir N-tcrminal part and divcrgc in 
theirC-terminus. A g a i n , thc two fornis arc gciicratcd by alternative splicingof 
a primary traiiscript derivcd from a singlc copy gcne altlioiigli thc splicing 
nicchanisni appears to be different from that of synapsiii I n i R N A . In 
accordancc with the biochemical propcrties of the isolated proteins. synapsin 
IIa and IIb are smaller in size than synapsin Ia and b .wi th 586 and 479 amino 
acid residucs. respectively (Südhof ct a l . . 1989a). 
A comparison ofthe primary structurc ofthe four synapsiiis revcaled that the 
protcins arecomposed o fa mosa icofcommon and individual doniains (Südhof 
et a l . . 1989a; F ig . 2-4). Synapsin I and II contain a large Iiomologoiis region at 
the N-terminal part which can be divided into thrce domains. Thc amino 
terminal domain ( A ) contains the phosphorylation sitc common to all proteins 
and is Iiighly homologous.Tli is is followed by a stretch (B) ofweakcr Iiomology 
which is rieh in small amino acids such as A l a and Scr .Thc tliird domain (C) is 
the largest, displaying again high homology among all four proteins. This 
domain appears to contain thc rcgions responsible for iiiteractioii with actin 
and synaptic vesicles (see below). It is both liydropliobic and Iiighly eliargcd and 
may form multiple amphipatic u-helices and B-sheets. There are several 
stretchesof liydrophobic amino acids flankcd by charged residucs which may be 
responsible for the inscrtioii of synapsin I into the hydropliobic pliase of 
phospholipid bilayers (Benfenati et a l . . 1989a; Bcnfenati el a l . . I989b. sce 
bclow). 
The C-tcrminal parts of thc synapsins arc variable (Fig . 2-4). Synapsins Ia 
and Ib sliare a long, proline-rich, eollagcnasc-scnsitive sequencc (D) whieh 
SYNAPSIN DOMAIN MODEL 
COMMON VARIABLE 
Ser-P 
Synapsin Ia E^SKVsXI 
A B 
Ser-P 
Synapsin Ib 
A B 
Ser-P 
Synapsin Ila R$N \ \N 
A B 
Ser-P 
Synapsinl lb f ^ N X \ \ 
A B 
Ser-P Ser-P 
PROLINERICH V/A 
D E 
Ser-P Ser-P 
PROLINERICH Iill 
G H 
G I 
Fig. 2-4 Domain model Ior the synapsins. See tex,t fordctails. Reproiluccd from Südhol 
et al. (iyS9a) by eopyriglit perniission ol' the A A A S . 
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contains thc two phosphorylation sitcs for C a t '-calmodulin-dependent pro-
tcin kinase typc II. Xhis is Iollowcd by the domains E and F whieh arc diffcrcnt 
duc to alternative splicing (scc abovc). Synapsins IIa and IIb have only a short 
common scqucncc (G) which is rich in proline, followcd by their altcrnatively 
spliecd carboxy-tcrmini ( H , E , I ) . Interestingly, the carboxy-terminal domain of 
synapsin IIa (E ) is highly homologous to the earboxy-tcrminal domain of 
synapsin Ia (E) with the last 18 amino acids bcing identical. 
A comparison of thc synapsin sequences with that ofcytoskeletal proteins, in 
particular v i l l in , profil in, gelsolin, protein 4.1 or other actin-binding protcins 
revealed no significant homologies. This is in contrast to prcvioiis suggcstions 
by othcr laboratories (Baincs and Bcnnet . 1985; McCaffcry and De Gennaro . 
1986) and confirms that thc synapsins reprcscnt a separate protein family. 
2.2.2.2 Interaction of Synapsin I with SSVs and the Cytoskeleton 
The interaction of synapsin I with the membranc of SSVs and phospliolipid 
vesicles has bccn charactcrizcd in detail (Schicbleret a l . . 1986; Benfcnati ct a l . . 
1989a; Bcnfenati ct a l . . 1989b). Synapsin I binds rcversibly and with high 
affinity (K c | approx. 10 n M ) to purified synaptic vcsicles (Sehicblcr ct a l . . 1986; 
Steiner ct a l . , 1987). Phosphorylation on thc tail wcakens this interaction 
(Huttncr et a l . , 1983; Schiebler et a l . , 1986).The binding to SSVs appcars to 
involvc two diffcrcnt components. First, it was shown that thc head of thc 
molecule intcraets strongly with purc phospholipid bilayers when acidic 
phospholipids arc prcsent (Bcnfenati et a l . , 1989a). Parts of the molecule 
(probably loeated in domain C) pcnctrate into the hydrophobic core of the 
membranc. Whi le this interaction does not rcquirc an acceptor protcin. a 
second binding component was identified which is dependent on a still 
unknown protcin component in thc SSV membrane (Benfenati et a l . . 1989b). 
This interaction involvcs thc tail of the molecule and is phosphorylation-
dcpendcnt. However, it remains to be established which domain ofthe synapsin 
I molecule is primarily responsible forthe specificityofthe interaction with S S V 
mcmbranes. Thc protcin-dependent binding component may be involved 
sLiggesting that thc tail convcys specificity. Howcvcr , this does not explain the 
specifiety of the association of synapsin II .which Iaeks the tail domain D, with 
SSV membrancs (Browning ct a l . . 1987). 
In addition to membrane binding. the intcractions ofsynapsin I with various 
eytoskcletal protcins, particularly actin, havc been charactcri/.ed. Dephospho-
synapsin I bimdles actin filaments ( B ä h l e r a n d Grecngard. 1987; Pctrucci and 
Morrow. 1987).This effect is rcduccd upon phosphorylation of the head of thc 
molecule and is virtually abolished when synapsin I is phosphorylated at thc tail 
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sitcs or at all three sitcs (Bäh lc r and Grecngard, 1987). A detailed analysis of 
actin binding and actin bundling using different fragments of thc synapsin 1 
molecule revealed that thc head contains at Ieast two different actin binding 
sitcs and that thc tail is required for bundling.The precisc mcchanism ofact in 
bundling remains to be established. It docs not appcar to involve self-
association of synapsin I (Bäh le r et a l . . 1989a). 
The interaction of synapsin I with other eytoskcletal protcins is Icss well 
defined. Binding has bccn rcported to occur with spcctrin (Baincs and Bennet, 
1985). neurofilaments (Goldenring et a l . . 1986) and microtiibiiles (Baiiies and 
Bennett. 1986; Petrucci and Morrow. 1987). the lattcr apparently under 
phosphorylation control (Petrucci and Morrow. 1987). The interaction of 
synapsin II with cytoskcletal proteins has not been investigatcd so far. The 
similarities betwccn synapsin I and synapsiii I l in domain C suggest that 
synapsiii II. Iike synapsin I. niiglit interact with actin. 
2.2.2.3. Proposcd Functions 
Al thougl i the functions ofthc synapsins are still not fully uiidcrstood, a concept 
Iias evolvcd which assigns a central role to these protcins in the synaptic Iifc 
cycle of SSVs (Dc Cami l l i and Greengard, 1986). According to this model, 
synapsin I (and, by analogy, also synapsin II) is involved in thc regulation of thc 
traffic of SSVs in thc nervc terminal by forming a reversible Iink between 
synaptic vesicles and an actin-based cytomatrix. Recently, crosslinking struc-
tural eleiiients Iiavc bcen visualizcd directly using cryo elcctron microscopy 
(Landis , 1988; Landis et a l . , 1988; Hi rokawa et a l . . 1989).Thcy are thought to 
be responsible for the clustering of synaptic vcsicles in proximity to the releasc 
sitcs. A n iiicreasc in thc phosphorylation state of synapsin I Icads to a 
dissociation of the vesicles from the actin nctvvork (sec abovc; Sihra et a l . . 
1989). allowing tlieiii to move to thc plasma membrane and undergo 
cxocytosis .Thus. phosphorylation of synapsin I would rcgulatc thc aniount of 
vesicles availablc for exocytosis in response to an incomiiig actioii potcntial. 
This iiiodel is supported by a varicty of different studies which show that all 
physiological or pliarmacological manipulations that triggcr or facilitate 
nciirotransmiltcr release cause a rapid and transicnt phosphorylation of the 
synapsins (for revicw sce Ncstler and Grecngard. 1984; Dc Camil l i and 
Grccngard . 1986). Synapsin I phosphorylation docs not appcar to be directly 
involved in thc exocytotic process itself but rather in makii ig more vesicles 
availablc for Iusion when incrcased neurotransmitter release is required.This 
concept was supported considerably by microinjcction studies using the squid 
giant synapse as a iiiodel system (Llinas ct a l . . 1985). Injection ofdephospho-
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synapsin I Icd to an inhibit ion of transmitter release without affccting 
presynaptic currents. In contrast, the phosphorylated forms were without 
effeet. Injcetion o fCa + + -ca lmodul in -dependen t protcin kinase type II (i.e. the 
kinase which phosphorylates the tail rcgion of synapsin I) did not trigger 
ncurotransmitter relcase but Ied to a significant inercase of transmitter relcase 
in response to a depolarizing stimulus. 
2.2.3 Synaptophysin 
Synaptophysin (also refcrrcd to as p38) is the major integral membranc protcin 
o f S S V s ( J a h n c t a l . . 1985;Wiedenmannand Franke. 1985 , seea l soF ig .2 - l ) . It 
was discovercd indepcndently by several laboratorics using immunochemical 
methods (Bock and Hel le . 1977 [named synaptin in this study: Gaardsvoll et 
a l . . l988] ; Jahne ta l . , 1985;WicdenmannandFrankc , l 9 8 5 ; O b a t a e t a l . , 1986; 
Devoto and Barns tablc 1987; LecIerc ct a l . . 1989) due to its high immunoge-
nicity. Numcrous monoclonal and polyclonal antibodies havc been gcncrated. 
and some of them are commercially availablc. It is an abundant protcin within 
the brain. corresponding to 0.3% of total cerebral eortex protein or 7% of 
synaptic vesicle protcin (Knaus et a l . . 1986; .Iahn et a l . , 1987). In addition. 
synaptophysin is expressed by a variety of pcptidc-sccreting endocrine cells and 
related tumors (see section 2.4.2). A t thc prcscnt time. synaptophysin is one of 
thc best studicd vesicle proteins. It is widely acceptcd as standard cytochemical 
marker for nerve terminals and for neurocndocrinc cclls as well as for tumors 
derivcd from corresponding tissues. but its function is still not undcrstood. 
2.2.3.1 Structurc and Orientat ion in thcVcs ic l c Membrane 
Synaptophysin is an acidic membrane protein (pI approximately 4.8) with an 
apparent molecular weight (monomer) of38,000 daltons (.lahn et a l . . 1985; 
Wiedenmann and Franke. 1985). It is N-glycosylatcd (Rchm et a l . . 1986),with 
a slight difference between the neuronal and endocrine form in the siigar part of 
thc molecule (Navone ct a l . , 1986).The primary structurc ofsynaptophysin has 
becn determincd (Südhof ct a l . . 1987; Lcubc et a l . . 1987; Bucklcy et a l . . 1987). 
The m R N A eneodes for a protcin of307 amino acids. Bascd on hydrophilicitv 
analysis ofthe amino acid side chains. a structural modcl was proposed (Südhol 
ct a l . . 1987; Leubc et a l . . 1987; see F ig . 2-5) which was rcccntly confirmed bv 
fragment analysis using domain-spccific antibodies (.Iohnston et a l . . 1989a). 
Synaptophysin has four transmembrane domains which are separated by short 
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Fig. 2-5 Model ofthe transmembrane structure ofbovine synaptophysin. Amino acids 
are given in single Ietter code. Modified from Südhof et al. (19S7). 
hvdrophilie sequenees. The transmembrane domains contain stretches of 
limited sequence homology, suggesting that they vvcre formed by genc 
duplicatioii events. Both the C' and the N termini are faeingthe cytoplasmic side 
of the vesiele.The N-terminal part on thc cytoplasmic side is short. containing 
approx. l>S amino acid residucs. N o signal sequence is observed. The 
intravesicLilar Ioops contain two potential N-glycosylation sites. but apparently 
only the one Ioeatcd on the first Ioop is uscd (Johnston. .lahn and Südhof, 
unpublished observations). Similarly, cystcines arc found only in the domains 
inside the vesicle.The cytoplasmic C-tcrminal domain is about 90 amino acids 
long. It cari'ies most of the antigenic sites (Jahn ct a l . . 19S.v. Johnston et a l . . 
19S9a) and eontains 10 copies of an unusual pentapcptide rcpeat (consensus 
sequencc: T y r - G l y - P r o ( G l n ) - G l n - G l y ) . No homologies to other protcins were 
found whcn data banks were searched. However. the lail has some superficial 
similaritiy with keratin and synexin (Creutzet a l . , 1988). but more significantly, 
with octopus rhodopsin.Thc lattcr possesses a very similar pentapcptidc repcat 
in its C-terminal domain (8 rcpcats. consensus scquencc:Tyr-Pro-Pro-Gln-Gly; 
Ovchinn ikove t a l . . 1988). 
Svnaptophvsin has bccn sequcnecd from rat. human, covv and Torpedo 
electric organ (Südhof ct a l . , 1987; Lcubc et a l . . 1987; Johnston et a l . . 1989a; 
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Cowan ct a l . . 1990). allowing a comparison ofconserved and variable domains. 
In thc mammalian spccics. synaptophysin is highly conserved, with 88% 
idcntity between all threc species (Johnston ct a l . . 1989a).Thc changes arc 
conccntratcd in thc two intravcsicular domains. In contrast. Torpedo synapto-
physin is more divergent, with only 62% amino acid similarity with rat 
synaptophysin (Cowan et a l . , 1990). Interestingly, the tail is lcast conserved but 
apparently preserves a gross similarity in its overall structure (rich in Tyr and 
Pro) .The longest stretchcs of identical amino acids (14 and 12 residucs) were 
found at thc aminoterminal rcgion ofthe fourth transmembrane domain and in 
the first intravesicular loop. respectively. It wi l l be ofintcrcst to detcrmine the 
primary structurc in more distant species (e.g. invcrtcbrates) in order to Icarn 
more about the functional constraints of the scquencc in cvol i i t ion. 
Thc subunit structure of the protein is still iinclear. Depending on thc 
cxperimental conditions, synaptophysin behavcs as a dimer (Wiedcnmann and 
Frankc. 1985; Jahn ct a l . . 1987). trimer (Rehin et a l . . 1986) or hexamcr 
(Thomas et a l . . 1988a, see below) formcd from idcntieal subunits. Sincc thc 
cysteinc residues are rapidly oxidised, resulting in artificial ol igomerization. 
more work is required to determine the prccise structure and to evaluate 
whether disiilfidc bridgcs are involved. 
2.2.3.2 Functional Propcrties 
A s already mentioned. thc biological role of synaptophysin is i inknown. 
Howcver. thc protein cxhibits sevcral uniqiic propcrties which may be of 
functional importanee. 
Synaptophysin is phosphorylated on tyrosine residues by cndogenoiis 
tyrosine kinase activity (Pangct a l . . 1988a). In fact. the protein appears to bc 
one of the Iew major endogenous siibstrates for tyrosine kinases in biaii i 
(Hira i io et a l . . l988).This property is sharcd with otl icr vesicle proteins (Pang 
et a l . . 1988a). notably p29 (scc bclow; Baumert et a l . . 1990). The kinase 
rcspoiisible for this phosphorylation appears to be c-src which is cnrielied in 
vesicle fractions (Pang ct a l . . 1988b; Barnekow ct a l . . 1990 in press). 
In addition. it was reportcd that thc cytoplasmic tail binds Ca ' ' -ions (Rel im 
et a l . . 1986). makii ig it a possible candidatc transducing the C a 1 ' sigiial into 
exocytosis of SSVs. Fur t l icrmorc, it was dcmonstratcd that synaptophysin 
forms an ioii chaiinel whcn incorporated into planar Iipid membranes (Thomas 
ct a l . . 1988a).Thc channcl displayed an averagc conductance of 154pS.with thc 
open probability bcii ig Iinearly dcpciidcii t on thc mcmbiane potential. 
Add i t ion of a tail-specific monoclonal antibody Icd to alterations ofthe channcl 
propcrt ies .Tlie functional significance rcmains to bc established. Alternative 
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functions havc been proposed l'or synaptophysin such as an organizing role in 
thc gcneration and maintcnance o f S S V s or a rolc in thc interaction ofvcsielcs 
with cytoskelctal elements (Johnston et a l . . l989a). 
2.2.4 Synaptobrevin 
Synaptobrevin is a protcin which cxists in two liiglily Iiomologoiis isot'orms 
which are also refcrred to as V A M P - I and V A M P - 2 (Trimblc ct a l . . 1988; 
Baumert ct a l . . 1989; Elfcrink et a l . . 1989; S ü d h o f e t a l . . 1989b). It is an 
abuiidant integral mcmbrane protcin of SSVs with an appaiciit niolecular 
wciglit of 18.000 daltons when separatcd by SDS-polyacrylamidc gcl cleetro-
phoresis (Fig. 2- l ) .The protcin was eloncd and sequenccd from several species 
(Trimblc et a l . . 1988; Südhof ct a l . . 1989b; Elferink et a l . . 1989) and 
monoclonal and polyclonal antibodies are available Ior its characterization 
(Baumert et a l . . 1989). 
Synaptobrcvin is a small protein. eonsisting of 116 amino acids in mammals. 
with iio sigiial scquence. Most ofthe amino acid residucs are Iiighly hydrophilic, 
with only one predicted membranc spanning domain close to the C-terminal 
end ofthe molecule (Trimble et a l . . 1988; S ü d h o f e t a l . . 1989b; Elfcrink et a l . . 
1989; F ig . 2-6). Limited pioteolysis of synaptobrevin reconstitutcd in protco-
liposomes providcd support for the view that thc protein spaiis the membranc 
in its ciitirety (Südhof et a l . . 1989b). 
COW M S A - T A A T A P P A - - - A P A G E G Q P P A P P P N 1 T S N R R 1 Q Q T Q A Q V D E V V D I M R V N V D K V L E 
rat (iSOfOrm 2) M S A - T A A T V P P A - - - A P A G E G G P P A P P P N L T S N R R L Q Q T Q A Q V D E V V D I M R V N V D K V L E 
rat (iSOfOrm 1) M S A - P A Q - - P P A EGT E G A P G G G P P G P P PNT T S N R R L QQT Q A Q V E E V VDI I R V N V D K V L E 
TorpedO M S A P P S G P A P D A Q G G A P G Q P T G P P G A P P N T T S N R R L QQT Q A Q V E E V V D I I R V N V D K V L E 
DrOSOphila ME NN E A P S P S G S H N NDF P I L P P P P N A N D N Y N Q F G D H Q I R N N N A A Q K K L Q Q T Q A K V D E V V G I M R V N V E K V L E 
N-TERMINAL DOMAIN (VARIABLE) CENTRAL CONSERVED 
R D Q K L S E L D D R A D A L Q A G A S Q F E T S A A K L K R K Y W W K N L K M M I I L GVI C A I I L I I I I V Y F S S 1 
R D Q K L S E L D D R A D A L Q A G A S Q F E T S A A K L K R K Y W W K N L KMMI I L GVI C A I I L I I I I V Y F S T 1 
R D Q K L S E L D D R A D A L Q A G A S V F E S S A A K L K R K Y W W K N C K M M I M L G A I C A I I V V V I V l Y I F T • 
R D Q K L S E L D D R A D A L Q A G A S Q F ES S A A K l K R K Y W W K N C K MMIM L G G I GAI I V I V l I I Y F F T 1 
R D Q K L S E L G E R A D Q L E Q G A S Q F E Q Q A G K L K R K Q W W A N M K M M I I L G V I A V V L L I I V L V S V WP S S S D S G S G G G N K AI T Q A P P H 1 
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Fig. 2-6 Sequence comparison of synaptobrevin Irom different species. Amino acids 
are given in single Ietter eode. Adapted from Südhof et al.. 1989b.The sequenees for 
Torpedo and rat are IromTrimbIe et al. (1988) and Ellerink el al. (1989). respective-
b-
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The striking feature of synaptobrevin is its high degree of conservation in 
phylogenetically distant animal spccies. Synaptobrevin is thc first vesicle 
protein identified in invertebrates (Drosophila, scc S ü d h o f e t a l . . L989b). A 
comparison of the sequcnecs published so far (Fig . 2-6) rcveals four domains 
(Südhofe t a l . . 1989b).Thc N-terminal region is ofvariablc size and is divergent 
in distant spccies, with no significant homologies between Drosopliilo and 
vertebrates. This region also contains the major differences between the two 
isoforms found in the rat and ends in dibasic residues. It is followcd by a stretch 
of 63 amino acids which is conserved to an extraordinary degree. A p p r o x i -
matcly 80% of thc residues are identical between Drosophila and cow. In 
addition. thc fcw changcs arc mostly duc to replacements by amino acids with 
very similar propcrties ( G l u for A s p and Ile for M e t ) . The degree of 
conservation is much higher than that observcd for synaptophysin between 
Torpedo and mammals (sec above), indicating an essential functional role of 
this domain. It ends in a clusteroffour positively chargcd amino acids.This part 
is followcd by the mcmbranc-spanning domain which consists of 20 amino 
acids, also wcll conservcd,with a high average hydrophobici tyThe C-terminus. 
which probably extcnds into the lumen of the vesicle, is again divergent. It is 
vcry short in rat. eow and Torpedo (2 amino acids) but comparativcly long in 
Drosophila (22 amino acids) (TrimbIe ct a l . . 1988; Südhof et a l . . 1989b. 
Elferink et a l . . 1989; sec Fig . 2-4). 
A t thc prescnt t imc, littlc information is available about thc biochemical 
propcrties of synaptobrevin. It is tempting to spcculate. however. that 
synaptobrevin has an csscntial function in the exo-cndocytotic cyclc o f S S V s . In 
contrast to synaptophysin. thc most conserved part of thc synaptobrevin 
molecule is located in the cytoplasmic domain directly adjacent to thc surfacc of 
thc vesicle suggesting that its main function residcs in this domain. Clearly, 
synaptobrevin is a strong candidate for mediating membranc interactions 
involved in exo-endocytosis, but its function remains to bc rcsolvcd. 
2.2.5 P65 
P65 was the first ofthe major integral S S V membranc proteins Io be discovcrcd 
(Matthew ct a l . . 1981). It was charactcrizcd with the aid of two monoclonal 
antibodies (48 and 30) raiscd against rat brain membranes. P65 appcars as a 
single, somewhat "fuzzy" band of 65.000 daltons when analyzed by S D S -
polyaerylamidc electrophoresis(Fig. 2-1). A similar. probably identical protein 
was also independentlv described (Obata et a l . . 1987).The protein appears to 
contain conserved domains sincc the monoclonal antibodies cross-rcact with 
similar proteins in lower vertebrate specics (Matthew et a l . . 1981 ).The protein 
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was purified from rat brain by affinity chromatography but was not further 
characterizcd (Bixby and Reichardt, 1985). 
A g a i n . the function of this protein is not known. Howevcr, two intcresting 
propcrties werc described which might offersome clucs to thc functional rolc of 
p65. A calmodulin-binding protein was identified in secretory vesicles from 
sevcral organs (Bader et a l . . 1985; Fournier and Trifaro, 1988) which was later 
identified as p65 (Trifaro et a l . . 1989). If these results wil l bc confirmed by 
futiirc studies. p65 would rcprcscnt the major calmodulin-binding protein of 
synaptic vesicles. making it a sccond candidatc. in addition to synaptophysin, 
for transducing the calcium signal in cxocytosis. In addition. it was found 
reccntly that a vesicle protein which is probably idcntical to p65, posscsscs 
agglutinating activity and binds gangliosides (Popoli and Mengano. 1988; 
Popoli et a l . . 1989).The primary structure of p65 has rccently bccn determined 
(Pcrin et a l . . 1990). It is a transmembrane glycoprotcin of 421 amino acid 
residues with one membrane spanning domain close to the N-tcrminus (thc 
latter is Iocated insidc thc vesicle) .The cytoplasmic tail of p65 contains two 
copics of a 116 amino acid repeat which share 41% idcntical amino acid 
rcsidues.These rcpeats arc scparated from thc membrane by a doamin ofhighly 
chargcd residues. Thc cytoplasmic repeats cxhibit striking homology to thc 
regulatory ( O ) domain of protein kinase C (identity between 32 and 40% 
depending on the isoform). A p65 cxpression construct covering the two 
repeats, resulted in a recombinant protcin which binds acidic phospholipids 
with high affinity and is capable of agglutinating red blood ccls. Prcliminary 
evidence indicated that the recombinant protein binds to thc hydrophobic 
portion ofthe phospholipids and may inscrt partially into thc bilayer (Pcrin et 
al . , 1990). Thus. p65 has emerged as a strong candidatc for mediating 
C a + + - b i n d i n g and membranc fusion during cxocytosis. 
2.2.6 SV2 
SV2 was discovered when monoclonal antibodies were raised against vesicle 
protcins of the marine electric ray and was subsequchtly found to be prescnt 
also in mammalian synaptic vesicles (Buckley and Kelly. 1985). A similar. 
probably identical protein. was characterizcd indcpcndcntly (Walker et a l . . 
1986). 
A t thc prescnt t ime. structural information o f S V 2 is l imi ted .Thc apparent 
molecular weight of SV2 is approximately 100.000 daltons. Pulse-chase 
experiments in PC12 cclls revealed that a precursor form of 64.000 daltons 
cxists which is immunoprecipitated by the monoclonal antibody.These results 
indicate that the protein is highly glycosylatcd (Buckley and Kcl ly . 1985). 
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Rccciit ly. the isolation o f c D N A clones was reported, inereasing the possibility 
that thc primary structure wil l be determined in the near futurc (Buckley and 
Kel ly . 1989). 
2.2.7 P29 
P29 is an integral membrane protein with an apparent molccular weight of 
29.000 daltons and an isoelectrie point of approximately 5.0 (Baumert et a l . . 
1990). The protein is not glycosylated. Apparently, it is Iess abundant than 
synaptophysin. synapsin 1. p65 or synaptobrevin (sec F ig . 2-1) but thc precise 
amount of p29 in purified vesicles remains to be determincd (Baumert et a l . . 
1990). 
P29 exhibits two interesting propertics. First, two monoclonal antibodies 
raiscd against p29 display a limited cross-reactivity with synaptophysin, 
indicating thc prcscnce of related epitopcs. Second, p29, Iikc synaptophysin. is 
phosphorylated on tyrosine residues by endogenous tyrosine kinase activity 
(Baumert et a l . , 1990; see also Pang et a l . , 1988a). It wil l be of interest to 
evaluate the precise rclationship between these two proteins when the amino 
acid sequcncc of p29 is clucidatcd. 
2.2.8 Rab3 
Rab3 is a GTP-b ind ing protein ( G protcin) belonging to the elass of thc 
so-called small, ras-relatcd G protcins. This class includes more than 20 
monomeric proteins with a molccular weight in the range of 20.000 - 28.000 
daltons. Thcy arc in part mcmbrane-bound but do not contain membrane-
spanning scgments in their amino acid sequcncc (Touchot et a l . . 1987; 
Barbacid, 1987; Chardin , 1988). A s f o r m a n y o t h e r s m a l l G-protcins, rab3was 
first identificd by c D N A cloning (Touchot et a l . . 1987) and shown to be specific 
for ncurons and endocrine cclls by Northern blotting (Matsui et a l . . 1988; 
Olofsson et a l . . 1988; Sano et a l . . 1989) and immunocytochcmistry (Mi /oguch i 
et a l . . 1989). In a recent study, it was shown that membranc-bound rab3 is 
exclusively assoeiated with SSVs (Fischer v. Mol la rd et a l . . 1990). In addition. a 
soliiblc pool of this protein was found to be prcscnt in mammalian brain .The 
nature of the membrane association of rab3 remains to be established but 
appcars to involve a covalcnt modification. Both the soluble and the 
membrane-bound form of rab3 were shown to bind detergent (in contrast to 
rab3 expressed in bactcria). suggesting posttranslational addition of hydro-
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phobic side groups to both forms. Prcliminary evidenee indieates that thc 
modification of the membrane-bound form may bc different from that of thc 
soluble form. In addition. these modifications appcar to be different from those 
of ras proteins which wcre shown to be farncsylated and partially palmitoylated 
(Hancock et a l . . 1989; Fischer v. Mol l a rd et a l . . 1990). 
Thc function of rab3 is unknown. Howcver. therc is increasing evidencc that 
G protcins arc involvcd in directing intracellular membrane interactions, 
inc ludingcxocytos is (Howcl le t a l . , 1987 ;Val la re ta l . . 1987; B o u r n c 1988). In 
partieular. the small G protcins scc4 and yp t l havc been implicated in 
controlling vcctorial membrane traffic within the Golg i apparatus and between 
the Golg i apparatusand the plasma membrane. respcctivcly (Scgcvct a l . . 1988; 
Schmitt ct a l . , 1988; Salminen and Novick , 1987).The existcnee offree and 
mcmbranc-bound pools ofthesc proteins Ied to the suggestion that thc protcins 
cyclc between mcmbranc-bound and free states in parallel with the Iife cyclcs of 
the transport vcsieles (Segcv et a l . . 1988; Bourne, 1988; Walworth ct a l . . 1989). 
It is not known whcther rab3 undergoes similarcyclcs and how the specificityof 
its interaction with SSVs is mediated. Howevcr, it is Iikely that rab3 is involved 
in controlling a step in the synaptic cycling of SSVs. 
2.2.9 Proton ATPase 
In contrast to the other SSV-proteins dcseribcd here, thc vcsicular proton pump 
is characterizcd both with respect to its structure and its function. A full 
discussion of this cnzyme. also rcferred to as vacuolaror V - A T P a s e . is beyond 
the scope of this chapter and thc reader is referrcd to sevcral recent revicws 
(Rudnick. 1986; A l - A w q a t i , 1986; Mc l lman et a l . . 1986; Schneider. 1987; 
Scharschmidt and Van D y k c 1987; Nelson and Tai/.. 1989; Forgae 1989). 
Soon afterthe development ofvesiclc purification proccdiires it was reported 
that synaptic vesicles contain ATPase activities which differ from thc sodium-
potassiuin ATPase (Hosic , 1965; Brec re t a l . , 1977). Howevcr. only reccntly it 
becamc clcar that most of this ATPase activity is contributed by a proton pump 
(StadlerandTsuki ta , 1984; Harloset a l . . 1984; Hel l et a l . . 1988) which bclongs 
to the vacuolarclassofenzymcs ( H c l l ct a l . , 1988; Wangct a l . . 1988; Cidon and 
Sihra. 1989;Yamagata and Parsons. 1989; but scc alsoYamagata ct a l . . 1989, for 
the charaetcrization of an E r E 2 ATPase from Torpedo synaptic vcsiclcs).This 
proton pump gcneratcs an elcctrochemical potential which providcs the energy 
for the uptake of neurotransmitters (Marshall and Parsons. 1987; Phil ippu and 
Matthaei . 1988; Maycox et a l . . 199()).The class ofvacuolar proton pumps is 
primarily responsible for the acidification of intracellular organcllcs (yeast and 
plant vacuolcs. Iysosomes. cndosomes. eoatcd vesiclcs. sccrctory organelles 
44 2 Membrane Protcins of Synuptic Vesieles 
etc.; for review sce Rudnick. 1986; Forgac 1989). In ccrtain eases. it is 
incorporatcd intothc plasma membrane, e.g. in kidncy cpithelia (Brown ct a l . . 
1988) and may play a role in acid regulation ( A l - A w q a t i . 1986; Forgac. 1989). 
Thus. this cnzyme is not spccifically locatcd on SSVs but is shared with a wide 
range of intracellular membrancs which providc a functional interconncction 
between thc Golg i complex and thc plasmalemma (Rudnick. 1986; Forgac 
1989) . 
Thc structural characterization ofthe vacuolar proton pump was thc subject 
of intensc effort of several different laboratorics. Most ofits subunits havc bcen 
cloncd and scquenced from different sources (Mandel et a l . . 1988; Manolson et 
a l . . 1988; Hirsch et a l . . 1988; Z imniak et a l . . 1988; Bowman et a l . . 1988a; 
Bowmann et a l . . 1988b; Nelson et a l . . 1989; S ü d h o f e t a l . . 1989e).There is 
general agrccmcnt that thc pump is a largc hetero-oligomer of approximatcly 
300-700 k D a . However, the precisc subunit composition is not known and may 
vary in different organellcs or different specics. thosc from plants and lowcr 
eukaryotcs having a simpler subunit structure (for an overview sce Forgae 
1989). Several subunits display limited scqucncc homologies to corresponding 
subunitsofthe mitochondrial F , r F | - A T P a s e indicating that thcycvolvcd from a 
common ancestral g c n e T h e pump contains a strongly hydrophobic subunit 
which is covalently modified by D C C D and has bcen shown to form thc proton 
channel (Sun ct a l . . 1987). Fu r thc rmore the ATP-bind ings i tc was localized on 
the 70 k D a subunit (for review see Forgae 1989). 
In addition to thc proton pump, a chloridc channcl was found in synaptic 
vcsiclcs which provides eompensatory chloridc influx during vesicular acidifi-
cation (Maycox et a l . , 1988;Jahn et a l . , 1990).The channcl protcin Iias not becn 
identified. So far. it is not knovvn if and how this channcl is related to chloridc 
channels charactcrized in other endomcmbrane systems, e.g. endosonies 
(Mcl ln ia i i et a l . , 1986; Schmid et a l . . 1989). 
2.2.10 Additional Protcins Associated with SSV Membranes 
2.2.10.1 Protcoglycan 
A proteoglycan originally identified in synaptic vcsiclesof 7brperfo(Stadlerand 
D o w e 1982; Walkeret a l . . 1983; Carlson and Kel ly . 1983) was also found to be 
preseiit in mammalian synaptic vesicles. It is liiglily antigenic and reprcscnts the 
major antigcn of most ofthe carly antibodies raised against synaptic vesicles of 
electric rays ( e g . Hooper ct a l . , 1980; Carlson and Kelly. 1980; Von Wcdel ct 
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a l . . L981;Theresa-Joncsct a l . . 1982).Thc molcculc isstronglyacidic, beingrich 
in glucosaminc, iironic acid and sulfate (Carlson and Kcl ly . 19(83). T l i c 
proteglycan apparently lacks a cytoplasmic domain sinee it is inaeeessiblc to 
antibodies or protein labeling ageiits iinless the vesicles are disrupted (Carlson 
and Kelly. 1983).Thus, it appcars to be located cxclusively in the interior of the 
vesiele. beiiig partly soluble.The proteoglycan accounts for a major part of the 
total protein ofcholinergic vesicles. It is found only on a subset of synapscs in 
the mammalian ncrvous system. In the Torpedo elcetrie organ. part of the 
proteoglycan appears to be seeretcd during cxocytosis sinee recycling vesicIcs 
contain niucli Iess of this constitucnt (Stadler and K i c n c 1987). Howcver. in 
another study only a small amount of it is relcased from Torpedo synaptosomes 
uponstimulation (Kul ine t a l . . 1988).Thisdiscrepancynecdstobercsolvcd. A n 
immunologically related, but structurally slightly different proteoglycan was 
found within the cxtraccllular matrix (Caroni et a l . . 1985; Carlson ct a l . . 1986; 
Stadler and Kiene . 1987). It is not clear whether this matrix proteoglycan is 
derivcd from synaptic vcsiclcs. A better understandiiig of thc role of these 
molecules in the synaptic membrane Iife cycle wil l be dependeiit on the 
development of iniprovcd tools for the study of their protcin corc. 
2.2.10.2 Syi iapt icVcsic lc Proteins from the Elcctr ic Organ of LMcetric Rays 
A s mentioned abovc. synaptic vcsiclcs of the electric organ of electric rays can 
be isolatcd in a Iiighly purificd prcparation and havc bcen studied iiitciisely. It 
would bc cxpected that proteins esscntial for vesicle function arc conserved 
Irom Torpedo (or Narcine) to mammals. Major protcins first discovered in 
Torpedo (SV2 . proteoglycan. synaptobrevin) werc subsequently discovered in 
mammals and. viee versa, mammalian protcins were discovered in Torpedo 
synaptic vesicles. e.g. synaptophysin (Cowaii et a l . . 1990) and synapsin I 
(Volki iai idt et a l . . 1987). Some proteins. howcver.wcre only found in Torpedo 
and the occurreiicc of corresponding proteins in mammals rcmaiiis to be 
demonstrated. These include the ATP-transporter which was idcntified by 
different labeling strategies as a 34.000 dalton protcin (Stadler and Fenwiek. 
1983; Lee and Witzemann, 1983; L c e and Witzemann, 1987) and two more 
proteins of unknown function: V A T - I which is tissue-spccific for clcctroniotor 
ncurons (Li i i ia l et a l . . 1989). and S V P 25, an integral membrane glycoprotein 
(Volknandt et a l . . 1989). 
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2.3 Membrane Proteins of Large Dense Core 
Vesicles (LDCVs) 
2.3.1 Prcliminary Remarks 
In contrast to SSVs .which can be isolated in high yicld and purity. L D C V s can 
only bc prcpared in minute quantities. partially contaminated with other 
organelles. Thereforc, relativcly little information is available about their 
membrane composit ion. L D C V s were isolated in sufficient quantity and purity 
only from highly spccialized organs. Relatively pure L D C V fractions were 
obtained from thc neurohypophysis (Nordmann et a l . . 1979: Gratz l et a l . . 1980: 
Russell . 1980;). In addit ion. secretory granule fractions can be obtained from 
the adrenal mcdulla (Smith and Winkler . 1967).These granules are thought to 
be closely related to L D C V s of catecholamincrgic ncurons. Furthermore, 
preparations highly enriched in L D C V s of sympathetic ncrves werc obtained 
from splcnic ncrvc ( K l c i n et a l . . 1982). A second problem associatcd with the 
study of L D C V membrancs is that they are filled with a hcterogcnous cocktail 
of protcins (sce Chapter 3) which must bc differentiated from the membrane 
protcins. It is thercforc not surprising that most of the identificd membrane 
protcins of L D C V s arc enzymes or transporters for which functional assays arc 
available such as thosc associated with uptakc, biosynthcsis or proccssing of 
catccholamincs and ncuropeptidcs.Thus, most ofthe information available for 
these protcins is derived from work on specific systems (e.g. sympathetic 
ncurons. adrenal mcdul la . anterior and posterior pituitary) and little is known 
about their distribiition in the central nervous system. A t the prescnt time. no 
general membranc marker is available for neuronal L D C V s . Howcver. thc 
reccnt advanccs in elucidating the primary structure of some of these protcins 
should aid in thc development of improved tools ( cDNA-probes . antibodies) 
for anatomists and ccll biologists. 
2.3.2 Membrane Proteins Involved in Catecholamine Uptake 
and Hydroxylation 
It is well established that noradrenaline is synthesiscd from dopamine within 
thc Iumen ofcatecholaminergic vesiclcs.This reaction is mcdiatcd by dopamine 
-ß-hydroxylase . In addit ion, the following componcnts arc involved: a 
transport system for monoamines, an encrgizing systcm for thc uptakc which is 
provided by a proton pump of thc vacuolar type (sec section 3.2.9). and a 
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transmembrane shuttlc for clectrons which is provided by cytochrome b5<,|. A l l 
of these protcins are well characterized (for review see Winkler ct a l . . 1986; 
N juse t a l . , l986;Johnson, 1988: Ph i l ippuandMat thae i , 1988).andtheprimary 
structurcs o f d o p a m i n e - ß - h y d r o x y l a s e (Lamouroux et a l . . 1987). cytochrome 
b s i , i (Pcrin et a l . . 1988) and of most subunits of the proton pump (see section 
2.2.9) were recently elucidatcd. Dopamine -ß -hydroxy lasc is a dimcric protein. 
consisting of two identical subunits of 65,000 daltons. Aside from thc signal 
scquence. no obvious mcmbranc spanning region was found in the amino acid 
sec|ucnce (Lamouroux et a l . , 1987).The biochcmical nature of its membranc 
binding is still unclear. Apparently. no part of thc molecule extcnds to thc 
cytoplasmic side ofthe vesiclc membrane (Taylor et a l . . 1989).The monoamine 
carricr has recently bccn identified by affinity-labcling (Isambcrt and Henry. 
1985; Isambert et a l . . 1989). It appears to be a membranc protcin of 
approximatcly 70.000 daltons which was confirmed by radiation-inactivation 
analysis (Gasnier et a l . . 1987). Antibodies or structural data arc not yct 
available. 
Cytochromc b s r , i >s a Iiydrophobic protein. with 6 membrane spanning 
domains and sliort cytoplasmic tails at both thc N - and C- terminal cnds of the 
molecule.Thc protcin Iacks a signal sequence and is not N-glycosylatcd (Perin 
et a l . . 1988). It is still unclear how the heme groups are coordinatcd in thc 
molecule (Esposti ct a l . . 1989).This protein is also involvcd in thc proccssing of 
neuroaetivc pcptides storcd within L D C V s and secrctory granulcs sinee it 
providcs electrons rcquired for the catalytic cycle of the peptidyl-glycinc 
a-amidating monooxygenasc (Kcnt and Fleming, 1987; Pruss and Shepard, 
1987). Al though a recent study suggcsts a widesprcad distributioii of this 
protcin in ncurons and ncuroendocrinc cclls (Russell , 1987; Pruss. 1987; Pruss 
and Shepard, 1987), a thorough ininiunocytoehemical study invcstigating its 
tissue and subcellular distribution is still rcquired. 
It should be notcd that all ofthese proteins may also bc prescnt in SSVs ofthe 
sympathetic nervous systcm (revicwed in Winkler . 1988;Thureson-Klein and 
K l e i n , 1990). 
2.3.3 Mcmbranc Proteins Involved in Peptide Processing 
The Iast stcps in propeptidc-pcptidc conversion occurduring niaturation ofthe 
sccretory vcsicle.Thesc include proteolytic tr inii i i ing by highly specificexo- and 
eiidopeptidases. acetylation and amidation (Russell . 1987; L o h . 1987).Various 
enzymcs prescnt in pcptidc containing secretory vesicles havc becn purificd. 
and the priniary structure of some of tlieni. including the aniidating cnzyme 
(peptidyl-glycine « -amida t ing monooxvgenase) (E ipperc t a l . . 1987; Stoffcrset 
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al . , 1989) and carboxypeptidase E (Frickeret a l . , 1986) havc bcen reported (sec 
Fisherand Scheller, 1988; Fu l le rc t a l . , 1988; Frickcr. 1988; E i p p c r a n d Mains . 
1988; Sossin ct a l . . 1989; Mains et a l . . 1990 for revicw). Al though these 
cnzymcs appear to be mostly soluble. it appcars that some of them may bc 
synthesized as membranc-bound precursors. containing a membrane-spanning 
domain close to their C-tcrminus (e.g. peptidyl-glycine a-amidating monooxv-
genase; Eipper et a l . . 1987; or carboxypeptidase E ; Fr ickcr et a l . . 1986). A 
similar domain was found in K E X 2 . an cndopeptidase studied in yeast. that is 
able to clcavc correetly prepro-opiomclanocortin when introduced into a 
mammalian ecll line (Thomas et a l . . 1988b). The mammalian eoimtcrpart. 
howevcr, has not been identified. 
Thcsc protcins are prcscnt in a varicty of peptide sccreting endoerinc cells 
and in the ncrvous systcm (Russell . 1987; Frickcr, 1988; E ippc r and Mains , 
1988), inaking them candidates for gencral markers specific for L D C V 
mcmbranes. However,very little is known about thcir ccllular and subcellular 
distribution in thc mammalian C N S sincc most of them arc prcsent in low 
amounts. 
2.3.4 Membranc Protcins of Unknown Function 
For the reasons outlined above. little is known about L D C V membrane 
protcins which cannot be identified by functional assays. A scries of 
membrane-bound glyeoprotcins was described from the chromaffin granule 
(for review see Winkle r et a l . . 1986). One of thcm. termed G P I L has a 
widespread distribution in endocrine and exocrine glands. including thc 
posterior pituitary (Obendorf ct a l . , 1988a). It cxhibits a molecular wcight of 
approximately 100.000 daltons. It is different from the SSV-protcin SV2 ( H . 
Winklcr , personal communication) but appcars to be similar, if not identical. to 
a glycoprotein first characterizcd in secretory granules of thc exocrine 
pancreas. termed GP-2 (Obendorf et a l . , l988a). Thc pancreatic GP-2 is 
processcd from a mcmbrane-bound to a soluble form during granule matura-
tion (Havinga et a l . . 1984; Havinga et a l . . 1985; Paqucttc et a l . . 1986). 
Rccently, it was shown that it is not an integral membrane protcin but anchored 
via covalent bonds to phosphatidylinositol ( L c Bel and Beattie, 1988). It 
remains to bc established whe thc rGPI I orone of the otherglycoproteins ofthe 
chromaffin granule membrane is also found in L D C V s of the brain. 
A different protcin with an apparcnt molecular weight of 120.000 daltons was 
reccntly charactcrized from the membrane of neurosecretory granules of the 
posterior pituitary (Caorsi and Gonzalez . 1989). Immunocytochcmistry rev-
ealed a specific localization in the hypothalamo-hypophyscal systcm. indicating 
that it may not occur on L D C V s of other ncurons. 
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2.4 Cellular and Subcellular Distribution of SSV 
Proteins 
In thc following paragraphs, wc wi l l attempt to give a short overview aboiit thc 
ccllular and subcellular localization of synaptic vcsiclc protcins, with special 
reference to work donc on S S V protcins.This discussion is largely restrictcd to 
mammalian specics. 
2.4.1 Distribution of SSV Protcins in thc Nervous System 
2.4.1.1 Ccllular and Tissue Distribution 
A l l proteins which in ncurons are specific for SSV membranes, namcly synapsin 
I and II (De Camil l i et a l . . l983a; Südhof et a l . . 19<S9a). synaptophysin 
(Wiedenmann and Franke. 1985; Navonc ct a l . . 1986). p29 (Baumert ct a l . . 
1990). synaptobrevin (Baumert et a l . , 1989), p65 (Matthew ct a l . , 1981) and 
SV2 (Buckley and Kelly, 1985). arc widcly distributed in ncrvc terminals of 
both the central and pcripheral ncrvous systcm (Figs. 2-7-2-9). Light 
microscopy immunostaining of a variety of tissues and brain regions with 
antibodies dirccted against any of thcsc protcins produced similar staining 
pattcrns (Fig. 2-9) corresponding to those expcctcd for ncrvc terminals. 
Typieally. isolated puncta or rows of puncta corresponding to '*en passant " 
varicosities were obseived. each punctum representing a singlc ncrve terminal 
(Figs. 2-7-2-9). In some cases. staining patterns fordifferent SSV proteins wcrc 
virtually identical. In other cases, differences in thc staining intensity of 
individual nerve terminals suggested some variation in the stoichiomctric ratio 
of thc various protcins bctwccn different ncrvc terminals. For some of these 
proteins. notably synapsin and synaptobrevin. this may bc cxplaincd partially 
by the existcncc ofdifferent molecular isoforms. Ant ibodies specific for each of 
the foursynapsins revcaled that the relative conccntration ofthe four molecules 
varies in individual ncrvc terminals. Somc terminals appear to lack certain 
isoforms (Südhol et a l . . 1989a). Similarly. the tvvo knovvii isoforms of 
synaptobrevin ( V A M P - 1 and V A M P - 2 ) have a different, although partially 
overlapping. distribution (Elferink et aI.. 1989). So far. no clear correlation 
bctwccn this hcterogencity and other propcrties of ncrve cndings. such as the 
neurotransmittcr phenotype, has bccn found. 
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Fig. 2-7 Localization ofsynaptophysin by immunofluorescence in a lum-thick pIastic 
section of the rat cerebellar cortex.The staining pattern is represented by puncta of 
immunoreactivity (white) which represent individual nervc endings. In the molecular 
laycr (ML) they are denscly apposcd to each other and outline the dendritic trees(d) of 
Purkinje cells (PC). Small arrows point to axo-somatic synapses on Purkinje cell 
pcrikarya and a Iong arrow to the faint immunoreactivity in the Ciolgi complex ofone of 
thcse cells. Clusters of puncta in the granule cell Iayer (CiL) represent synaptic 
glomeruli (g). Calihration bar: 30 um. 
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Fig. 2-8 Localization of synapsin I by immunofluoresence in the skclctal muscle of the 
rat (extensor digitorum longus). Synapsin I immunoreactivity (demonstrated by 
rhodamine fluorescence) is shown in (A) . Both varicose nerve endings, which surround 
and outline blood vessels (v). and motor nerve terminals are immunoreactive. (B) 
shows lhe same Iield shown in (A) alter counterstaining with fluorescein-conjiigated 
a-bungarotoxin (a toxin whieh binds to the nicotinic cholinergic receptor) to reveal the 
Iocation and morphology of motor end plates. Calibration bars: 20 um. 
SSV proteins were also dctccted at unexpectcd locations. For examplc, some 
of these protcins were found in a variety of sensory nerve endings including 
muscle spindles. Ciolgi tendon organs. and sensory endings ofthe inner car (De 
Camil l i ct a l . . 198Sa: Scarfone ct a l . . 1988; Baumert et a l . . 1990). 50 nm 
vcsiclcs. reminiscent of SSVs. havc becn observed in these sensory nerve 
endings by electron microscopy. but a secrctory function has not been 
documented. In addition. thesc proteins arc prescnt in ncrve terminals ofthe 
posterior pitiiitary vvhosc only knovvn function is to secrete ncuroaetivc 
peptides into blood capillaries via a class of L D C V s . thc so called neurosccre-
torv granules. In thesc terminals. SSV proteins wcre found to be selcctively 
localized on vesicles moiphologically identical to SSVs (Navone et a l . . 1989). 
Thc function of thesc niicrovesicles, which arc cIiistcred at the side of the 
endiiig directly faeiiig blood capillaries. is unknown (for review see Morris et 
al . . 1987). 
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Conversely, synapsin I and synapsin II arc lacking Irom a specific groiip of 
presynaptic eIemcnts. those forming thc so-called ribbon synapses. although 
othcr SSV protcins are present in these terminals (Favre et a l . . 1986; Scarfone 
et a l . . 1988; Mandel l et a l . , 1989). R ibbon synapses arc found in sensory organs 
and posscss special morphological and functional propcr t ics .The presynaptic 
elcments are locatcd either in the cell body of sensory cells (e.g. hair cell of the 
inner ear) or at the end of small celIular processes very different from typical 
axons (e.g. photoreceptors. retinal bipolar cells). They contain a peeuliar 
electron-dense structure, the " r ibbon" or ribbon-like structure which is 
surrounded by SSVs (Sjös t rand, 1953; Smith and Sjös t rand . 1961; K i d d . 1962: 
Flock, 1964).The r ibbon,which is alwaysdirectly adjaccnt to postsynaptic sites, 
is thought to be involvcd in directing SSVs to relcase sites (Bunt , 1971; Gray 
and Peasc 1971). In ribbon-containing nerve terminals, transmitter release is 
controlled by graded potentials rather than by action potentials (Roberts and 
Bush. 1981). It is possible that the lack of all synapsins from these synapses is 
Fig. 2-9 Localization of synaptophysin (p38) and synapsin I (syn I) by immunofIuor-
escence in the muscular Iaycr ofthe vas deferens of the rat. Rows of small Huorescent 
puncta represent varicose nerve terminals interspersed with layers of smooth muscle 
cells. Calibration bar: 50 um. Reproduced from Navone et al. (1988) by copyright 
permission of Munksgaard International Publishers. 
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related to these liighly peeuliar propcrties. reflccting a difference in the 
nioleeular meelianisms ot' S S V elustering and exoeytosis. 
2.4.1.2 Subeellular Loealization 
The widespread presence of synapsin (De Cami l l i et a l . . 1983a; De Camil l i et 
a l . . 1983b; Navone et a l . . 1984; S ü d h o f e t a l . , 1989a; Navone et a l . . 1989), 
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Fig. 2-11) Hleetron micrograph showing the Ioealization of synapsin I in a nerve ending 
of the bovine liypotlialamus. Immunogold labeling of a Iysed isolated nerve ending. 
Ciold particles are seleetively localized on SSVs. Note lack of labeling of mitochondria. 
ot' Iargc vacuolar profiles (v). and of the plasmalenima, including its presynaptic portion 
(portion between two arrows) recognizable by the clustering of SSVs and by the 
presence of an attached piece of post-synaptic spacialization. Calibration bar: 140 nni. 
Reprodueed from De Camilli et al. (1988b) by copyright permission of Alan R. Liss 
Publishers. 
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Fig. 2-11 Sclcctivc Iocalization of synapsin. synaptophysin (p38), pl<S and p29 on SSVs 
in nerve terminals of the hovine hypothaIamus. Eleetron micrographs showing 
immunogold labeling of Iysed synaptosomes. In all l'ields gold particles are concentrated 
on the surface ofSSVs.Virtually no gold labeling is visible on the surfaee o f L D C V s or on 
other membranes. Calibration bar: 100 nm. Reprodueed from Navone et al.( 1986) and 
Baumert et al. (IWO) by eopvright permission ofthe Rockefeller University Press. 
synaptophysin (Wiedenniann and Franke. 1985; Navone et a l . . 1986;Tixier-
Vida l et a l . . 1988). synaptobrevin (Baumert et a l . . 1989). p65 (Matthew et a l . , 
1981; Navone et a l . , 1989). p29 (Baumert et a l . . 1990) and SV2 (Buekley and 
Kel ly . 1985) on virtually all SSVs was documented by a variety of electron 
mieroseopie teehniques including labeling of ultrathin frozen scctions. pre-
embcdding immunoperoxidase. and immunogold and immunoferritin labeling 
ofbrain tissiie. synaptosomes. or purificd vesicle fractions (Figs. 2-10 and 2-1 1: 
sce also Jahn and Maycox. 1988; H c l l et a l . . 1988; Baumert et a l . . 1989). 
Further confirmation was obtained by subeelliilar fractionation of rat brain. 
Svnapsin I and II. synaptophysin. synaptobrevin. p65 and p29 copurify with 
svnaptic vcsiclcs (Huttneret a l . . 1983; .Iahn et a l . . 1985: Brovvninget a l . . 1987: 
Baumert et a l . . 1989; Floor and Fcist. 1989: Baumert ct a l . . 1990; and 
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uiipuhlishccl observatioiis) although lhe idea that synaptophysin and pft5 are 
colocalized Iias recently been disputed (Volkiiai idt et a l . . 1988). 
SSVs are organelles which are Iunetionally intereonneeted by membrane 
fusion-fission cveiits with other intraccllular membraiies such as the plasma 
membrane, endocytic vcsiclcs and vcsiclcs of thc traiis Golg i network (for 
revicw see Kelly, 1985; Mcl ln ian et a l . , 1987; Burgcss and Kelly. 1987; De 
Camil l i and Jahn. 1990). Accordingly, small pools oftliese protcins havc been 
detected in cisternae in nerve teminals. tubulo-vesicular eleiiients and multi-
vesicular bodies in axons and pleomorpliic vcsiclcs in the traiis regioii of thc 
Golg i complcx (Navone et a l . . 1986; Baumert et a l . . 1989;Tixicr-Vidal et a l . . 
1988; Baumert et a l . . 1990; see Janctzko et a l . . 1989. for Ihc Golgi-Iocalization 
of SV2 in Torpedo ncurons). In this respcct. some differenccs were observed 
between thc proteins synaptophysin. p29 and p65 and the protcins synapto-
brevin and synapsiii I.The former protcins wcrc clcarly prcsent in the rcgion of 
thc Golg i complex vvlicre they are probably loealized in iiewly synthesized 
vcsiclcs or in vcsiclcs recycled from ncrvc terminals (sce section 2.5.2.1). 
Synapsin 1 and synaptobrevin. however, vvcre not detectable in the Golgi 
complex region (Navone et a l . . 1980; Baumert et a l . . 1989).Thc synapsins. as 
pcriplicral membrane proteins (see section 2.2.2). are synthesized on free 
ribosomcs in the cytoplasm and associatc posttranslatioiially with their target 
meiiibranes. In contrast, synaptobrevin is thought to span the eiitire vesicle 
membrane (sec section 2.2.4). but it is not clear whether it is synthesized on 
free or membranc-bound ribosomes. Lack ofdetectable immunoreactivity for 
these proteins in the region of the Golg i complex raises the possibility that the 
association of both proteins with S S V membranes occurs distallv to the Golg i 
complcx. 
It has becn shown that cxpression of sevcral of thesc proteins during 
development inercascs in parallel with synaptogeiiesis (sce c.g. Lohmann et 
a l . . 1978; G r e i f a n d Reicliardt. 1982; Dc Camil l i et a l . . 19S3a; D c G c n n a r o c l 
a l . . 1983; Lcvitt et a l . . 1984; Knaus et a l . . 1980; Weiss et a l . . 1980; Chun and 
Sliatz, 1988; Leclerc et a l . . 1989). A lhorougli study ofcliaiiges in the pattern ol' 
intraccllular distribution of synaptophysin and synapsin I during development 
Iias been recentlyearricd out in eulturcd liippocanipal ncurons (Lindslcy ct a l . . 
1987; Fletcher et a l . . 1989; Fletcher. De Camil l i and Banker, manuscript in 
preparation). Thcse cells express fully differentiated axonal and dendritic 
processes in vitro (Banker and Waxmai i . 1988). Both synapsin I and synapto-
physin are prcferentially targeted to axons Irom thc beginning of thcir 
differcntiation. Howevcr. they exhibit a rather diffuse distribution in the distal 
axons Lintil appropriate contacts with postsynaptic cells arc made.When such 
COiitacts are established. both proteins undergo rapid redistribution and clustcr 
at presynaptic contaet sites. This suggests that SSVs or their respcctivc 
precursor membranes arc concentratcd in distal axons beforc synapses are 
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formed. It remains to be seen whether synapsin is already associatcd with the 
membrane of S S V precursors bef'ore they eliister at prcsynaptie sites. A similar 
sequence of events has also been observed in situ by immunocytochemistry. 
Non-synaptic accumulations of synapsin I in distal axons wcre obscrvcd at sitcs 
where axon endings arrivc before functional synapses are established (Chun 
and Shatz. 1988). L o w c r levels of synapsin I are observed in distal axons for 
whieh arrival at thc target sitcs coincides with the beginning of synaptogenesis 
(De Camil l i et a l . . l983a; Levitt et a l . . 1984; Chun and Shatz. 1988). 
In sharp contrast to the abundance of synapsin. synaptophysin. synaptobre-
vin and p29 in the membranes of SSVs, thcsc protcins wcrc not deteetable by 
immunocytochemical teehniques in the membranes of L D C V s (Navonc ct a l . . 
1984; Navonc ct a l . , 1986; D c Cami l l i and Navonc. 1987; Baumert ct a l . . 1989; 
Navone et a l . . 1989; Baumert et a l . , 1990). This striking difference was 
confirmed by subcellular fractionation of ncrve terminals of thc posterior 
pituitary where an almost complete separation of thc SSV-proteins from 
neiirosceretory granules (the L D C V s of thc posterior pituitary) was achieved 
(Navone ct a l . , 1989).Thcsc data show that the membrane composition o f S S V s 
and L D C V s is dissimilar, ruling out that SSVs arc dcrivcd from recycling L D C V 
membranes as suggested by othcrs (see also section 2.5.2.1). 
It should bc notcd that the lack of significant amounts of the major S S V 
membrane protcins from L D C V membranes has becn disputcd by some 
authors. Most of the data favoring the prescncc ofthcsc proteins on L D C V s is 
based on subcellular fractionation experiments carried out with sucrose density 
gradients (see e.g. Agoston and Whittaker. 1989; Obendorf et a l . . 1989). A 
bimodal distribution of synaptophysin was observed on these gradients. the 
dcnse fraction comigrating with neuropeptidcs. Howcver, it cannot be ruled 
out that in these studies thc dense pool reprcscnts SSVs associatcd with other 
membrane structures, e.g. the prcsynaptic plasma membrane, unbroken nerve 
terminalsor L D C V s . It i swc l l known that in thc C N S a majorpart ofthe vesicle 
Iraetion remains associatcd with thc plasma membranc and migrates towards 
dcnsc regions of sucrose gradients during subcellular fractionation (Von 
Schwarzcnfeld, 1979). Thcrefore, immunogold clcctron microscopy of thcse 
fractions is required before a conclusion ean be reached. Clcarly. it cannot be 
ruled out that a minor pool of S S V membrane proteins is prcsent on L D C V 
membranes. A l s o , it is possiblc that the prescnec of a small pool o f S S V proteins 
in dense gradieiit fractions is due to their prcscncc on immature L D C V s as 
suggested by images such as that shown in F ig . 2-17F. 
N o elcctron microscopic data are available with rcspect to the distribution of 
L D C V membrane proteins in the nervous system. Therc is Iittle doubt that 
somc protcins arc shared with SSVs and other membranes of thc vacuolar 
systcm, c.g. the proton pump and possibly also the chloridc channel. It remains 
to be established whether L D C V s contain membranc proteins which are 
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specific for thcse organelles. Hopefully, antibodies wi l l soon be available for 
L D C V membranc protcins, allowing to closc this gap in our knowledge 
concerning the interrelationship of their membrancs with those of other 
intraccllular organelles. 
In summary, the available data support the concept that all SSVs in all nerve 
terminals share a set of abundant membranc protcins independent of their 
specific neurotransmitter content. Dcspite some minor degree of heterogene-
ity, forexample that due to isoform variability of synapsin and synaptobrevin. it 
appears that the S S V membrane has a highly dcfined composition where the 
concentration of each protein is controUed. This composition must be 
maintained diir ing recycling.The stoichiometry ofthe proteins is still unknown, 
Fig. 2-12 Color micrograph showing the Ioealization of synapsin I immunoreactivity 
with immunoperoxidase staining in cultured hippocampal neurons.The micrograph was 
takcn with Nomarsky optics to visualize unlabeled cell processes.The perikaryon of a 
large neuron from which several dendrites irradiate is visible at the eenter of the field. 
The meshwork of thin curvilinear processes is represented by axons. Immunoreactivity 
appears in the form ofyellow-brown puncta and rods. As shown by electron microscopy 
(T. Fletcher. P. De Camilli and G . Banker in preparation). each of them is represented 
by an axo-dendritic nerve terminal. Calibration bar: 15 ^im. Unpublished micrograph by 
T. Fletcher, G . Banker and P. De Camilli. 
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but cstimatcs havc becn made Ibr synapsin I and synaptophysin (for each 
approx. 20—10 monomer copics/vcsiclc). It is difficult to imagine hovv all these 
proteins can fit onto the vcsicle surface (a single IgG molecule, forexample, is 
cIearly visible as a major bIeb on the vesicle surface in thc elcetron microscope 
(unpublished observations)). It is tempting to spcculate that at Ieast some of 
thc major protcins form a scmirigid superstructiirc which might. in addition. 
explain the highly uniform size and thc remarkable osmotic stability of SSVs. 
This sliould bccomc clcar in futurc studies. 
2.4.1.3 S S V Proteins as Marker for Synapses 
Duc to their specific Iocalization in ncrve terminals, S S V protcins represent 
optimal markers for synapses and for ncrvc terminals in general (Fig . 2-12). 
Antibodies directed against these proteins can be used to visualize and 
quantitate synapses in immunocytochemical and immunochemical studies (see 
e . g . G o e l z e t a l . , 1981; D e C a m i i l i e t a l . . l983a;Weisset a l . . 1986; M e t z e t a l . , 
1986; Brock and O'Cal laghan, 1987; Wharton ct a l . . 1988; Walaaset a l . , 1988). 
Their early e.xpression during development makcs thcm iinique tools for the 
study of synaptogenesis (Levitt et a l . . 1984; Knaus et a l . . 1986; Weiss et a l . , 
1986; Burry et a l . , 1986; Mason 1986; Chun and Shatz. 1988; Leclerc et a l . . 
1989). In addition. synapsin I which is expressed at significant concentration 
only in ncurons. is one ofthe best neuronal markers available (Dc Cami l l i et a l . , 
1983a). Its exprcssion by a given cell can bc considered as an important 
criterion for neuronal differcntiation (see section 2.4.2). 
2.4.2 Distribution of SSV Protcins Outsidc thc Ncrvous 
System: Localization in Synaptic-Like Microvesiclcs 
( S L M V s ) of Endocrine Cells 
Although SSVs arc generalIy thought to bc organcllcs specific Ibr nerve 
endings. many of their peculiar and abundant membrane protcins. iiainely 
synaptophysin. synaptobrevin. p29. p65 and S V 2 . werc detectcd at high 
coneciitrations also in endocrine cclls speciaIized for thc rcgulatcd secretion of 
pcptidc hormones (Matthew et a l . . 1981; Bucklcy and Kc l ly , 1985; Wieden-
mann and Franke, 1985; Navone et a l . . 1986; Baumert ct a l . . 1989; Baumert et 
a l . . L990).These includc cclls of thc anterior pituitary. chromaffin cclls of the 
adici ial medulIa. endocrine cel lsof the pancreas (Fig. 2-13). ceIlsofthe diffuse 
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Kig. 2-13 Localization ol synaptophysin (p38). synapsin I (syn I) and synaptobrevin 
(pl<S) in endocrine tissues by immunofluorescence. (A) and (B) show sections of the 
adrenal gland, (C) and (D) sections of pancreatic islcts. Synaptophysin and synapto-
brevin immunorcactivities are present both in nerve terminals (small arrows) and in the 
cells of the adrenal mcdulla and endocrine pancreas. Synapsin I immunoreactivity is 
detectable only in nerve terminals. No immunoreactivity for any of these proteins is 
visible in cells ol the adrenal eortcx (ac) or ol thc exocrinc pancreas (ex.p). Calibration 
bars: (A) and (B). 80 um: (C) and (D). 40 um. Reproduced from Navone et al (1986). 
Baumert et al. (1989) and Baumert et al. (1990) by copyriglit pcrmissioii of the 
Rockefeller University Press and Oxford University Press. 
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Fig. 2-14 Color micrograph showing the prcsencc of synaptophysin in endocrine cells 
and axonal varicosities of the stomach mucosa as demonstrated by immunoperoxidase 
labeling. Calibration bar: 15 jtm. 
endocrine system ofthe gut (Fig. 2-14) and Cce l l so f the thyroid.These protcins 
were also detected in several cell lines derived from such tissues such as G F L 
cells, PC12 cclls (Navone et a l . , 1986; Lowe ct a l . , 1988; Baumert et a l . , in 
press). insulinoma cells (Fig. 2-15) and A t T 2 0 cells (Lowe et a l . . 1988;Tooze et 
a l . . 1989; own unpublished obscrvations). A t least synaptophysin is also 
prescnt in a variety of tumors derived from neurocndocrine cells (Wiedenmann 
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Fig. 2-15 Doublc-immunofluorcsccnce staining of four insulinoma cclls (RIN5) with 
antibodies against secretogranin I (chromogranin B) and against synaptophysin.The 
different distribution ol thc two antigens indicates a localization on different 
intraccllular organelles. Puneta of secretogranin I immunoreactivity. which represent 
individual secrctory granules. are particularly concentrated in distal portions of the cell 
processes (arrows). Synaptophysin immunoreactivity is particularly concentrated in the 
centrosomal area. Calibration bar: 25 um. Unpublished observations byA.Thomas and 
P. De Camilli: antibodies directed against secretogranin I wcre kind gift of Drs. Huttner 
and Rosa. 
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et a l . . 1986; Buffa et a l . . 1987). In fact. synaptophysin (forwhich polyclonal and 
monoclonal antibodies arc commercially available from sevcral soiirecs) is novv 
rcgarded as one ofthe most reliable markers for this elass of tiimors (Chejfcc ct 
a l . , L987 ;Gouldetal . , L987;Miettinen, l987 ;Bishopeta l . , L988 ;Leubeetal . , 
1988; scc alsoehapter7). D u c to thc clinical importancc ofs i ich markers, it will 
be of intcrest to detcrmine vvhcther the other SSV proteins colocalized with 
synaptophysin in endocrine cells. notabIy S V 2 , p65, p29 and synaptobrevin. are 
also present in these tumors. 
In contrast to the integral membrane proteins disciissed above. thc synapsins 
arc eitherabsent (Dc Cami l l i ct a l . . 1978; De Camil l i et a l . . 1983a; Fried ct a l . . 
1982; Haycock et a l . . 1988; Tooze et a l . . 1989) or present only at vcry Iovv 
coneentrations ( B ä h l c r e t a l . . 1989b) in endocrine tissiies. Howevcr. they arc 
expressed by endocrine cells grovvn in vitro iindcr conditions which resiilt in the 
development of neuronal characteristics. i .c . thc cxpression of neurite-like 
proccsses (Haycoek ct a l . . 1988; Toozc et a l . . 1989; ovvii impublished 
observations). A similar induction of synapsin I cxpression was observed in 
PC12 cclls which wcrc differentiated by nervc grovvth factor (Romano et a l . . 
1987). In contrast. the Ievcl ofsynaptophysin exprcssion remained unchanged 
Fig. 2-16 Localization of synaptophysin on microvesicles distinct from sccrelorv 
granules in a cell of the anterior pituitary. Electron micrograph showing an ultratliin 
frozcn section Iabcled by immunogold. Gold particles are localized on pleomorphic 
microvcsicies (arrows). Some ofthem are directly adjacent to granule (G) membranes. 
Calibralion bar: l30nm. Reproduced from Navone et al.. (1986) by copyright 
permission of the Rockefeller Univcrsity Press. 
2.4 Ccllular und SubccIIuIur Disirihuiion ofSSV Proteins 63 
(unpublishei1 obscrvatioiis) or rathcrdecreased undcr these conditions (Vetter 
and Betz. 1989). 
The siibeelkilar distribution of some of the SSV membrane proteins in 
endocrine cclls vvas analyzcd by both Iight and electron microscopy immuno-
l''ig. 2-17 Ciallery of electron micrographs illustrating the localization ol synaptophysin 
(p38). p29 and cytochrome bs<,i (cyto b56l) in subcellular organelles ol endocrine cclls 
Iinniimogold labeling of agarosc-embedded homogenates of box ine anterior pituitary 
(A-D) and adrenal mcdulla (E-Ci). Bolh synaptophysin and p29 arc selectively Iocalized 
on microvesicles (synaptic-like microvesicles, SLMVs) and no immunoreactivity Ior 
these proteins is visible on secretory granules. In F a p29-positive small membrane 
evagination of a vacuole with a partially dense corc is shown. TTiis structure may 
represent an immature granule. If so. the ligure suggests that separation of SI.MV 
protcins from secretory granule membranes takes place (or is completed) during 
secretory granule niaturatioii. The intense labeling of secretory granule membranes 
aftercytochrome bs(,i immunolabeling. indicates that their surfacc is freely accessible to 
antibodies and represcnts a positive control for the absence of synaptophysin and p29 
immunoreactivity. Calibration bar: 200 nm. Rcproduccd from Navone et al. (1986) and 
Baunierl et al. (1990) by copyright pcrmission ofthe RockefcTIcr Uiiiversity Press. 
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Fig. 2-18 Hlectron micrograph demonstrating the localization of synaptophysin on 
small endocytic vesicles in undifferentiated PC12 eelIs (A and B) and in C I l O cells 
transfectcd with synaptophysin c D N A (C). Immunogold labeling of cells which have 
been exposed Ior 1 Iir to an extracellular tracer (liorscradisli peroxidase) beforc fixation 
in ordcr to label endocytic compartments (for experimental details see Johnston et al.. 
198%). In both cell types immunogold label selectively decorates the surface of round 
or elongated microvesicles. Some of them are also positive for the extracellular tracer as 
shown by their content ofdark peroxidase reaction product. Harger pcroxidasc-positivc 
vacuoles. probably Iate endosomes or lysosomes. are unlabeled by immunogold. Notc 
Iaek of labeling of the plasmalemma. Calibration bar: 200 nm. Reproduccd Irom 
.lohnston et al. (1989b) by copyright permission ofOxford Univcrsity Press. 
cytochemistry as vvell as by subcellular fractionation (Navone et a l . . 1986; 
Franke et a l . . 1986; Obendor fc t a l . . 1988b; Fournieret a l . . 1989; Baumert et 
a l . . 1990). ResuIts from oiir Iaboratories suggest that at Ieast synaptophysin. 
synaptobrevin and p29 are loealizcd on a popuIation of microvesicles cleaiTy 
distinct from secretory granules. A t the light microscopic level o l resolution. 
immunoreactivity for thcse proteins was concentrated particularly in thc region 
ofthe Oolgi complex while immunoreactivity forcontcnt protcins ofsecretory 
granules was detcctcd primarily in the periphcral regions ofthe eell (Navone ct 
a l . . 1986; see Fig . 2-15). Immunogold clcctron microscopy showed that both 
synaptophysin and p29 were found primarily on a popuIation of pleomorphic 
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microvesicles (synaptic-likc microvesicles, refeired Io as S L M V s ) which were 
sparscly distributcd throughout the cytoplasm, oftcn present in small groups 
under the plasmalemma. and concentratcd particularly at the trans-side of the 
G o l g i complex and around ccntrioles. Secretory granules were consistentlv 
unlabeled, with the exception of occasional small evaginations of their 
membranes (Navone et a l . . 1986; Baumert ct a l . . 1990; Figs. 2-16, 2-17. 2-18a 
and b). Organelles with such evaginations may represent immature granules. If 
this is the casc. such images may indicatc that sorting of SSV membrane 
protcins from secretory granule membranc proteins is complcted during 
granule maturation (Baumert et a l . . in press). 
L i k e SSVs. S L M V s are Iabelcd by endocytie traccrs. suggcsting that they can 
undcrgo fusion with the plasmalemma and subsequent reinternalization by 
cndocytosis (Johnston et a l . . 1989b; F ig . 2-18a and b). In fact. synaptophysin 
was detectcd at low conccntration in the plasmalemma. and synaptophysin-
positive omega figurcs in thc plasmalemma were observed (Navone et a l . . 1986; 
Johnston ct a l . . 1989b). S L M V s are likely to be reeyeling organellcs which 
shuttlc between the plasmalemma and thc Go lg i complex. 
The selcctive Iocalization of synaptophysin and p29 was confirmed by 
immunoisolation of S L M V membranes from extracts of endocrine cells and 
tissues using immobiliz.ed monoclonal antibodies for synaptophysin as immu-
nosorbent. P29 and synaptobrevin copurify with synaptophysin on the 
immunobeads (Baumert et a l . , 1990). In clectron microscopy, immunoad-
sorbccl oigancUes are represented primarily by pleomorphic microvesicles and 
by only few secretory granules (unpublished observations). 
It is still debated whether a Iow conccntration of SSV membranc proteins is 
also present in matiire secretory granuIc membranes. A g a i n . most of the 
confIicting data are based on subcellular fractionation. using bovine adrenal 
mcdulla or related cell Iines as model systems. In thesc studies, eomigration of 
SSV-markcrs with thosc ol secretory granules during sucrose densin gradicnt 
centrifugation was used as criterion for colocalization (Obendorfet a l . . 1988b: 
Fournieret a l . . l989;Trifaroet a l . . 1989). In one casc. SSV-protein containing 
organellcs were immuno-isolated. resulting in the cosedimcntation o f 9 0 % of 
peptide hormone (Lowe et a l . . 1988). Unfortunatcly. no immunoclectron 
microscopy is available Ior any ofthese fractions. making it difficult Io evaluatc 
whether thc secretory granule fractions from thc dense parts of thc sucrose 
gradients are contaminatcd with microvcsicIes.While most authors prcsenlly 
agree that synaptophysin is primarily concentrated on a popuIation of 
microvesicles different Irom secretory granules (Navone et a l . , 1986; Wieden-
mann et a l . . 1988; Obendorfet a l . . 1988b; Navonc et a l . . 1989; Baumert ct a l . . 
1990) the amounl of synaptophysin and of the other S S V proteins present on 
the secretory granule membrane is a subjeet of controversy (Schilling and 
G r a t z l . 1988; Wicdcnmann et a l . . 1988; Obendorfet a l . . 1988b; Fournicrct a l . , 
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19<X9).We havc rcccntly rc-evaluatcd this issuc using bovine adrenal mcdulla as 
model system.While there was a clear codistribution of some synaptophysin 
with chromaffin granule markers on sucrose density gradients. treatmcnt ofthe 
granule Iraction with synaptophysin-immunobeads Ied to an almost complete 
removal of synaptophysin containing membranes. Ieaving behind a membrane 
fraction rieh in cytochrome bs(,i and dopamine -ß -hydroxy lasc but with only 
traccs of synaptophysin (Fischer v. Mol la rd et a l . . 199(); unpublished observa-
tions).These findings suggest that synaptophysin present in chromaffin granule 
membrane preparations is due mostly to eontamination by microvesicles. 
supporting the view that the membranc composition of S L M V s and secretory 
granules is dissimilar. 
2.5 SSVs and LDCVs - Organelles of Two 
Distinet Pathways of Regulated Exocytosis in 
Neurons 
Thc identification and characterization ofvesicle-specific membranc protcins. 
in particular of S S V protcins, has allowed new approaches to the study of the 
Iife cyclc ofthese organclles. namely their biogencsis. transport to release sitcs 
and cxo-endocytosis. In thc following sections,we wil l briefly discuss some of 
the implications derived from thc study ofvcsiele membrane proteins whieh are 
relevant for membranc traffic in ncurons and endocrine cells. For a more 
general overview. the rcadcr is referred to our recent revicw published 
clsewherc (De Camil l i and Jahn, 1990). 
2.5.\ Synthesis and Axonal Transport ot' SSV and L D C V 
Membranes 
SSVs 
It is unclear whether SSV membranc proteins lcavc the Golg i apparatus as part 
of the mature SSV or in precursor membranes from which SSVs originate at 
Iater stages. e.g. after transport into thc nervc terminal. A s mentioned abovc. 
most of the S S V membrane proteins are enrichcd in the area of thc Golg i 
2.5 SSVs und LDCVs 67 
complcx. Thc ii iorpliology of membranes positive for S S V protcins in thc 
vicinity of thc Golg i apparatus was recently analyzcd in dcvcloping Iiypothal-
amic ncurons (Tix ie r -Vida l ct a l . . 1988) and in electromotor ncurons of 
Torpedo marmorata (Janetzko ct a l . . 1989), using synaptophysin and SV2 as 
markers, respectivcly. These membranes arc represented by plcomorphic 
vesicles and vacuoles. However. in these studies newly formed membranes 
could not be distinguished from rctrogradely transported membranes. It is 
Iikely (see section 2.4.1.2) that a large fraction of SSV membranc protcins 
present in thc region ofthe Go lg i complcx reprcscnts membranes recyclcd from 
nervc terminals. SV2 containing structures were analyzcd in the axons of 
Torpedo electromotor neurons and found to be highly licterogcneous. including 
SSV-Iike structurcs. irrcgularly sliaped vesicles and multivesicular bodies 
(Janetzko et a l . . 1989). The first may represent anterogradely transported 
organelles, thc last retrogradely transported organelles.Working with the same 
systcm. Kienc and Stadler (1987) used metabolic labeling of thc vesicular 
proteoglycan to study selectively anterogradc axonal transport of SSV precur-
sor membranes. Accord ing to this study, synaptic vesiclcs are transported as 
morphologically homogeiieous small vesicular structures which are loaded with 
acetylcholine only after arrival in the ncrve terminal. In contrast, typical 50 um 
SSVs did not accumulate proximally to sites where axoplasmic transport was 
intcrri iptcd by a cold block (Tsukita and Ishikawa. 1980). 
W h c n niotor neurons of the rat sciatic nervc arc ligatcd. cqual amounts of 
SV2 and synaptophysin immunoreactivity accumulate on both sidcs of thc 
crush whcrcas synapsin I is found only on thc proximal sidc (Bööj ct a l . . 1980; 
Dahls t röm and Böö j , 1988; Bööj ct a l . . 1989).These data are consistcnt with a 
stcady-state flow of intrinsic SSV membranc proteins in both directions. 
Howcver. thc immunorcactive structurcs accumulating on both sidcs of the 
crush havc not yet bcen identified by elcctron microscopy. Synapsin I which is 
transported only distally is probably brokcn down in nervc terminals. 
In coiicl i ision. the iiature of the membranous organelles which dcliver SSV 
membranc material to thc synaptic terminals is still iinclear. A t thc present 
t imc, it cannot be riiled out that SSV membrane proteins are transported as part 
of Iieterogcneous tubulo-vesieular clcments.These organellcs may be cTosely 
related to S L M V s of endocrine cclls, bcing convertcd to homogeneous 5(1 um 
SSVs by a nerve terminal specific mechanism after arrival in nervc endings. 
2.5.1.2 L D C V s 
Like endocrine secretory granules. L D C V s arc assemblcd in thc region ofthe 
trans-Golgi nctwork. Aggregation and precipitation of secretory peptides is 
tlioiiglit to play a major rolc in thc biogenesis o f L D C V s (chapter3). It has becn 
68 2 Mcinbranc Proteins of Synuptie Vesicles 
shown that a givcii neuron may contain L D C V s with different peptide content, 
and that different L D C V s may be targetcd to distinct ccllular compartments. 
Content hetcrogcneity of L D C V s is thought to rcsult from a differential 
insolubilization of different peptide products at thc exit from the trans-Golgi 
nctwork. L D C V s Ieavc the region of the Golg i complex as fiilly assemblcd 
organelles, although content maturation continues duringtheir transport to thc 
sites of release. A x o n Iigation results in thc accumulation of L D C V s proximally 
to thc ligation site (Tomlinson, 1975). The fate of L D C V membranes after 
cxocytosis remains unknown due to the lack of immunocytochemical mem-
branc markers and is still a controversial issue (sce section 2.5.2.1). 
2.5.2 Exo- Endocytosis of SSVs and L D C V s 
2.5.2.1 Membrane Recycling 
Thc recycling o f S S V s in nervc terminals has bcen intensely studied in a tiumber 
of modei systems (Heuser and Reese. 1973; Ceccarelli et a l . , 1973) and is the 
subject of several rcviews to which the reader is referred (Heuser. 1978; 
Z immermann. 1979; Ceccarelli and Hur lbut . 1980; Kelly. 1988). In Iullv 
dcveloped synapses, SSVs are ciustcred at spccialiscd scgmcnts of the 
prcsynaptie plasma membrane, the activc zoncs ,which arc in preeise register 
with postsynaptic spccializations. In thesc cTiistcrs, they are thought to be 
Ioekedviasynapsin I bridges t o a w e b o f a c t i n filaments.When ncrvctcrminals 
are dcpolarized. voltagc-sensitive calcium channels open. C a f 1 cnters the cell 
and triggers cxocytosis of SSVs .Th i s proccss is extremely fast (lcss than 200 iis 
Iatcney between calcium cntry and transmittcr release) and tiglitly controlled 
by an array of modulatory mechanisms (Augustine et a l . . 1987; De Cami l l i and 
.lahn. 199()).The vesicle membrane is retricved by cndocytosis and used for the 
reformation of SSVs. 
A number of obscrvations indicatc that undcr conditions of moderate 
activity SSV membranes may not complctely flattcn into the plasmalemma but 
rather undergo a vcry transient fusion suffieient to allow neurotransmittcr 
release (Cecearelli and Hurlbut . 1980; Valtorta et a l . . 1988;Torri-Tarelli et a l . . 
1990). TTiey arc then retrievcd directly at the site ol release. without 
involvenicnt of cTathrin-coatcd vesicles or of an "endosomal" intermediate 
(Ccccarelli and Hurlbut , 198();Torri-Tarclli ct a l . . 1987; fo ra different view see 
Mi l l e r and Heuser. 1984). Under these conditions. no intcrmixing occurs 
between S S V membranes and the presynaptic plasma membranes. This is 
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supported by the observation that no SSV membrane proteins are visible in the 
presynaptic plasma membrane, in spite of electrophysiological evidcnee for 
quantal sccretion of neurotransmitter (Valtorta et a l . , 1988). 
Af tc r intcnse Stimulation, however, the number of SSVs decrcases and 
eoated vesicles and cisternac become abundant (Heuser and Rccsc . 1973). 
Numerous exocytotic profiles arc observed under thcsc conditions when nerve 
preparations arc fixed by ultrarapid freezing(Heuserct a l . . 1979;TorriTarelli et 
a l . . 1985). Furthermore. S S V membrane proteins are dctcctablc in thc plasma 
membranc (Von Wedel et a l . . 1981;Theresa-Joncset a l . . 1982: Robitaille and 
Tremblay. 1987;Valtortact a l . . 1988:Torri-Tarelliet a l . . 199()).The intraccllular 
cistcrnae arc Iabelled by extracellular tracers such as horscradish pcroxidasc 
vvhen Stimulation is pcrformed in their presence. Thcse cisternac probably 
represent an "endosomal" compartment of the nerve terminal and eventually 
disappear in parallel with the reformation of SSVs.This demonstrates that thc 
nerve terminal has the eapacity to regenerate SSVs from Iargc preciirsor 
membranes (Heuser and Reesc. 1973).Thcse cistcrnae may also represent the 
organellcs responsible for sorting membranc constituents destined to retro-
grade transport or for aceepting S S V protcins delivcred by anterograde 
transport (see section 2.5.1.1). 
Regulatcd exocytosis o f L D C V s is Icss well charactcrized. Secretory peptides 
which can only bc synthetized in the cell body arc degradcd after release. 
Therefore, functional L D C V s cannot be rcformcd in the nervc terminal .Their 
membranes must rccycle via thc Go lg i apparatus to be iised for another round 
of exocytosis. A t Icast in the case of thc posterior pituitary there is evidence 
siiggesting that the recycling of L D C V s might involve vacuoles in the samc sizc 
range of L D C V s (Theodosis et a l . . 1976: Morr is and Nordman. l98()).Thesc 
studies as well as oiir findings that SSVs and L D C V s havc different membrane 
compositions (Navone ct a l . . 1984; Navonc ct a l . . 1986; Baumert et a l . . 1989; 
Navone ct a l . . 1989; Baumert et a l . . 1990), have clcarly rulcd out that SSVs are 
directly formed Irom recycling membranes ol L D C V s . T h i s was suggestcd as a 
mechanism Ior SSV formation (Kelly. 1988; Boarder, 1989). 
Since the fate of L D C V membranes after exocytosis is Iargcly unknown, it 
cannot bc excluded that endocytosed membrane components of L D C V s are 
delivcrcd to a sorting compartment common to both SSVs and L D C V s vvithin 
thc ncrvc terminal (e.g. thc Iargc membrane structurcs mentioned above; see 
Fig . 2-2()a). If this is thc case. such a compartment must havc thc capacity to 
separate SSV proteins from L D C V proteins and to distingiiish between SSV 
proteins which arc designed for re-use in the terminal from those SSV and 
L D C V membrane proteins which are designed for retrograde transport. 
More vvork is required to imravcl thc completc membrane cycTes o fSSVs and 
L D C V s and the precise intcrrelationship between them. It cannot bc excluded 
that the conccpts outlined above do not apply to specializcd systems. For 
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example, the relationship bctwcen L D C V s and small densc core vcsicles (SSVs 
ofcatccholaminc containing ncurons) present in the varicosities ofsympathetic 
ncrvcs remains to be established. Both types of vcsicles are abundant in the 
varicosities and both contain catecholamincs. while only L D C V s contain 
secretogranin and ncuropcptides (Rosa et a l . , 1985; Dc Cami l l i and Jahn. 1990; 
Thureson-Klc in and K l e i n , 1990). In addition. thc mcmbranesofboth L D C V s 
and SSVs in synipathetic varicosities contain the eatccholaminc carrier, thc 
proton pump and cytochrome b ^ , (Phil ippu and Matthaei . 1988; Winkler . 
1988). A localization of S S V proteins in the varicosities at thc clectron 
microscopic level has not yet been reportcd. In this systcm, thc concept that 
SSVs are dcrivcd from L D C V s still prevails (for a full diseussion see Winkler . 
1988). Al though wc favor thc view that this systcm is similar to other ncurons. 
with a elcar separation ofthe pathways for L D C V s and SSVs (Thureson-Klein . 
1983; Thureson-Klein and K l e i n , 1990; De Camil l i and Jahn. 1990). more 
experiments are nccded to resolve this issue. 
2.5.2.2 Regulation of Exocytosis 
Thcre is incrcasing evidencc that exocytosis of SSVs and L D C V s is diffeien-
tially eontro l lcd .Thc relative proportion of peptide and classical ncurotrans-
mitter secrction varies with thc pattern of Stimulation. It appcars that a high 
ITequency of Stimulation, interrupted by silcnt intcrvals, is optimal for peptide 
seerction whereas maximal release ofclassical transmitter is already achieved at 
Iower frcquency with continuous Stimulation (Lundberg and Hökfe l t . 1983: 
Poulain and Theodosis, 1988). These diffcrences may partially rcflect the 
involvement ofdiffercnt C a + f chaiinels (Rane et a l . , 1987; Hi rn ing et a l . , 1988; 
Smith and Augustine, 1988; Mar t in and Magistretti . 1989). A n alniost 
complete dissociation of L D C V a n d SSVcxocytos is was observed rcccntly in 
the frog neuromuscularjunction. Appl ica t ion ofa-latrotoxin Ied to a complete 
and irreversible exocytosis of virtually all synaptic vcsicTcs witl i in thc ncrve 
terminal. Howevcr, thc n u m b c r o f L D C V s containingcalcitonin-gene related 
peptide was not signifieantly dccrcased (Matteoli et a l . . 1988; Fig . 2-19).These 
data suggest that the trigger mechanism for both types of vcsiclcs is different 
and Support the Iivpothesis that undcr physiological conditions SSVs and 
L D C V s respond to the ratc and amount o f C a + + - i n c r c a s e in a different manner 
(Smith and Augiis t ine. 1988). 
Thc concept of separate control of S S V and L D C V cxocytosis is further 
supported by thc observation that exocytosis of SSVs and L D C V s occurs al 
different sitcs. A s discusscd above, SSVs arc concenlratcd in ncrve endings in 
proximity to active zones. Their relcase occurs scleetively at these sites. In 
contrast. tlierc is strong evidcnce indicating that L D C V s undergo exocytosis 
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primarily away from activc zoncs of nerve terminals (Z l i u ct a l . , 1986). L D C V s 
are often found at high coneentration in cell bodies and dcndritcs (Morrison et 
a l . . 19N4) wherc thcy arc likely to undergo exocytosis.Within synapscs, L D C V 
cxocytosis almost ncvcr occurs at the active zone but rather at a more distant 
Iocation of the plasmalemma ( Z h u ct a l . , 1986;Thurcson-Klcin and K l e i n , 
1990). 
Fig. 2-19 Differential effect of ((-Iatrotoxin on exocytosis of L D C V s and SSVs at the 
frog neuromuscular junction. (A) shows a control nerve terminal whcre LDCVs 
(arrowhead) represent about L% of the total vesicle content. (B) and (C) show nerve 
terminals incubated for 1 hr in a Ca 2 +-free solution in the prcsenee ofa-latrotoxin. In 
these terminals. all SSVs. but not L D C V s , have disappeared as a result of massive 
exocytosis. A single LDC 1 V (arrowhead) surrounded by an SSV frec cytoplasm is visible 
in (B). Three L D C V s clustered in front of the synaptic cleft arc visiblc in (C). 
Calibration bars: (A)340um; (B)529 um; (C) 178um. Reproduced from Matteoliet al. 
(1988). 
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2.6 SLMVs and Secretory Granules: Two 
Pathways of Exocytosis in Endocrine Cells 
The discovcry of S L M V s (an endomembrane systcm of endocrine cells and 
endocrine tumors whieh shares major membrane proteins with SSVs and which 
is different from the respectivc secretory granules) raises the question of how 
thcse organelles arc related to the classical regulatcd and eonstitutive pathway 
of secretion. A s in ncurons, thc differcnce in the membrane composition 
betwecn S L M V s and secretory vesicles cxcludcs a simplc prccursor-product 
relationship between thc two organelles as suggested by others (Lowe ct a l . , 
1988; Kelly, 1988; Boardcr. 1989). Instcad. we have proposed that S L M V s 
represent organelles with distinct biogenesis and a completely independent 
function (Navonc ct a l . . 1986; De Cami l l i and Navone. 1987; De Cami l l i and 
Jahn. 1990).This function remains to bc dctermined. A n important clue was 
recently obtained when a fibroblast cell Iine ( C H O cells) which naturally docs 
not e.xprcss S S V protcins, was transfectcd with thc gcnc for synaptophysin 
(Johnston ct a l . . 1989b). In thc transfectcd cclls. synaptophysin was incorpo-
rated into microvesicles vcry similar in sizc and intraccllular distribution to 
S L M V s of endocrine cells. In addition, these vcsiclcs were also Iabelcd by 
a b C 
Fig. 2-20 MocIel of exo-endocytotic pathways in fibroblasts (a). peptide hormone-
secrcting endocrine cells (h) and neurons (c). SSVs: Small synaptic vesicles; L D C V s : 
Large dcnse core vesicles; SLMVs: Synaptic-Iike microvesicles; T G N : Trans-Golgi 
Network; G C : Golgi complex; C V : Coated vesicles. See text for details. 
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extracellular tracers raising the possibility that S L M V s are related to an early 
endosomal compartment (Johnston et a l . , 1989b; F ig . 2-18c). Furthercharac-
terization suggcsted that these microvesicles are idcntical with thc microvesi-
cles that rccyclc the transferrin rcceptor (Johnston et a l . . 1989b). Since it is 
likely that a membranc protein expressed in a foreign cell accumulates in the 
membrane type most closcly related to that in which it is normally present, 
these findings raise the possibility that S L M V s may be related to microvesicles 
involved in the rccycling of plasmalemma reccptors. According to this model, 
S L M V s vvould represent the endocrine adaptation of a recycling pathvvay 
present in all cclls and. furthermorc, SSVs would represent an even morc 
extreme adaptation of the same pathway (Fig. 2-2()).This issuc is currently 
undcr investigation in our laboratories. 
2.7 Conclusions 
In this chapter,we have attcmptcd to give an overview ofthe best characterizcd 
membrane protcins of synaptic vesicics and the advanccmcnt in thc ficld of 
neuronal membranc traffic which were possiblc by the usc of these protcins as 
markers. Thc study of these protcins has allowcd major progress in our 
understandingofthe biogenesis and Iife cyclesofSSVs and. to a lessercxtent. of 
L D C ' V s . firmly establishing them as functionally and structurally different 
organelles. In addition. the similaritics betwecn SSVs and S L M V s as wcll as 
thosc bctwccn L D C V s and secretory granules in ncurons and endocrine cells, 
respectively, Iias aidcd the development of new concepts for neuronal sccretion 
in the contcxt ofestablished pathways ofexocytosis in otl icrcclIs. Al though the 
iiioleeular composition of SSVs is presently undcrstood better than that of any 
other scci'cttiry organclle, our picture is far from complctc and thc characteri-
zation of new proteins may quickly outdate this revicw. Presently. thc function 
of most ofthe SSV proteins dcscribed Iierc is unki iowi i . 1 Iowever,we hope that 
thc detailed knowledge of their structure and their properties wil l allow 
functional studies. Ieading to thc elucidation of the molecular mechaiiisms 
involved in thc exo-endocytotis of these organelles. 
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3 Chromogranins/Secretogranins -
Widespread Constituents of the 
Secretory Granule Matrix in 
Endocrine Cells and Neurons 
Wicland Ii Huttner, Hans-Herniann Gerdes and Palrizia Rosa 
3.1 Introduction 
In certain specialized eukaryotic cclls such as neuroendocrine ( N E ) ccIls and 
ncurons. thc final stcp in thc sccrction of signalling molecules such as peptide 
hormones, neuropcptides and "classical" neurotransmitters (e.g., acetylchol-
ine) is a highly regulated evcnt .The cellular basis for the regulated relcase of 
these molecules is the existcnce of specific organelles in which these molecules 
arc stored at high concentration and from which thcy arc relcased when thc ccl l 
rcccivcs an appropriate stimulus. N E cells contain two typcs of such secretory 
organclles.These are (a) the small "transparent looking" synaptic vcsiclcs of 
ncurons and their countcrparts in endocrine cclls. and (b) the Iarger 
"dense-corcd" secretory granules of endocrine cells and their countcrparts in 
neurons (thc so-called Iarge densc core vesicles). whieh wc shall colleetively 
rcfcr to as " N E granules". 
N E granules arc thc organelles used for the storage and release of peptide 
hormones and neuropeptides. N E granulcs form in the trans Golg i network 
( O r c i e t a l . l987 ;Toozee ta l . l9<X7;ToozeandHuttner. 1990). M o s t N E g r a n u l e s 
contain. in addition to tlicir specific peptide hormonesor neuropeptides. one or 
more of the chromogranin/secretogranin (Cg/Sg) proteins (Rosa et al. 1985a. 
Abbreviat ions: 
C'g. chromogranin; N E . neuroendocrine; Sg. secretogranin: S D S - P A G E , 
sodium dodecyl sulfate polyaerylamidc gel clcctrophorcsis. 
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1985b; W i n k l c r ct al . 1986; Eiden ct al . 1987; Fischcr-Colbric et al . 1987; 
Huttncr et al . 1988). The Cgs/Sgs have a much wider tissue distribution than 
any individual pcptide hormonc or neuropeptide and arc the most widcspread 
markers for the matrix of N E granulcs known. 
It is thc purpose of this artielc 1. to revicw the biochemical, cell biologieal 
and molecular biological data available for the Cgs/Sgs. and 2. to summarize 
and compare the immunohistochemical data on thcsc proteins in normal and 
neoplastic human N E cells and tissues. 
3.2 The Chromogranir^Secretogranin Protein 
Family - Molecular and Cell Biology 
The Cgs/Sgs are a family of secretory proteins which share many propertics, 
including a widesprcad occurrcnce in N E granules (Rosa ct al . 1985b; 
Fischer-Colbrie et al . 1987). Three proteins have so far been established to 
belong to thc Cg/Sg family: chromogranin A ( C g A ) . chromogranin B (CgB) 
(also called secretogranin I, Sgl) and secretogranin II (SgII), for nomenclature 
see Eiden et al . 1987). Other acidic proteins such as thc 32-35 kd " H I S L - 1 9 " 
antigen (Kr isch ct al . 1986; 1988) and thc 21-24 kd protein " 7 B 2 " (see 
Marcinkicwicz ct al. 1986. and rcfs. therein; Martens 1988),which also have a 
widesprcad distribution in N E granules and which might turn out to bc 
members of the Cg/Sg protein family in a wider sense, wi l l not be discussed. 
The first member of this protcin family to be idcntificd was C g A . w h i c h was 
ciriginally dcscribed and characterized as thc major secretory protcin of the 
bovine adrenal mcdulla (Helle 1966; Blaschko et al . 1967; Smith and Winkler 
1967). It was independently idcntificd as a secretory protcin ofthe parathyroid 
gland. referred to as secretory protein I (Kemper et al . 1974). Subsec|iicntly, it 
was shown that C g A of the adrenal mcdulla and secretory protein I of the 
parathyroid gland wcre very similar, if not identical, proteins (Cohn et al. 
1982). 
The sccond member of the Cg/Sg family to bc identified was SgII ,which was 
independently described as an M r 70,000 siilfated secretory protein (p7()) ofthe 
bovine anterior pituitary (Rosa and Zanin i 1981; Zanin i and Rosa 1981) and an 
M 1 86,000-84,000 tyrosine-sulfated secretory protein (p86/84) of the adrenal 
meduIla-derived cell line PCT2 (Hut tnerand Lee 1982; Lec and Huttner 1983). 
Subsequently. it was shown that a protein immunologically related to p70 was 
present in thc adrenal medulla and that this protcin as well as p86/84 of PC12 
cells wcre thc samc as p70 of thc anterior pituitary (Rosa and Zanin i 1983; Rosa 
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ct a l . l985b). SgII has previously been called T S P 86/84 (Rosa et al. 1985a), 
GP-87 (Chanat ct al . 1986, 1988) or chromogranin C (Fischer-Colbric et al. 
1987). 
The third member of the Cg/Sg family to be dcscribed was C g B (SgI),which 
was first characterizcd as an M r 113,000-105,000 tyrosinc-sulfated secretory 
protein (pl l3/pl()5) of PC12 cells (Huttner and Lec 1982, Lee and Huttner 
1983).This protcin was subsequcntly detected in the bovine adrenal mcdulla 
(Fa lkensammcre t a l . 1985). 
Fol lowing their initial eharacterization, the widespread distribution of C g A 
(L loyd and Wilson 1983; O ' C o n n o r et al . 1983a, 1983b; Cohn ct al . 1984; 
Somogyi et al. 1984), SgII (Rosa et al . 1985a, 1985b) and C g B (SgI) 
(Fischer-Colbrie et al . 1985; Rosa et al . 1985b) in peptidc-sccrcting N E cells 
was established, as is dcscribed in detail below (see also refs. inTabs. 3-2 and 
3-3). C g A - and CgB-Iike proteins have been detected in various vertebrate and 
invertebrate spccies (Rieker ct a l . 1988). 
3.2.1 Structure and Biochemical Properties 
Over thc past four years, thc primary structure ofbovine , human, porcine and 
rat C g A (Bcncdum et al. 1986; Iacangelo ct al . 1986; A h n ct al. 1987; Koneck i 
et a l . 1987; Hclman et al . 1988a; Iacangelo et al . 1988a, 1988b; Hutton ct al . 
1988a; Parmeret al . 1989), of human and rat C g B (Sgl) , (Benedum et al . 1987; 
Forss-Pettcr ct al. 1989) and of rat and human SgII (Gerdes et al . 1988, 1989) 
has been deduced from the c o r r c s p o n d i n g c D N A sequenccs (Fig. 3-1). Mueh of 
thc informatioii about the thrcc proteins rcvealed by these and other 
biochemical studies is listed inTab. 3-1. Except for the cleavcd signal peptides, 
the Cgs/Sgs arc vcry hydroplii l ic proteins with a high proportion of cliarged. 
mostly acidic, amino aeid residues.These structural leatures eontribute to the 
remarkable property of all threc protcins to reniain soluble after boiling 
(Hut tnerand Lce 1982; R o s a e t a l . l985b) .Al l th recpro tc insarecharae tc r izcd 
by vcry low isoeleetric points, with C g A (pI ~ 4.8) bcing the most acidic and 
C g B (pI = 5.2) bcing thc lcast acidic polypeptide.Thesc low isoeleetric points 
arc not only duc to thc high proportions of acidic amino acid residues but also 
rcsLilt from post-translational modifications such as phosphorylation, sialyla-
tion and sulfation (Fischer-Colbrie et al . 1982; K iang ct al . 1982; L c c and 
Huttner 1983; Rosa ct al . 1985b, and rcfs. tlierein). 
A n uncxpectcd finding of the c D N A cloning work was that thc actual 
polypeptide leiigth ofthcsc proteins. particularly in the casc o f C g A (Bcncdum 
ct a l . 1986; Iacangclo ct a l . 1986) and C g B (Benedum ct al . 1987). is 
considcrably Icss than thcir apparcnt M r on S D S - P A G E . The anomalous 
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Fig. 3-1 Schcniaiic diagram of the primary structure of luiman chromogranin A 
(hCgA). chromogranin B (IiCgB) and secretogranin II (hSgII). 
electropliorctic niobility of thc Cgs/Sgs is. for thc most part, not duc to 
post-translational modifications but refleets an inhercnt property of tIic 
unmodified polypeptidcs, presumably thc abundaiicc of acidic amino acid 
residiies. as observed for certain othcr acidic protcins. e.g.. the neiirofilament 
polypcptidcs (Kaufmann ct al . 1984). 
Thc scqucnccs of the Cgs/Sgs further rcvealed that. although all t l i iec 
proteins sliare scveral common propcrties, C g A and C g B are strueturally more 
closcly related to each othcr than eithcr protcin is to S g l l . C g A and C g B 
contain a liighly homologous. disulfide-bonded loop structure iiear thcir 
N-termini and another homologous sequence at their C-termini (Bcnedum ct 
al. 1987).Thc disulfide-bonded Ioop structure is not found in SgII, which Iaeks 
cystcine rcsiducs.whereas a significant homology to thc C-terminal sequence of 
C g A and C g B is present in SgII (Gerdcs et al . 1988. 1989). 
Finally.wc know about twootherstruetural and biochemical propertics ofthe 
Cgs/Sgs which wil l bc discusscd in detail below as thcy are probably related to 
their function(s). First, all tliree proteins contain multiple dibasic residues 
which are potential sites for thc proteolytic processiiig to smaller. perhaps 
biologically active. peptides. Sccondly. these proteins bind calcium with 
3.2 Ilie CTiromograninfSeaetograiiin l'rotein Paiiiily 97 
Tab. 3-1 Propertics of the ehromogranins/secretogranins. 
Properties Chromogranin A Cliromogranin B Secretogranin Il 
M 1 in SDS-PACH 75.000-85.000 100.000-120.000 84.000-87.000 
Mol . wt. (cDNA-deduced) 48.000 76,000 67.000 
Isoeleetric point 5.0-4.8 5.2-5.0 5.1-4.9 
Heat stability yes yes yes 
Signal peptide yes yes yes 
Subcellular Iocalization N E granules N E granules NE granules 
Sccreted yes yes yes 
Calcium binding yes yes yes 
affinity high i iM N D N D 
numbcr of sitcs many ND ND 
aggregation yes yes yes 
Post-translational modifications 
N-glycosylation no no I l O 
O-glycosylation yes yes yes 
( i A G cliains yes N D N D 
Phosphorylation Sei. Thr Ser.Thr Ser.Thr 
Sulfation Tyr*, carbohydrate Tyr, carbohydrate Tyr. carbohydr 
Proteolytic processing yes yes yes 
a-amidation yes (pancreastatin) N D ND 
CcTIuIar distribution 
endocrine cells yes yes yes 
neurons yes yes yes 
exocrine cclls no no no 
constitutive cclls no I l O I l O 
For refs., sce text. ND. not determined. *Only in some species. 
niodcrate affinity ;it multiple sitcs (RoiHcn and Gratz l 1986; G o n e t al. L988; 
Cozzi and Zanini L988) and aggregate in thc presence of this divalent cation 
( ( ior re t al. 1988; Gcrdese t al . 1989; G o r r e t al. l989).These propertiesare 
probably a reflcction of both the excess negative chargc and the presumptivc 
seeondary structure ol these proteins.which Iargely consist of hcliees and turiis. 
allovving intra- as well as intermolecular calcium binding. 
f Bayerische 
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3.2.2 Subccllular Localization 
3.2.2.1 Immunocytochemistry 
Immunoelectron microscopic data show that the Cgs/Sgs arc present in the 
matrix of N E granules (Rosa et al . 1985a; Varndcl l et al . 1985; Ehrhart et a l . 
1986;Hashimotoeta l . 1987;Hearn 1987;Si lverc ta l . 1988;Tougardetal. 1989; 
Steineret al . 1989; Bassetti et al . 1990) which arc also known to contain peptide 
hormones and neuropeptides. In some cases, co-localization of the Cgs/Sgs 
with specific hormones in N E granules has bccn demonstrated directly by 
double immunoelectron microscopy (Ehrhart et al. 1986; Hashimoto ct al . 
1987; Silvcr ct al . 1988; Steiner et al . 1989; Bassetti et a l . 1990). Immuno-
reactivity for the Cgs/Sgs has also bccn dctected in thc Golg i complex 
(Hashimoto et al . 1987;Tougard et al . 1989). 
3.2.2.2 Subcellular Fractionation 
Consistcnt with the results of immunocytochemistry, all three Cgs/Sgs are 
largcly rccovered in subcellular fractions enriehed in N E granules, as exem-
plified for chromaffin granulcs (Rosa ct al . 1985b; Wink le r et al. 1986). 
3.2.3 Biosynthesis and Proteolytic Proeessing 
The rclativc proportion of the individual members of the Cg/Sg family in a 
givcn tissue (e.g.. the adrenal medulla) differs across species. and in a given 
species (e.g.. cow) differs across tissucs (Rosa et al. 1985b; for rcview scc 
Fisehcr-Colbrie ct al . 1987).This suggcsts that the synthesis of the individual 
Cgs/Sgs is differcntially regulated. Indeed, different protcin and m R N A lcvcls 
for C g A and B after neurogcnic and humoral stimulation have been reportcd 
(Sietzcn et al. 1987; Fischer-Colbrie et al. 1988). Glueocorticoids incrcase thc 
amoiint o f C g A m R N A and protein. but do not appear to affcct thc levels of 
C g B a n d S g I I pro te ins(Rauscheta l . 1 9 8 8 ; G r i n o e t a l . 1989; Fiseher-Colbriect 
al. 1989). Phorbol csters also inerease thc C g A m R N A levcl and thc synthesis 
ofthe protein (Murrayet al . 1988; Simon et al. 1989); thc detailed mcchanisms 
undcrlying thesc cvcnts remain to be established. 
After translation, translocation into the lumcn of the rough cndoplasmic 
reticulum and signal peptide cleavage, the Cgs/Sgs undergo a variety of covalcnt 
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modifications during their passage from the rough endoplasmic retieulum to 
the trans Go lg i nctwork, including formation of a single disulfide bond (only 
C g A and C g B ) , O-glyeosylation, phosphorylation (largcly on serinc) and 
sulfation of carbohydrate and tyrosine residues (Kiang et al. 19<S2; Rosa ct al . 
l985b; Bencdum et al . 1987; Fischcr-Colbric ct al . 1987. and rcfs. thercin; see 
Tab.3-1) . In thc trans Golg i nctwork, the Cgs/Sgs are packagcd into N E 
granules (Tooze and Huttner. 1990). Secretory protcins that normally are not 
packagcd i n toNEgranu l c s are re-routed to these organellcs i fcomplcxcd to thc 
Cgs/Sgs (Rosa et al . 1989). In N E granules, the Cgs/Sgs undergo partial 
proteolytic proccssing during their storage (Rosa ct al. L985b; Fischer-Colbrie 
et a l . 1987; Hutton et al . 1987a. l987b; Wohlfarter et al. 1988). Defined 
proteolytic produets of the Cgs/Sgs includc betagranin (Hutton et al . 1987a: 
1987b; 1988a) and pancreastatin (Tatemoto et al . 1986; E idcn 1987; Huttner 
and Benedum 1987; Koneck i et al . 1987; Iacangelo et al . 1988b; Sekiya et al . 
1988; Schmidt et al . 1988b; Funakoshi et al . 1989) in the case of C g A . and 
G A W K in the case of C g B (Benjannct ct al . 1987). Upon Stimulation of 
cxocytosis, thcse proteins and their proteolytic fragments are rcleased into thc 
cxtraccllular space (Blaschko et al . 1967; Rosa et al . 1985b). C g A and C g B 
havc bccn dctected in thc blood plasma (O 'Connor and Bernstein 1984; 
O 'Connor and Deftos 1986; Wiedenmann et al . 1987). 
3.2.4 Functions 
Thc physiological function of the Cgs/Sgs is still an open qucst ion.Thc Cgs/Sgs 
may have extracellular rolcs in that the intact protcins or proteolytic fragments 
derived from them cxcrt biological activities on target cells (E idcn 1987; 
Huttner and Benedum 1987; Simon et al . 1988). Thc dcterminatioii of the 
primary structure of C g A . C g B and SgII has shown that all three proteins 
contain multiple dibasic sitcs for potential proteolytic proccssing (Bcncdum et 
al . 1986. 1987; Iacangclo et al . 1986; Gerdcs et al. 1988. 1989). C g A is the 
precursor of pancreastatin. a peptide which partially inhibits glucose-induced 
iiisii l in release from thc isolated pancreas and regulated protcin secretion from 
certain other cclls (Tatemoto et al. 1986; E idcn 1987; Huttner and Bcnedum 
1987; Koneck i et al . 1987; Iacangclo et al . 1988b; Sekiya et al. 1988; Schmidt ct 
al. 1988b; Fasciotto et al. 1989). In addition, tryptic fragments o f C g A partially 
inhibit regulated cxocytosis from isolated chromaffin cells (Simon et al . 1988). 
O n the other hand, full-length C g A appears to excrt similar inhibitory actions 
as pancreastatin (Greclcy et al. 1989). Thus. it is possible that C g A and its 
proteolytic products function as autocrine. paracrine or even endocrine 
regulatory agcnts on secretory processes, although it remains to be established 
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whether the above in vitro observations reflect the true functions ofthe C'gs/Sgs 
in vivo. 
It has also been suggested that the Cgs/Sgs have intraecllular roles in the 
paekaging and/or proeessing of certain peptide hormones and neuropeptides 
( R o s a e t a l . l985a, 1985b;Seidahetal . 1987). I t i s c o n c e i v a b l c t h a t t h e l o w p H -
and Ca 2 + -p romo ted aggrcgation of the Cgs/Sgs may be relevant in this regard 
(Gerdeset al . 1989; G o r r e t a l . 1989). In thiscontcxt, it is interesting that in the 
bovine anterior pituitary, thyroid-stimulating hormone and lutcinizing hor-
mone, which arc eo-packaged together with the Cgs/Sgs into N E granules of 
thyrotrophs and gonadotrophs, are also co-packaged with these proteins into a 
subpopulation of N E granulcs of somatomammotrophs that are distinct from 
anothcr N E granule subpopulation containing growth hormone and prolaetin 
(Bassetti et al . 199()).These observations arc consistent with the possibility that 
the Cgs/Sgs and certain peptide hormones eo-aggregate in the packaging 
process. 
3.3 The Chromogranin/Seeretogranin Protein 
Family - Markers for Neuroendocrine Cells 
3.3.1 Ccllular Distribution in Normal Cclls and Tissucs 
Prior to deseribing thc eellular distribution of thc Cgs/Sgs in normal and 
neoplastic cells and tissues. wc would Iike to discuss possiblc causes for an 
apparent Iaek or variability of immunoreactivity in certain immunohistochcm-
ical preparations.Thc Cgs/Sgs (a) vary greatly in abundancc between different 
cell types and different N E granulcs. (b) may be compIcxcd to othcr molecules 
in situ (c) cxhibit marked sequenee variations across species, and (d) undergo 
extensive post-translational modifications (seeTab. 3-l) .These fcaturcs may 
contribute to a reduced immunoreactivity of thc Cgs/Sgs, which should bc 
borne in mind in thc interpreation of negative or variable immunohistochem-
ical results. 
3.3.1.1 A n i m a l CeIIs and Tissucs 
The ceIlular distribution of C g A . C g B and SgII in normal animal N E cells. as 
revealed by immunohistochemical studies from many laboratories. is prcscnted 
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inTab. 3-2. For a givcn tissuc, the ccllular distribution of thcse three protcins is 
sometimes overlapping and sometimes complementary (Rosa et al . L985b; 
Rindi et al . 1986; Fiseher-Colbrie et a l . 1987).The lattcr finding is particularly 
important sinee it implics that Iaek of immunoreactivity for a specific protcin 
may not necessarily mean the absenee of all membcrs of this protcin family in 
gcneral. Thus. thc usc of a eocktail of antibodies against all three Cgs/Sgs 
appears to be thc mcthod of choice to identify N E granule-containing cclls in 
thc futurc. However, even then it cannot be excludcd at present that certain N E 
granule-containing cclls may lack immunoreactivity. 
3.3.1.1.1 NervousSystem 
A l l three Cgs/Sgs havc becn detectcd in neurons (secTab. 3-2). In fact. thesc 
proteins arc more widespread markers of N E granules of neurons than any 
known nciiropeptide. However, as exemplified for thc cercbellar cortcx, thc 
immunoreactivity for SgII (Cozzi ct a l . 1989) is morc restricted than that for 
markers of small N E vcsicles, e.g. synaptophysin (Navonc et al. 1986).This 
most probably reflects the more widcspread occurrence of small N E vcsiclcs 
than N E granulcs in neuronal tissue. 
3.3.1.1.2 Endocrine System 
Many endocrine cells havc bcen found to bc strongly immunoreactive for 
Cgs/Sgs.Thcsc include endocrine cells of the anterior pituitary, C-cclls of the 
thyroid. chicf-cells ofthe parathyroid, chromaffin cclls of thc adrenal medulla, 
various islet cells of the pancreas. N E c e l l s of thc bronchial and gastiointestinal 
tract. of Iymph nodes and ofthe thymus, as vvell as Merke l cclls ofthe skin (see 
Tab. 3-2)'. 
Many Cg/Sg-positive N E cellscontain all three ofthese proteins; howcver, as 
originally noted (Rosa et al . 1985b), sevcral N E cell types have bccn found that 
appear to express only onc or two of them. For cxample, C-eells of thc thyroid 
contain C g A and SglI but appear to Iaek C g B immunoreactivity (Rindi et al. 
1986); chicf-cclls of the parathyroid contain C g A but appear to Iack C g B and 
SgII immunoreactivity (Lassmann et al . 1986). 
Rcccntly, antibodies direetcd against defined C g A fragments such as 
betagranin (Hutton et al . I988b) and pancreastatin (Schmidt ct al. 1988a) or 
against defined C g B fragments such as G A W K (Igiichi et al. 1988; Salahuddin 
et al. 1989) have also bccn uscd to investigatc thc distribution of thcse Cg/Sg 
products in N E cells. 
Tab.3-2 Immunohistochemical iclentification of chromogranins/secretogranins in normalanimalNEeells . 
Cel ls Chromogranin A Chromogranin B Secretogranin II 
Ncurons Cohn ct al. 1984 
Somogyi ct al. 1984 
Nolan ct al. 1985 
Lassmann ct al. 1986 
Volknandl cl al. 1987 
++ Rosa ct al. 1985b ++ 
++ Fischer-Colbrie et al. 1985 ++ 
4f Lassmann cl al. 1986 ++ 
Rosa ct al. I985b 
Cozzi et al. 1989 
Lassmann ct al. 1986 
EncIocrinc cclls of lhe 
anterior pituitary 
A C T H O'Connor ct al. 1983a 
Cohn et al. 1984 
Rundle cl al. 1986 
+ Rundlc ct al. 1986 Rosa et al. 1985a 
Rundlc et al. 1986 
FSHA-H + OConnor et al. 1983a 
+ Rundlc ct al. 1986 
++ Rindi cl al. 1986 
Rindi et al. 1986 
Rundle et al. 1986 
Rosa et al. 1985a 
Rindi et al. 1986 
Rundle ct al. 1986 
GH O'Connor et al. 1983a 
Cohn et al. 1984 
Rundlc cl al. 1986 
Rundlc ct al. 1986 Rosa et al. 1985a 
Rundle ct al. 1986 
Hashimoto ct al. 1987 
Prolaclin O'Connor et al. 1983a 
Cohn ei al. 1984 
Rundlc el al. 1986 
Rundle cl al. 1986 Rosa et aI. 1985a 
Rundlc et al. 1986 
Hashimoto ct al. 1987 
TSH Cohn ct al. 1984 
Rindi et al. 1986 
Rundlc cl al. 1986 
++ Rindi ct al. 1986 
Rundle ct al. 1986 
++ Rosa ct al. 1985a 
++ Rindi et al. 1986 
+ Rundlc el al. 1986 
Unspcciricd 
C-cclls of thc thyroid 
Chief-cclls of thc parathyroid 
Chromaffin cclls of thc 
adrcnal mcdulla 
O'Connor ct al. 1983a + ^ Rosa et al. 1985b ++ Rosa et al. 1985a 
Cohn C l al. 1984 + Fischcr-Colbric et al. 1985 ++ Rosa et al. I985b 
Soniogyi C l al. 1984 ++ Lassmanri Cl al. 1986 ++ Lassmann et al. 1986 
+ Nolan ct al. 1985 
• • Lassmann c l al. 1986 
< * O'Connor et al. 1983a Lassmann cl al. ] 4 X 6 ++ Rosa cl al. 1985b 
+ t Cohn et al. 1984 - Rindi et al. 1986 _ Lassmann et al. 1986 ++ Nolan et al. 1985 ++ Rindi ct al. 1986 
- Lassmann et al. 1986 
+1 Rindi et al. 1986 
+ O'Connor et al. 1983a + Fischer-Colbrie et al. 1985 Lassmann ct al. 1986 
- Cohn ct al. 1984 - Lassmann ct al. 1 9 X 6 + Rindi ct al. 1986 
Nolan et al. 1985 - Rindi ct al. 1986 ++ Lassmann et al. 1986 
+ * Rindi et al. 1986 
* t O'Connor et al. 1983a ++ Rosa ct al. 1985b ++ Rosa et al. 1985b 
++ Cohn et al. 1984 ++ Fischer-Colbrie ct al. 1985 ++ Lassmann ct al. 1986 
++ Somogyi ct aI. 1984 ++ Lassmann ct al. 1986 ++ Rindi et al. 1986 
++ Nolan ct al. 1985 t f Rindi et al. 1986 + Yoshic et al. 1 9 X 7 
* * Lassmann ct al. 1986 ++ Yoshic ct al. 1987 
++ Yoshie ct al. 1987 
Islct cclls of the pancrcas 
A cclls ++ Ehrhart ct al. 1986 
++ Grubc ct al. 1986 
++ Rindi et al. 1986 
++ Yoshie et al. 1987 
++ Ehrhart et al. 1988 
+ Buffa ct al. 1988a 
+ Rindi et al. 1986 
Yoshie et al. 19X7 
+ Buffa ct al. 198Xa 
++ Rindi et al. 1986 
+ Yoshic ct al. 1987 
+ Buffa et al. 1988a 
Tab. 3-2 (coiitinued) 
Cel ls Chromogranin A Chromogranin B Secretogranin II 
B cclls O'Connor cl al. 1983a 
Ehrharl el al. 1986 
Grube cl al. 1986 
Rindi el al. 1986 
Yoshic el al. 1987 
Ehrhart el al. 1988 
Rindi cl al. 1986 
Yoshic cl al. 1987 
Rindi ct al. 1986 
Yoshie ct al. 1987 
D cclls Ehrhart el al. 1986 
Grubc et al. 1986 
Yoshic cl al. 1987 
Ehrharl cl al. 1988 
Yoshic el al. 1987 Yoshie ct al. 19X7 
PP cclls + Ehrhart ct al. 1986 
+ Grubc ct al. 1986 
++ Rindi ct al. 1986 
+ Yoshic ct al. 1987 
+ Ehrhart ct al. 1988 
+ Buffa ct al. 1988a 
Rindi ct al. 1986 
Yoshie ct al. 1987 
+ Rindi el al. 1986 
+ + Yoshic ct al. 1987 
Unspecified O'Connor ct al. 1983a 
Cohn ct al. 1984 
Nolan ct al. 1985 
Lassmann ct al. 1986 
Rosa ct al. 1985b + 
FischcrColbric el al. 1985 + 
Lassmann ct al. 19X6 
Rosa et al. 1985b 
Lassmann cl al. 1986 
NF.-cells ol Ihc 
Bronchial tract 
Gastrointcslinal tract 
Lymph nodcs and thymus 
Nolan et al. 1985 ND ND 
* Lauwcryns Ct al. 1987 
Cohn et al. 1984 ++ Rosa ct al. 1985b + Rosa ct al. 1985b 
Nolan et al. 1985 ++ Fischcr-Colbrie ct al. 1985 - Lassmann ct al. 1986 Lassmann et al. 1986 ++ Lassmann Ct al. 1986 - Rindi ct al. 1986 Rindi ct al. 1986 t t Rindi ct al. 1986 + Bufla ct al. 1988a 
Buffa ct al. 1988a + Buffa ct al. 1988a 
Hoguc-Angeletti & Hickey, ND ND 
+/-
1985 
Nolan ct al. 1985 
Mcrkclccllsofuhcskin - Nolanetal.l985 ND ND 
++ Gauweilcr ct al. 1988 
++ Hartsehuh & Weihe 1988 
++ Harlschuh Cl al. 1989 
++ all or the majority of N E cclls rcported to bc immunoreaclive 
+ Ihc minority of NE cclls rcportcd to bc immunoreactivc 
no detcctable immunoreactivity 
ND Not determined 
* Commcrcially available monoclonal antibody LK2H1() uscd to dctect immunoreaclive chromogranin A 
Notc that thc rcsults obtained for sevcral ariimal spccics arc compilcd in this Table, which cxplains somc of the apparcnt discrcpancics. 
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3.3.1.2 Human N E Cells and Tissues 
The cellular distribution of C g A , C g B and SgII in normal human N E cells, as 
revcaled by immunohistochemical studies from many laboratories, is presented 
in Tab. 3-3. For C g A , many of these studies have been performed using the 
monoclonal antibody LK2H1( ) describcd by L loyd and Wilson (1983) which is 
commercially available (e.g., from Camon.Wiesbaden, F . R . G ) . For C g B , so far 
only one study using monoclonal antibodies has been reportcd (Pelagi et al. 
1989). 
3.3.1.2.1 NervousSystem 
So far, only a fcw studies have been published on the Cgs/Sgs in normal human 
nervous systcm (seeTab. 3-3).These show that C g A and C g B are present in 
human neurons. 
3.3.1.2.2 Endocrine System 
A variety of normal human endocrine cclls have been shown to contain 
members of thc Cg/Sg protein family. Thcsc include endocrine cclls of thc 
anterior pituitary, C-cells of the thyroid. chicf-cclls of the parathyroid, 
chromaffin cclls of the adrenal medulla, islct cells of thc pancreas, N E cclls of 
the bronchial and gastrointcstinal tract and Merke l cells ofthe skin (Tab. 3-3). 
Most of thesc studies have bccn conccrncd with C g A , using the monoclonal 
antibody LK2H1() (scc as tcr isks inTab. 3-3). Da t aon thecc l l u l a rd i s t r i bu t i on 
o f C g B and SgIl arc. so far, scarccr. Recently, an antibody against a defined C g B 
fragmcnt, G A W K . has bccn uscd to study the distribution of this protcin in 
human N E tissues (Bishop et al. 1989). 
3.3.2 Occurrence in Neoplastic Human Cells and Tissucs 
The occurrence of C g A . C g B and SgII in human N E tumors, as revcaled by 
immunohistochemical studies from many laboratories, is presented in Tab. 
3-4. 
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3.3.2.1 Ncrvous Systcm-Derived Tumors 
On ly iieuroblastomas and paragangliomas havc so far bcen studied for the 
occurrenec of Cgs/Sgs. Whereas most paragangliomas wcre found to be 
immunorcactivc for C g A and C g B by most investigators (secTab. 3-4; sec also, 
however, Scheithauerct al . 1986),only a few neuroblastomasshoweda-most ly 
weak - immunoreactivity with antibody LK2H1() for C g A . N o immunoreac-
tivity in ncuroblastomas was observed using antibodies against rat C g B (Lloyd 
et al . 19(S<S). S tudicsontheoecurrcnceofSgII in human nervous-systemderived 
N E tumors have not yct bccn reported. 
3.3.2.2 Endoerine System-Derivcd Tumors 
Many N E tumors derived from thc endocrine system have been shown to 
contain Cgs/Sgs (see Table 3-4). Most studies have focusscd on C g A . using thc 
monoclonal antibody LK2H1( ) . 
Pituitary adcnomas have only bccn studied with antibodies agaiiist C g A and 
C g B (secTab. 3.4).Whereas prolactinomas showed no immunostaining with 
antibody LK2H1( ) . these adeiionias coii ld be immunostained with polyclonal 
antibodies against C g B (Lloyd et al . 1988). So far. no data cxist on thc 
expression of SgII in pitiiitary adcnomas. 
Plieochromocytomas and mcdullary thyroid carcinomas have bcen shown to 
express thc Cgs/Sgs uniformly (seeTab. 3-4). 
For gastrointcstinal earcinoids and N E carcinomas. C g A has been shown 
(with the possiblc exeeptions of some hind-gut carcinoids) to be a vcry rcliable 
marker (secTab. 3-4) .While thcse tumors appear to express Iargc amounts of 
C g A , they secni to contain Icsser amounts of C g B and SgIL showing weaker 
immunohistochemical reactioiis for thc latter two proteins (Weileret al . 1987; 
L loyd et al . 1988; Wicdenmann et al. 1988). 
Pancicatie islet cell tumors have been studied for the expression of the 
Cgs/Sgs in detail. Ineontrast toear l i c r f ind ings(Lloyd et al . 1984). it is now wcll 
accepted that C g A is well detectablc in pancreatic insuliiiomas as well as in 
pancreatic glucagonomas. gastrinonias and hormonc-inaetive tumors (sceTab. 
3-4). Concerning the expression of C g B and SglI in islet cell tumors. all 
iieoplasias studied,with thc cxception ofgastrinomas (which werc found to lack 
C g B iminnuoreactivity). showed immunoreactivity with antibodies against 
these two protcins (Wiedei imann et al. 1988). 
In contrast to the above mcntioncd tumors, small eell carcinomas of the Iung 
have been shown to express only C g A , and only in a Iow percentage of cascs 
(seeTab. 3-4).While two s tud ics (Lloyd et al . 1988; Weileret al . 1988) reported 
Tab.3-3 Immunohistochemical identification ol chromogranins/secretogranins in normalhumanNEceTls. 
Cells Chromogranin A Chromogranin B Secretogranin II 
Ncurcms 
Endocrine cells of the 
anierior piiuitary 
ACTH 
- * I . l o y d & W i l s o n 1983 
- * W i l s o n & I . l o y d 1984 
++* I . l o y d et a l . 1986 
++ L l o y d ct a l . 1988 
++ S c h m i d ct a l . 1989 
l . l o y d ct a l . 1985a N D 
N D 
N D . 
F S H A - H ++* l . l o y d et a l . 1985a N D N D 
C K I . l o y d et a l . 1 9 8 5 a N D N D 
Prolactin 
T S H 
- * I . l o y d ct a l . 1985a 
++* I . l o y d ct a l . 1985a 
N D 
ND 
N D 
N D 
Unspecified ++' 
++ 
+ + « 
I . l o y d & W i l s o n 1983 
O ' C o n n o r ct a l . 1 9 8 3 b 
W i l s o n & I . l o y d 1984 
++ I l a g n ct a l . 1 9 8 6 
+ + L l o y d ct a l . 19X8 
+ S c h m i d et a l . 1989 
++ I l a g n ct a l . 1986 
CnxTls of the thyroid ++ L l o y d & W i l s o n 1983 
++ O C o n n o r ct a l . 1 9 8 3 b 
+ + * W T l s o n & I . l o y d 1984 
+ + R i n d i ct a l . 1986 
+ + * L a u w c r y n s ct a l . 1987 
S c h n i i d ct a l 19X9 N D 
C h i c f c c l l s o f the p a r a t h y r o i d ++* L l o y d & W i l s o n 1983 ++ L l o y d ct a l . 19XX N D 
++ O ' C o n n o r et a l . 1 9 8 3 h - S c h m i d ct a l . 19X9 
++ W i l s o n & I . l o y d 1984 
++ I Iagn ct a l . 1 9 8 6 
++ K i n d i ct a l . 19X6 
++ l l c a r n , 19X7 
C h r o m a f n n c c l l s o f t h c 
a i k e n a l meduUa ++* l . l o y d & W i l s o n 1983 ++ I l a g n ct a l . 1986 ++ H a g n ct a l . 1986 
++ O C o n n o r ct a l . 1 9 8 3 b ++ S c h o b e r ct aJ. 1987 ++ S c h o b e r ct a l . 1987 
++* W i l s o n & I J o y d 1984 ++ I . l o y d CI a l . 19XX 
++* L l o y d et a l . 1985b ++ S e h m i d e l a l . 1989 
++ H a g n ct a l . 1 9 8 6 ++• I . l o y d et a l . 1986 
++ S c h o b e r et a l . 1987 
++* W i c d e n m a n n Ct a l . 1988 
+ + * L l o y d et a l . 198X 
Is lc t c e l l s o f thc p a n c r e a s 
A c e l l s ++ O ' C o n n o r et a l . 1 9 8 3 b ++ R i n d i ct a l . 19X6 + R i n d i c l a l . 1 9 8 6 
++* L l o y d et a l . 1984 + L l o y d ct a l . 198X + W i e d e n m a n n c l a l . 1988 
++* V a m d e l l ct a l . 1985 + W i e d c n m a n n et a l . I 9 X X 
++ G r u b e ct a l . 1986 ++ S e h m i d et a l . 19X9 
++ R i n d i et a l . 1986 
+* W i e d e n m a n n et a l . 198X 
B c c l l s ++ O ' C o n n o r ct a l . 1 9 8 3 b N D N D 
+ * I . l o y d ct a l . 1984 
* V a r n d c l l ct a l . 1985 
+ G r u b c et a l . 1986 
+• W i e d e n m a n n et a l . 1988 
D c c l l s ++ O ' C o n n o r ct a l . 1 9 8 3 b N D N D 
++* V a r n d c l l et a l . 1985 
- C m i b c et a l . 1986 4 * W i c d c n m a n n et a l . 1988 
Tab. 3-3 (continued) 
Cells Chromogranin A Chromogranin B Secretogranin II 
P P c c l l s _ * V a r n d c l l ct a l . 1985 + S c h m i d ct a l . 1989 N D 
- G r u b c ct a l . 1986 ++* R i n d i et a l . 1986 
U n s p c c i f i c d ++* L l o y d & W i l s o n 1983 + I l a g n ct a l . 1986 _ H a g n et a l . 1986 
++ O ' C o n n o r ct a l . 1 9 8 3 b + I . l o y d ct a l . 1988 + W i c d c n m a n n ct a l . 1988 
++* W i l s o n & L l o y d 1984 + W i c d c n m a n n c l a l . 1988 
++ I l a g n et a l . 1986 
++* L l o y d ct a l . 1988 
+ * W i e d c n m a n n c t a l . 1988 
N E ^ e l l s o f t h c 
B r o n c h i a l t rac t ++ W i l s o n & L l o y d 1984 N D N D 
++ • L a u w c r y n s ct a l . 1987 
G a s t r o i n t c s t i n a l t rac t ++* L l o y d & W i l s o n 1983 + L l o y d ct aI. 1988 + W i e d e n m a n n et a l . 1988 
++ O C o n n o r c l a l . 1 9 8 3 b + W i e d c n m a n n ct a l . 1988 
++* W i l s o n & L l o y d 1984 ++ P c l a g i c l a l . 1989 
+ + • F a c e r et a l . 1985 ++ S c h m i d ct a l . 19X9 
++* V a r n d c l l ct a l . 1985 
++ R i n d i ct a l . 1986 
++ P c l a g i et a l . 1989 
M e r k e l c e l l s o f thc s k i n _ * W i l s o n & L l o y d 1984 N D N D 
++ * H a r t s c h u h & W e i h c 1988 
++ * H a r t s c h u h ct a l . 1989 
S 
3 
s 
; 
v_3 
S 
= 
^ 
-
~ 
5 
++ a l l or the m a j o r i t y o f N I - c c l l s r c p o r t c d to be i m m u n o r e a e t i v e 
+ the m i n o r i t y o f N L c e l l s r epor tcd to be i m m u n o r e a c t i v e 
no de tec tab le i m m u n o r e a c i i v i t y 
N D N o t d e t e r m i n e d 
* C o m m e r c i a l l y a v a i l a b l e m o n o c l o n a l antib<xly L K 2 I I I 0 uscd to dc t cc t i m m u n o r e a c t i v e c h r o m o g r a n i n A . 
Tab. 3-4 Immunohistochemical identification ol chromogranins/secretogranins in human N E tumors. 
Tumor Chromogranin A Chromogranin B Secretogranin Il 
A d r c n a l M c d u l l a 
Phc<xhromocy toma ++ 3t f O ' C o n n o r ct a l . 1983b 
++ * 5/5 L l o y d & W U s o n 1983 
++ *25/25 W i l s o n & L l o y d 1984 
++ • 2 8 / 2 8 L l o y d et al 1985b 
++• 5/5 V a m d e l l e l a l . 1985 
++ N S S c h o b e r e l a l . 1987 
+ + 3 6 t f 6 K i m u r a e l a l . 1988 
++ N S l V l a g i e l a l . 1989 
++ 4/4 L l o y d ct a l . 1988 
++ 2/2 S c h o b e r e l a l . 1987 
++ 2/2 W i c d c n m a n n ct a l . 1988 
++ N S l>clagi ct a l . 1989 
++ in Schober c l al 1987 
++ 2/2 W i c d c n m a n n e l a l . 1988 
Breast 
A g y r o p h i l i c ca rc inoma 
G a s t r o i n t e s l i n a J T r a c t 
+ * 2f9 B u s s o l a t i et a l . 1985 
+ * 1/1 A z w p a r d i e l a l . 1986 
+ 3/3 N c s l a n d c l a l . 1986 
++ *8/20 B u s s o l a t i et a l . 1987 
ND N D 
S t o m a c h 
C a r c i n o i d 3ß W i l s o n & I . loyd 1984 
4/6 M ü l l e r et a l . 1987 
3/4 K i m u r a et a l . 1988 
1/1 W i c d c n m a n n ct al . 1988 
1/1 W i e d c n m a n n el a l . 1988 1/1 W i c d c n m a n n c l a l . 1988 
A d c n o c a r c i n o m a 
C o m p o s i t e ca rc inoma 
+ *28/150 O o i et a l . 1988 
+ * 1/1 U l i c h ct a l . 1988 
N D 
N D 
N D 
N D 
Tab.3-4 (continued) 
Tumor Chromogranin A Chromogranin B Sccrclogranin Il 
i J 
S m a l l i n t c s l i n e 
C a r c i n o i d ++ * 2f2 W i l s o n & l . l o y d 1984 + 12/13 W c i l c r et a l . 1987 + 1 5/15 W i e d e n m a n n et a l . 1988 
++ * 9/9 D a y a l c l al 1986 + ia L l o y d c l a l . 1988 + 8/13 W e i l e r et al . 1987 
++ * 9/11 N a s h & S a i d 1986 + 15/15 W i e d c n m a n n c l a l . 1988 
++ * 5/5 H c a m 1987 
++ * m L l o y d el a l . 1988 
++ * 15/15 W i c d c n m a n n ct a l . 1988 
N E ca rc inoma N D N D N D 
L a r g c i n t e s t i nc 
C a r c i n o i d ++ • 2/5 N a s h & S a i d 1986 + 1/1 W i c d c n m a n n ct a l . 1988 + 1/1 W i c d c n m a n n et a l . 1988 
++ 6/6 B i s h o p et a l . 1988 
++ 24A27 K i m u r a et a l . 1988 
++ * 1/1 W i c d c n m a n n ct a l . 1988 
N E carcin<wna ++ * 3/10 W i c k et a l . 1987 N D N D 
L i v e r 
C a r c i n o i d + 1/1 M i u r a and Shi rasawa 1988 N D N D 
L u n g 
C a r e i n o i d ++ * 9/9 S a i d et a l . 1985 + 14/14 W c i l c r et al 1987 + 14/14 W e i l c r et al 1987 
++ * 6/6 W a l t s ct a l . 1985 + 2/2 I . loyd et a l . 1988 
++ 14/14 W c i l c r ct a l . 1987 
++ 10/10 B i s h o p ct a l . 1988 
++ * 4/4 L i n n o i l a et a l . I9S.S 
S m a l l c c l l c a r r i n o m a + » 4/10 W i l s o n & L l o y d 1984 - 0/4 l . l o y d ct al . 1988 _ 0/1 W e i l e r c l al 1988 
_ * 0/12 S a i d et a l . 1985 - 0/1 W c i l e r c l a l . 1988 
0/12 W a h s c l a l . 1985 
- 0/10 B i s h o p et a l . 1988 
_ * 0/4 L l o y d et a l . 1988 
+ * B u f f a et a l . 1988b 
+ 1/1 W c i l e r c l a l . 1988 
+ * 18/32 L i n n o i l a et a l . 1OSS 
1 
2 = 
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N F . Iargc ce l l ca rc inoma ++ 3/11 M o o i e l a l . 1988 
+ * 1/52 P i e h l ct al . 1988 
+ * 2/15 L i n n o i l a e l a l . 1988 
N D ND 
M i i i i H e e.tr 
C a n i n o i d ++ * 1/1 M i N u l t & B o l c n 1985 N D N D 
++ 1/1 K i m u r a ct a l . 1988 
N e r v o u s s y s t e m 
G a n g l i o n c u r o b l a s l o m a N D N D N D 
G a n g l i o n e u r o m a N D N D N D 
M c d u l l o b l a s t o m a N D N D N D 
Ncuroblasti>ma + * 4 /10 W i l s o n & I . loyd 1984 - 0/2 l . l o y d ct a l . 1988 N D 
+ * 2/6 L l o y d et a l . 1986 
Parayang l ioma ++ * 5/5 W i l s o n & L l o y d 1984 + 3ß l . l o y d ct a l . 1988 N D 
++ * 4/4 Johnson ct a l . 1985 
++ * 9 ^ U o y d et a l . 1986 
- * 0/11 S c h c 1 l h a 1 1 e r el a l . 1986 
++ * 2 6 ^ 9 Johnson ct a l . 1988 
O v a r y + + " f / T " T j o y T & " w u s o n 1983 N D ~ N D ~ 
C a r c i n o i d ++ * 5/6 S l a g n o ct a l . 1987 
++ 2/2 B i s h o p ct a l . 1988 
++ ia K i m u r a ct a l . 1988 
Pancreas 
G a s l r i n o m a ++ » 1 1 / 1 1 L l o y d el a l . 1984 - 0/5 W i e d e n m a n n c l al . 1988 + 5/5 W i c d c n m a n n c l a l . 1988 
++ * iß V a m d c l l ct a l . 1985 
++ * 2ß C h c j f c c e( a l . 1987 
++ * 5/5 W i c d c n m a n n e l a l . 1988 
++ * 2n B o r d i ct al . 1988 
G l u e a g o n o m a ++ * 3ß I . loyd et a l . 1984 N D N D 
++ * 7/10 I l a m i d Ct a l . 1986 
++ * 3/4 C h c | f c c Ct a l . 1987 
++ *15/15 B 0 r d 1 ct al . 1988 
Tab.3-4 (continued) 
Tumor Chromogranin A Chromogranin B Sccrclogranin II 
Insu l inoma - * 0/5 L l o y d ct a l . 1984 0/4 L l o y d ct a l . 1988 + W 
+ * 7/15 C h c j f c c ct a l . 1987 + m W i c d c n m a n n ct a l . 1988 
+ * \ß B u f f a et a l . 1988b 
++ * 5P W i c d c n m a n n c l a l . 1988 
+ • 15/15 B o r d i c l a l . 1988 
P P o m a ++ *14/14 B o r d i e l a l . 1988 
S o m a l o s t a t i n o m a ++ in B i s h o p et a l . 1988 N D N D 
+ * i / i B u f f a e l a l . 1988b 
V I P o m a - * on C h c j f e c et a l . 1987 N D N D 
+ * 3/6 B u f f a et a l . 1988b 
++ * 1/1 B o r d i ct a l . 1988 
L n s p c c i f i e d N I : Iumors ++ 1/1 O C o n n o r ct a l . 1983b N D N D 
++* 5/5 L l o y d & W i l s o n 1983 
++* 15/20 W i l s o n and L l o y d 1984 
++ * 3ß W a l t s et a l . 1985 
N E Iumors w id iou t c l i n i -
cal hormona l syndrome ++ * 4/5 C h c j f e c el a l . 1987 N D N D 
+ * 6 # B o r d i ct a l . 1988 
++ 1/1 S o b o l et a l . 1989 
P a r a t h y r o i d 
A d c n o m a + 1/1 O ' C o n n o r et a l . 1983b + m l . l o y d e l a l . 1988 - 0/1 
+ * ia L l o y d & W i l s o n 1983 - 0/1 W c i l c r c l a l . 1988 
+ * 2ß W i l s o n & L l o y d 1984 
+ * 3ß L l o y d el al . 1988 
+ 27/134 O k a ct a l . 1988 
C a r c i n o m a + * 1/1 M u r p h y el a l . 1986 N D N D 
+ in W i e d c n m a n n c l a l . 1988 
P i t u i t a r y ( an te r io r ) 
A d c n o m a s 
A C T I I 6/8 D c S t e p h a n o ct a l . 1984 
0/14 L l o y d et a l . 1985a 
1/2 B u l f a c l a l . 1988b 
1/6 Stcfancanu ct a l . 1988 
ND N D 
FSHA-H 
GH 
P r o l a c l i n 
TSH 
N u l l ce l l 
* 1/1 D c S l e p h a n o et a l . 1984 
* 6/9 L l o y d el a l . 1985a 
* 1/1 B u f f a e l a l . 1988b 
* l / I L l o y d et al . 1988 
0/5 Stcfancanu c l a l . 1988 
9/9 D c S l c p h a n o ct al . 1984 
* 0/10 L l o y d et a l . 1985a 
* 2/2 Buf fa et a l . 1988b 
2/5 Stefancanu et a l . 1988 
* 0/15 D c S t c p h a n o ct a l . 1984 
* 0/5 L l o y d c l a l . 1985a 
* 072 B u f f a et a l . 1988b 
* OP I . loyd el a l . 1988 
0/5 S l c l a n c a n u c l aI. 1988 
3P L l o y d et a l . 1985a 
* 1/1 Buf fa et a l . 1988b 
0/5 S tcfancanu et a l . 1988 
* TP D e S t c p h a n o c l a l . 1984 
•12/17 L l o y d ct a l . 1985a 
* m Buf fa c l a l . 1988b 
' 6/6 L l o y d ct al . 1988 
2/9 Stcfancanu ct a l . 1988 
1/1 S o b o l et a l - 1989 
1/1 L l o y d ct a l . 1988 
N D 
+ 5P I . loyd et a l . 1988 
N D 
+ 5/6 L l o y d ct a l 1988 
N D 
N D 
N D 
N D 
N D 
p 
JZ 
'*r 
Vc 5 
1 
L n s p c e i f i c d + * 6/10 W i l s o n & L l o y d 1984 
+ * 5/6 L l o y d ct al . 1986 
++ 9/11 D c l i o s ct a l . 1989 
Tab. 3-4 (continued) 
Tumor Chromogranin A Chromogranin B Sccrctogranin II 
Prostale 
C a r e i n o i d - » 0/1 TunSa t I I e r r c ra e l a l . 1988 N D N D 
S m a l l ce l l c a rc inoma + * m Turba t -Her rc ra e l al 1988 N D N D 
M i x e d smal l ce l l 
adcnocarcin<nna + * 5/5 Turba t -Her rc ra et a l . 1988 N D N D 
S k i n 
M c r k c l ce l l tumor + * 2ß W i l s o n & l . l o y d 1984 - 0/1 l . l o y d ct al . 1988 N D 
+ * 2ß B u f f a e l a l . 1988b - 0/1 W c i l c r et a l . 1988 
++* 1/1 L l o y d c l a l . 1988 
+ 1/1 W e i l c r c l a l . 1988 
Thyroid 
C e c l l c a rc inoma ++ * 5/5 L l o y d & W i l s o n 1983 ++ 16/16 S c h m i d c l a 1.1987 + 16/16 S i h m i d ct a l . 1987 
++ 2r2 O ' C o n n o r c l a l . 1983b ++ 4/4 I . loyd ct a l . 1988 
++ * 6/6 W i l s o n & L l o y d 1984 
++ * 2 5 f l 5 S i k r i c l a l . 1985 
++ * Iß V a m d c l l ct a l . 1985 
++ • 4/4 L l o y d ct a l . 1986 
++ 16/16 S c h m i d ct a l . 1987 
++ * 4/4 L l o y d c l a l . 1988 
++ *60/60 S c h r i k l e r c l a l . 1988 
c a l c i l o n i n n c g a t i v c ++ 1/1 S o b o l et a l . 1989 
Thymus 
C a r c i n o i d + * 2/5 Herbst ct a l . 1987 N D N D 
N E carc inoma + * 1/1 B u f f a ct a l . 1988b N D N D 
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t Itenis 
E n d o m c I r i u m 
A r g y r o p h i l i c ca rc inoma + * l9ß6 Inoue c l a l . 1986 N D N D 
- * 073 Huffa c l a l . 1988b 
S m a l l c c l l c a rc inoma + * 1/1 M a n i v c l c l al 1986 N D N D 
Ccrvix 
smal l ce l l c a r c i n o m a + * 5/10 U l i c h c l a l . 1986 N D N D 
+ * 11/13 G c r s e l l et a l . 1988 
Urinary bladdcr 
smal l c e l l c a rc inoma + * 2ß B l o m j o u s c l a l . 1988 N D N D 
For each t issue, tumors are c lass i f ied acco rd ing Io c i ther h i s l o l o g i c a l appearanee or hormone pn>ducrion, as referred Io in the respcctive referenccs. 
++ a l l or the majori ty o f tumoT ce l l s rcpor tcd Io bc immunorcac t i ve 
+ thc minor i ty of tumor c c l l s reportcd to be i m m u n o r c a c ü v c 
no de lcc tab lc i m m u n o r e a c t i v i l y 
N D N o l determined, N S N o l spcc i f icd 
* C o m m e r c i a l l y avai lable m o n o c l o n a l a n ü b o d y L K 2 I I 1 0 used to dc tec l i m m u n o r e a c t i v e ch romogran in A . 
'I3ie numbcrs before and after Ihc slash rc fc r Io the tumors found to be i m m u n o r e a c l i v e and Ihc l o l a l tumors analy7cd, r c spec t ivc ly . 
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the lack of immunoreactivity for C g B and SgIl in tumors of this category, rcccnt 
prcliminary data (Wiedenmann and Huttner. unpublished obscrvations) 
suggcst that at lcast some of these tumors may express C g B and SgU. 
So far, only the expression of C g A has bccn determined in N E tumors of the 
breast, ovary, livcr, middle ear, prostate, thymus, utcrus, ccrvix and urinary 
bladdcr (sce Tab. 3-4). W i t h the exception of carcinoids, which appear to 
express C g A in a high pcrccntage of the cases examincd, all other N E tumors of 
these tissues examined showed only focal immunoreactions, and a relatively 
high iiumber of the cases studied was immuno-negative. 
CgA-pos i t ivc N E tumors arc not always positive for pancreastatin, whercas 
esscntially all pancrcastatin-positive tumors are also immunorcactivc for C g A 
(Bishop et al . 1988; Schmidt et a l . 1988a).This is to be cxpcctcd sincc C g A , the 
preeursor for pancreastatin, is not necessarily processed in every N E cell to 
immunorcactivc pancreastatin. 
In addit ion, the Cgs/Sgs may be useful tools in studying non-ncoplastic 
human N E disease as well as diseases in which N E cclls arc, presuniably. 
affected sccondarily (c .g. , M i l l e r and Sumner 1982; Pietrolctti ct al. 1986; 
Rode ct al . 1986). 
3.3.3 Molccular Characterization of thc Chromogranins/ 
Secretogranins in Human N E Tumors 
For several types of human N E tumors displaying Cg/Sg rcactivity in 
imniuiioliistochemistry, the prcsencc of thcsc proteins has bccn confirmed by 
immunoblotting. For C g A , these tumors include pheochromocytomas. bron-
chial and intestinal carcinoids, islet cell tumors, parathyroid adcnomas, small 
ccll carcinomas, Merke l cell tumors. medullary thyroid carcinomas. paragan-
gliomas and iicuroblastomas (L loyd and Wilson 1983; Sehniid et al . 1987; 
Schoberet al . 1987; Weileret al . 1987. 1988; L loyd et al. 1988; Wicdcnmann et 
al . 1988). In most cases, a major immunorcactivc polypcptide of M r 75.000 
idciitieal to that tioted in the adrenal medulla was observed. 
For C g B , tumors found to be positive by immunoblott ing include plieo-
cliromocytonias. bronchial and intestinal carcinoids, pituitary adcnomas, 
medullarythyroid carcinomas and islct ccll tumors (Schmid et al . 1987; Sehober 
e ta l . 1987;Weileretal . 1987, 1988 ;L loyde ta l . 1988;Wiedenmanneta l . 1988). 
In most eascs, immunorcactivc polypeptidcs of M 1 11().()0()-12().0()0 and 
several immunorcactivc bands of lower molecular wciglit wcre observed. 
For SgIL tumors found to be positive by immunoblotting include pheo-
chromocytomas, bronchial and intestinal carcinoids. islct cell tumors. medul-
lary thyroid carcinomas. Merke l cell tumors and ticuroblastomas (Schmid ct al. 
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1987; Schobcret al . 1987; Wei lc rc t al . 1987. 1988; Wiedenmann et al . 1988). In 
most cases. immunolabeling revealed a reactivc polypeptide of M , 86.000. 
similar to SgIl as observed in normal N E cells. In many of these cases, 
proteolytic fragments of the Cgs/Sgs vverc deteeted along with the full-length 
proteins. which werc probably. at least in part, the results of proccssing events 
occurring in vivo. 
3.3.4 Detection of Chromogranin/ Secretogranin m R N A s 
The availability of c D N A s for the Cgs/Sgs also allows the detection of thc 
corresponding m R N A s in normal and neoplastic human N E cells by in situ 
hybridization and/or Northern blot analyses. So far only few studies using this 
methodology have appeared (Deftos et al . 1986; Gazdaret al . 1988; Helman et 
al. 1988b; Siegel et al. 1988; L loyd ct al. 1989). In the case ofthe Cgs/Sgs. thc 
dcteetion ofthe m R N A s rather than the translation products may have scveral 
advantages. First, the detection of the m R N A s may in some instances be morc 
reliable than that of the protcin epitopes which, as outlined abovc, may not 
always be immunoreactive due to post-translational proccssing and epitope 
masking phenomena. Sccond, the ccllular distribution of thc m R N A s may 
dilTcr from that of the corresponding protcins, although recent studies 
(Forss-Pctter et al. 1989; L loyd et al . 1989) on C g A and C g B did not reveal 
obvious disercpaneies in this regard. Howcver, considcring a possiblc biological 
action of the Cgs/Sgs or their fragments on target cells, it cannot bc cxcluded 
that some cclls arc immunorcactivc for these proteins, not bccausc thcy express 
them but bccause they endocytosc thcm. Nerve growth factor provides a 
classical preccdcnt for a striking difference in ccllular distribution between the 
m R N A (which is found in the innervated non-ncuronal cells) and the protein 
(which is accumulated in the innervating neurons; Davics ct al. 1987). In such 
cases. the cletection of thc Cg/Sg m R N A s would allow a more reliable 
identification of N E cclls than that of thc respcctivc protcins. 
3.3.5 Detection of thc Chromogranins/ Secretogranins in 
Human Plasma and Serum 
Thc Cgs/Sgs and the peptides derived from them are physiologieally rclcased 
from thc cells that produce them. In the case of C g A . thc measurement of its 
eoneentration in the blood plasma has been shown to bc useful in the diagnosis 
of N E tumors and thc monitoring of thcir secretory activity (O 'Connor and 
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Dcftos 1986; O 'Connor ct al . 1989; Dcftos ct al. 1989; Moattari et al . 1989; 
Sobol et al. 1989). C g B , w h i e h is more abundant than C g A in human adrenal 
medulla and pheochromocytoma (Hagn et al . 1986; Benedum ct al . 1987), has 
also becn dctcctcd in human plasma and scriim and appears to be present at 
higher concentrations than C g A (Wiedcnmann ct al . 1987). Sinee thc 
expression ofthe individual Cgs/Sgs and thcir proteolytic processing in different 
N E cells is variable, the eomparative determination of thc conccntration and 
pattern ofthcse proteins and peptides in the plasma may well Iead to a refincd 
and casily applicable diagnostic procedure in N E discase (sec chapter 7). 
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4 Neural Cell Adhesion Molecule 
N C A M in Neural and Endocrine 
CeUs 
Keith Lcingley and Manfred GratzJ 
4.1 The Concept of Cell Type Markers 
Considcrablc interest has eentered over the last twenty ycars on the search for 
methods permitting the distinction between different cell types in complex 
tissues.While classical histological staining methods havc provcd invaluable in 
studying the ccllular architccture of tissues, the search for more specific 
teehniques that afford unambiguous identification of cell types was motivated 
by thc fact that piirely histological criteria frequently prove inadcquate in othcr 
than normal adult tissues. In immature and in pathological tissucs the 
microscopical appearance ofcel ls is often radically different from that found in 
the healthy adult. In addi t ion. increasing iise of isolatcd cells grown in tissuc 
cLilture has prompted thc use of critcria other than thosc bascd on ccllular 
morphology, whieh is rarcly identical to that of the in \Tvo counterparts of 
cultivated cclls and which may. morcover, bc influenced by tissue eulture 
conditions. 
Al though considerablc progrcss towards this goal has bcen achicvcd by thc 
development of histochemical methods, the major rcccnt advanccs have 
Iollowed the introduction and widcspread application ofimmunocytochemical 
tcchnology.This has dramatically altered both the way we recognize cells and 
indeed cven the way in which we define a given eell type. Thus in the 
pre-immunocytochemical cra cells were originally defined by their anatomical 
location and cellular morphology. which were correlated to their putative 
function. Forexample . s i lvcr impregnat ion methods have prcviously bcen very 
successfully cmployed to illustratc the delicate arborizations of Iargc ccrebellar 
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ncurons (Ramon y Cajal . 1905; Palay and Chan-Palay, 1974); in addition such 
staining methods suggcstcd thc function of such ncurons in terms of their 
multiple synaptic conncctions with other cerebellar neurons. Current use of 
immunocytochemical methods performs the same task more easily and in a 
much morc consistcnt manner (Mikoshiba et a l . , 1979; Recbcr et a l . . 1981; 
Langlcy et a l . , 1982b; Lohmann et a l . . 1981; Roth et a l . . 1981). Similarly, 
astrocytes,which had carly been visualizcd by Golg i methods as satellite cclls 
with end-fcet on blood vessels, may now be easily distinguished by thc use of 
antibodies to the protcin G F A P (Gl ia l Fibri l lary Ac id i c Protein) considercd to 
be specific for thesc cells (Dahl and Bignami . 1973; E n g and Bigbee. 1978). 
Such technologv has Icd to a redcfinition of astrocytes as cells which contain 
G F A R 
This spccificity of expression of certain protcins by certain cell typcs forms 
the basis of current use of immunocytochemistry to idcntify ccll types (for 
review see Langlcy et a l . , 1984).The preeisc mcchanisms that Icad to such 
spccificity of expression of certain proteins are not yet clcar. Howevcr it is 
evident that. whilc the gcnctic information contained in thc eell nuclcus aftcr 
fertilization is potcntially capable of coding for all protcins expressed by all cell 
typcs present in thc adult organism, during embryogcnesis reguIatory mcchan-
isms prcdispose thc expression of certain of these proteins and dctcrmine thc 
suppression of others. Pathological proccsscs may neverthclcss alter the 
normal course of cvents, resulting in up or down regulation of individual 
protcins in response to external st imuli . Morcover, cclls in tissuc eultiire havc 
been shown to respond to extcrnal factors, including growth factors and 
hormones. by altered expression of "cell specific" proteins (c.g. Doherty and 
Walsh. 1987; Grant et a l . . 1988). Howcver the mature normal cell may be 
defined as onc in which the expression of a numbcr of biochemical character-
istics has rcached a stablc statc. Thus, a givcn ccll type which was prcviously 
defined only by morphological criteria may now be aecorded a biochemical 
definition in termsofthe range ofproteins, glycoproteinsand lipidsexpressed. 
Whi lc a Iargc number of protcins are found to be present in many quite 
different cell types in the animal kingdom, a limited numbcr may be expcetcd 
to bc assoeiated with the specific nature or function of a givcn type and thus 
have a more restrieted cellular distribution. This property of ccll spccificity of 
such molecules permits their Lise as marker substances to distinguish between 
different cell typcs.Thc valuc ofthese molecules as ccll-type markers dcpcnds 
on their eapacity to be expressed by a cell in both normal and abnormal 
(pathological or in culturc) situations which may vary for certain proteins.This 
is particularly important when choosing a marker protein as a diagnostic tool in 
clinical practice. The elcganec and preeision of ccll labeling methods have 
outweiglicd such minor disadvantagcs and havc totally altercd pathological 
Iaboratory practicc for clinical diagnosis over rccent ycars. 
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A sccond aspcct of cell marker proteins should not be forgotten. It is 
reasonablc to suppose that the exclusive or predominant expression of a given 
protcin by a given cell type may be associated with the particular biologieal or 
physiological function of that cel l . Dur ing the sevcnties the search for neuron 
specific proteins was promptcd by thc conviction that such proteins would be 
intimately associated with brain function. This is clcarly the case for thc 
enzymes involvcd in specific neurotransmitter metabolism or for thc neuro-
transmitters themselves (for review see Langley et a l . . 1984). Extensive 
neiiropeptide mapping studies havc indecd taught iis a great deal about how thc 
brain fimetions (Hökfe l t et a l . , 1980).The link between cell marker protein and 
function is Iess evident in many other cases such as for example thc S-1()() 
protein (Matus and Mugha l , 1975), the function of which remains a mystery 
long after thc initial demonstration of its cellular specificity. 
This chapter wi l l concentratc principally on aspccts ofccl lular expression but 
also briefly mention the likely function ofvvhat has been more reccntly rcvcaled 
to be a family of related glycoproteins, collectively recognized under the name 
of neural ccll adhcsion molecule N C A M . 
4.2 The N C A M Family 
In order to bettcr understand the cellular distribution of thc different N C A M 
protcins, a bricf historical account of their discovcry and what is currently 
known oftheir bioehcniistry and molecular biology wil l be given.The discovery 
of this family ol marker protcins was motivatcd by the search for molecules 
implicated in the eonstruction of the cxtraordiiiary eomplexity of central 
nervous tissue.The adiilt human brain contains more than l() , s ncurons, each of 
which Iorms many synaptic connections. Such connections are not formcd 
iandomly but appear to follow overall dcsign principles that Iead to very 
specific inerconnecting pattcrns.The molecular mcchanisms by which neurons 
select their target cells to producc such selectivc networks havc intrigued 
neurobiologists for dccades. 
Threc iiidepciideiit Iaboratories in two different continents applied different 
experimental approaches in different aninial models to address tIiis question. 
Ovcr a relativcly short period of time, each publislicd reports on "brain specific 
molecules" which wcrc subsequently found to have associated ecll adhcsive 
pi'operties.Thus. Gera ld Edclman's group in New York uscd an expcrimental 
paradigm. modified from that uscd in carlier searehes for adhesion molecules. 
to select moleeulcs involved in the reaggregation of dissociatcd ehick retinal 
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cells (for rcviews sec Edelman, 19<S3, 1984a.b; Rutishauser, 19<S4). He 
succeeded in isolating and piirifying a molecule invoIved in such neural ccll 
aggregation and rcfcrrcd to it as neural ccll adhcsion molecule. It was soon 
realized that this molecule was the chick equivalent of a molecule previouslv 
idcntified by crossed-electrophoresis by Elizabeth Bock's group in Copenhagen 
from rat brain. ealled D 2 (j0rgensen and Bock, 1974; j0rgcnscn ct a l . . 1980). 
This was onc of several brainspecific protcins idcntified by this group at that 
time (Bock et a l . . 1975). Curiously, amongst these figured a molecule called 
synaptin. whieh was thc first dcscription of thc vcsiclc marker protein now 
called synaptophysin (see chapter2) . A third laboratory, Christo Goridis ' 
group in Marsei l le , using monoclonal antibody technology introduced in the 
1970's obtained an antibody recognizing a brain cell surfaec protein. BSP-2. in 
the mouse (Hi rn et a l . , 1981) which was subscquently shown to be thc mouse 
cquivalent of N C A M and D 2 (Faissner ct a l . . 1984; Noblc et a l . , 1985). 
The different data obtained on these three sets of molecules can thus now bc 
collated to build up a morc complete picture of the charactcristics of what has 
been agrecd since 1985 to be the same antigen, for which the namc N C A M 
originally givcn by Edelman has been adopted. Sincc independant studies had 
been performcd on what were originally considcrcd to bc unrclated molecules a 
number of initial contradictions appear whcn comparing thc carly literaturc on 
N C A M . D2 and BSP-2; for cxamplc whether or not glial cells express this 
molccu le .Whi lc many of thesc differenccs no Iongcr appear to exist certain 
species differenccs regarding the N C A M polypeptide forms expressed are 
evident: thcsc wi l l be diseusscd in more detail bclow. From the vast litcrature on 
N C A M sevcral basic charactcristics of this family can be singlcd out. 
A uniqiic gcnc coding for N C A M , containing nineteen principal cxons, is 
present in thc haploid genomc. A mechanism ofaltcrnativc Splicing is currcntly 
considcrcd (Rutishauscr and Gor id is , 1986; Owcns et a l . , 1987; Goridis and 
W i l l e . 1988) to givc rise to several species of m R N A the number ofwhich varics 
according to spceies. In the chicken brain three N C A M m R N A speeics of 7.4. 
6.7 and 4.3 have been detectcd and are thought to be translated into three 
principal N C A M polypcptidcs with molceular masscs of approximatcly 180. 
140 and 120 (referred to herc as N C A M 180. N C A M 140 and N C A M 120, 
equivalent to N C A M largc domain N C A M small domain and N C A M small 
surfaec domain) (Cunningham et a l . , 1987).The two larger forms contain a 
single transmembrane region and differ csscntially in the Iengths of their 
cytoplasmicdomains (Cunningham. 1986; Cunningham et a l . . 1987; Gcnnar in i 
ct a l . . 1984a.b; Nybroec t a l . . 1985; Barthelset a l . . 1987; Santoni et a l . . 1987). 
while the smaller isoform is anchored to the membranc by the intermediary ofa 
phosphatidylinositol rcsidue (Hc et a l . . 1987).The sequences cxtcrnal to thc 
ccll membrane of all thrce forms arc csscntially identical, containing fivc 
rcgions similar to those present in immunoglobulins (Barthels et a l . . 1987: 
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Cunningham ct a l . . 1987; Wil l iams, l987),which has Icd to thc classification of 
the N C A M gene as a member of the immunoglobulin super gcnc familv.The 
homophilie binding site. in addition to a heparin binding site and a "hinge" 
region. arc situated in thc extcrnal domain of the molecule (Cole et a l . . 
1986a.b; Cole and Glaser. 1986; Cole and Akeson . 1989; Frelingcr and 
Rutishauser. 1986; B e c k c r e t a l . . 1989). 
The situation appears to bc rather more complcx in rodents since in both the 
mousc (Gennarini ct a l . . 1986; Barbas et a l . . 1988) and the rat (Small et a l . , 
1987) five N C A M m R N A species arc detectable of7.4. 6.7. 5.2. 4.3 and 2.9 kb. 
tvvo of which seem to encode for N C A M 120 (5.2 and 2.9 kb). Thcse two 
m R N A s differ in the size of their noncoding rcgions. a first polyadenylation 
signal being uscd to generate the 2.9 kb m R N A and a sccond signal 2.3 kb 
downstream being used for the 5.2 kb messagc (Goridis and W i l l e . 1988; 
Barthels et a l . . 1987). By analogy with thc chicken thc 7 .4kb m R N A is 
considered to codc for N C A M 180. 
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Fig. 4-1 Schematic represeiitation of the N C A M genc. its transcription by alternative 
splicing and translation into the three principal N C A M polypcptidcs. illustrating thc 
position ofthe sequencescoded by different exons relative to the plasma membranc. the 
immunoglobulin-like domains and sites (arrowheads) of additional (tissuc-specific) 
"minor" exons and their coded sequences. 
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O i t h c 19 major exons in the N C A M c D N A exons 1-14 are used to generale 
the external sequences of all three polypeptides. exon 15 eodcs for the 
anchoring sequencc of N C A M 120 and exon 18 eodes for the additional 
cytoplasmic 30-40 k D insert unique to N C A M 180 (Fig. 4.1 and Murray et a l . , 
1986; Owens et a l . . 1987; Nybroe et a l . , 1988). Recently additional exons in the 
N C A M gene have been discovered. some of whieh eode for large sequences in 
N C A M isoforms in certain tissues. Thus muscle N C A M m R N A contains an 
exon situated between exons 12 and 13 called msd (muscle specific domain) 
encoding a 37 amino acid sequence unique to this tissue (Walsh, 1988). Smallcr 
additional exons have been found in rodent brain N C A M e D N A (Santoni et a l . , 
1989). In part icularexon Jt (30 bases) situated between exons 7 and 8 codes for 
a region in one of the immunoglobulin Iikc domains, that may bc closc to the 
liomophilie binding site and thus modify binding affinity (Santoni et a l . . 1989). 
Two more exons, one of only three base pairs, thc othcr of 15, both situated 
between exons 12 and 13 codc for a sequencc in the hinge region of thc 
molecule.Thcse additional exons can givc rise to minor heterogcneities in thc 
three principal N C A M translation produets, which may be fairly difficult to 
detect on immunoblots, since thc moIecular weights may differ very little from 
those of the principal forms. However S l nuclease protection assays providc 
elcarcut evidence of the existencc in brain of multiple forms of m R N A codiiig 
for these additional polypeptidcs.Theoretically 24 different m R N A specics arc 
possiblc giving risc to 18different N C A M polypeptides (Santoni ct a l . . 
1989). 
The molecules are modified post-translationally by phosphorylation. sulpha-
tion and glyeosylation (Lyles et a l . , 1984a; Nybroc ct a l . , 1988). Glycosylat ion 
has bccn particularly well studied since major changes in lcveIs of sialylation 
occur during normal brain development. Early so-called embryonic forms of 
N C A M contain high lcvels of polysialic acid groups,which markedly influcnecs 
thc adhesivc binding propcrties of the molecule (Edc lman . 1984; Rutishauser 
et a l . , 1985, 1988). N C A M isolatcd from adiilt tissue contains iiiuch Iess sialic 
acid. In addition to changes in polysialic acid, subsets of N C A M contain 
aiiothcrearbohydrate hapten, H N K - 1 , consisting of3'sulfated glucuronic acid 
(Noronha ct a l . , 1986) rccognizcd by antibodies first isolatcd as recognizing 
human natural kil ler cclls (Schuller-Petrovic ct a l . , 1983; Kruse et a l . . 1984). 
ThLis, in sumniary, although three principal size classes of N C A M polypeptides 
have been found in both nervous and other tissues, all N C A M molecules of the 
same size class are not identical. Somc may contain additional aniinoacid 
sequences. others may be modified post-translationally in slightly different 
ways either containing different lcvels of polysialyiation or different carbohy-
drate haptens (Wil l iams et a l . , 1985). 
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4.3 Cellular Distribution of N C A M 
4.3.1 Mcthodological Approaches 
Two basic approachcs havc bccn cmploycd to address the question of cellular 
N C A M expression: these may be broadly classified as morphological or 
biochemical. 
4.3.1.1 Immunocytochemistry 
The introduction by Coons et al . in 1941 of the use of flourcsccnt probes 
covalently bound to antibodies and latcr modifications (Coons, 1961) provided 
the first opportunity ofdireetly visualizing given protein tissue constituents at a 
ccllular level. Considerable technical progress in immunocytochemical 
methods has subsequently eliminated many of the drawbacks of thc early 
teclmiques and has Icd to the use of such methods as routine highly sensitive 
and specific staining procedurcs in pathological laboratories. Many techniques 
are currcntly available which differ in the probe or in the number of antibodies 
employed to visualize the molecule ofinterest. A l l depend for their success on 
the quality ofthe primary antibody i .c . its spccificity and alTinity for thc antigen 
in question (Swaab et a l . , 1977). The higher the affinity of the antibody, the 
more it can bc uscfully diluted: the greater the di lut ion, the lowcr background 
non-spccific staining wil l be, and thus the higher the spccificity of the staining 
pattern. 
This chapter will not attempt to review the advantages of individual 
methods. Howevei it is important to remember that technical differences alone 
may givc rise to apparcntly eonflictingobservations from different laboratories. 
In particular, the absence of staining may be simply due to the use of 
monoclonal antibodies with rclatively lowcr affinities than commonly found 
with polyclonal antibodies. In addition monoclonal antibodies are sometimes 
more sensitive to tissue fixation proccdures. Partieular care should also be 
excrciscd with certain monoclonal antibodies that recognize cytoplasmic 
epitopes of N C A M . since ccll permeabilization is a neccssary prerequisite for 
their use. 
O f the probes currently employed. fluorescent molecules such as lluores-
ceine isothiocyanate or rhodamine. orenzymes giving permanent preparations. 
such as pcroxidasc or alkaline phosphatase. havc provcd valuable Ior Iight 
microscopy. A t the ultrastructural level peroxidase has proved to be thc most 
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vcrsatilc. Col lo ida l gold particlcs bound cithcr to sccondary antibodies or to 
protcin A (Langley and Ai in i s , 1986; van den Pol ct a l . . 1986) arc particularly 
Lisefnl for labeling surfaee of antigens of isolated or ciilti ired cclls when 
morphometrie analysis can be performed. but are l imited by pcnctration 
problems when employcd on pre-embedding tissue sections. The Iaek of 
penetration into iiltrathin seetions has limited thc routine exploitation of 
post-embedding immunogold methods for N C A M localization. 
4.3.1.2 Bioehcmieal Approaehes 
Valuable information on eellularexpression of individual N C A M glyeoproteins 
has been obtained vvith combined immiinoehemical and protein separation 
techniques,which has only bccn partially possible with immunocytochemistry 
since antibodies spccifically reeognizing each of the thrce N C A M isoforms arc 
not available. In particiilar turnover studies have been performed on N C A M 
isolated by immunopreeipitation followed by gel electrophorcsis of extracts 
from cclls Iabeled with radioactive precursors (Hi rn et a l . . 1983; Lyles et a l . . 
1984b; Nybroe et a l . . 1986; Linneman et a l . . 1985). More commonly 
electrophorcsis and immunostaining of Western blots provcs to be simpler and 
adcqiiate for analyzing different N C A M isoforms in different tissucs (Rougon 
e ta l . , 1982;Hoffmanetal . , 1986;NagataandSehachner. l986) .Quant i ta t ionis 
possible when radioiodinated sccond antibodies or protein A are uscd to locatc 
the protein bands.The technique of crossed-electrophoresis (Boek. 1972) and 
E L l S A havc also provided quantitative estimates ofdiffcrcnt N C A M isoforms 
(Bock ct a l . . 1983).These methods have becn uscfully applied in biosynthetic 
s t u d i e s o f N C A M in culturcd ncurons, glial cells and tumor lincs. //; vivo studies 
on N C A M cxtractcd from the lateral gcniculate nuclcus after injection of 
radioactive precursors into the eye (which is followed by axonal transport of 
newly synthesized glyeoproteins along the optic ncrvc) has afforded compari-
sons with thc in vitro sitiiation (Nybroc et a l . . 1986). C c l l free translation of 
N C A M hasalsobecn invcstigated usingcrudc R N A preparations from cultured 
cclls and tissue homogcnates (Nybroc ct a l . . 1986). 
Post-translationaI modifications havc also bccn studied by immunoehcmical 
techniqiies. T l i c most important of thesc as alrcady mcntioned eonceriis 
polysialic aeid ( P S A ) content in the so-called embryonic form and is of special 
intcrest in pathology where frequently these forms reappear.Thus after ncrve 
iiijurv nevvly synthesized N C A M is found to be liighly sialylated which is 
probably related to the nced for Iess stability in intercellularcontacts duringthe 
period ofcel lular rcdistribution and tissue repair (Dani loffc t a l . . 1986a).The 
prescnce of high P S A forms of N C A M can be casily suspeeted from Westcrn 
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immunoblots by their appearance as broad diffuse bands of higher apparent M r 
(200-250 k D ) . Pretreatment of such forms of N C A M with neuraminidasc, 
which removes succcssive sialic acid residues from P S A chains, alters their 
anomalous elcctrophoretic profilc from a broad smcar to the descrete three 
banded pattcrn of adult brain N C A M (Rutishauscr, 1984).This siiggcsts that 
the thrcc principle N C A M isoforms are present during cmbryonic Iifc but are 
polysialylatcd. 
Othcr post-translational modifications affecting thc extcrnal domain of 
N C A M have becn studied. Sub-populations of N C A M polypeptides may be 
distinguished by their complement of carbohydrate epitopes. The H N K - I 
carbohydrate present on human natural kil ler cclls ( A b o and Balch, 1981) has 
bccn dcteetcd by successivc immunoprecipitation with different antibodies on 
various adhcsion molecules including L l . M A G and N C A M (Krusc et a l . . 1984; 
1985; Poltorak ct a l . . 1987). Only about 30 % o f N C A M isolated from rodent 
brain carry this epitope. It has been suggested that this carbohydrate may itself 
bc a Iigand in cell adhesion ( K ü n e m u n d et a l . , 1988). 
4.3.1.3 Hybridization Techniques 
Since the isoiation of cloncs of total or partial N C A M c D N A and their 
subsequent sequencing it has beeome feasable to examine thc expression of the 
N C A M mcssage citlier at a ccllular lcvel by the technique of in situ 
hybridization (whcrc a specific oligonucleotide probe or a probe derivcd from a 
partial c D N A is hybridized to tissue scctions) or in tissue R N A cxtracts by 
either Northern blots or S l nuclease protection assays.This is a particularly 
important development sinee such approaches not only eonfirm the capacity of 
a cell to synthesize N C A M , but also provide valuable information on its 
regulation at the genctic level. Such approaches are complcmcntary to studies 
employing antibodies, sincc in onc case thc message is dctcctcd while in the 
other its translation product, thc Iocalization of which is not always identical 
(Pricto et a l . , 1989). Furthermore the technique of S l nuclease protection 
analysis provides information on thc sequencc of the bascs in thc N C A M 
m R N A as wcll as the preeisc naturc ofthe exons present (Barthels ct a l . , 1987; 
Santoni ct a l . . 1989). Howevcr. in cclls or tissues whcre N C A M turnover is slow 
it may prove miich more difficult to dctect low levcls of the m R N A . while 
significant Icvcls of N C A M pcptidcs pose no problems for visualization with 
antibodies. 
Up to the present timc fcw reports of in situ hybridization studies have been 
published but. in contrast. m R N A analytical studics of tissue extraets arc 
numcrous (Covault et a l . , 1980; Murray ct a l . . 1986; Gcnnar in i et a l . . 1986) and 
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havc providcd very interesting data on developmental changes. Most early 
studies on N C A M distribution concentrated on embryonic development wherc 
the greatest changes in expression may be expected to occur in parallel with 
important tissue induction events. In this section we wil l concentrate mainly on 
N C A M expression in different cell typcsofadult tissues,wherc the phenotype is 
stable, before discussing some ofthe early modifications,which are frequently 
transitory or recurrcnt during cellular migration or initial stages of tissue 
formation. 
4.3.2 Ncurons 
4.3.2.1 Immunocytochemistry 
One of the earliest references to a molecule that was subsequently found to be 
equivalent to N C A M was published in a rcport of a search for brain specific 
ant igens(j0rgensenandBock, 1974 ;Bocke ta l . , 1974; 1975 ;Bocke ta l . . 1980). 
Fig. 4-2 Vihratome section of adult rat ccrcbellum immunopcroxidase labeled for 
N C A M . 
Note the intense staining of the molecular layer, the unstaincd cytoplasm of Purkinje 
cells and marked staining of granule cells. Bar = 20 um. 
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Fig. 4-3 Flcctron micrograph ot' rat cerebellar granule cclls Iabeled Ibr N C ' A M . 
The plasma membranes are intensely stained and cytoplasm is weakly immunorcactivc. 
Section not counterstained. Bar = 1 um. 
The D 2 antigen detected amongst scveral others. including protein 14-3-2 
equivalent to neuron specific enolase was found to bc absent from culturcd 
astrocytcs but enriched in synaptosomal fraetions of rat b ra in .Though this 
antigen appeared not to be limited to nervc terminals a neuronal origin was 
concludcd. A t the samc t imc ,whi lc much ofthe carly work of Edelman's group 
concentratcd on embryonic tissues. this group published direct immunocyto-
chemical evidence of N C A M expression ovcr thc entire surface of mature 
sympathetic neurons. cven though these were isolatcd from Iate embryonic 
chicks (Rutishauser ct a l . . 1978a). with an antibody prcviously found to be 
capablc ol inhibiting embryonic retinal cell aggregation (Brackenbury et a l . , 
1977; Rutishauser et a l . . 1978b). In contrast. a much more topographically 
icstricted expression has bcen rcportcd both in the retina (J0rgensen and 
Möller . 19c81) and also in eerebellum wherc it was considered to be confined to 
sMiaptic regions of thc neuronal membrane (.l0rgenscn and Möller. 1980). 
La tc r studies in both rodents and chickcns provided convincing evidence ofthe 
widespread expression of N C A M by all typcs of ncurons in vivo over their 
ent i resurfacc(sccFigs. 4-2and 4-3; Lang leye ta l . , 1982a. 1983; Dani lo f fe ta l . , 
L986b; Chuong et a l . . 1987). Such discrcpancies arc probably thc result of 
differences in the affinity ofantibodies uscd in different Iaboratories and also in 
different tissue fixation procedures. Immunoelectron microscopydid howcver 
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reveal interesting differences between different types of ccrcbellar neurons 
(Langley et a l . . 1982a; 1983). N C A M was detected in granule cells. which 
constitiite niimerically the vast majority ofcerebellar neurons, intracellularly in 
the perikaryon, although little was detected in their axons, in addition to at 
their cell surfacc. A n intracellular Iocalization was nevcr observed for the large 
cercbellar ncurons such as Purkinje cells, presumably because cytoplasmic 
levels wcrc below limits ofdetection.These data were interpreted as reflecting 
differences of N C A M transport or turnover in different types of neurons.The 
question of turnover rates of N C A M in ncurons of adult tissues is an intriguing 
one ,which has been addressed in the biosynthetic studies of Elizabeth Bock 's 
group.which reported that N C A M turnoverwas extremely slow in adult tissue. 
In fact it was calculated to decrease 350 fold during development (Linnemann 
et a l . , 1985). This would suggest that once N C A M is transported to the cell 
surfacc of Purkinje cells or to thc distant parallel fibrcs (axons) of granule cells 
in normal adult cerebellum. it is subject to very slow dcgradation, resynthesis 
and reinsertion in thc membrane. In contrast, synthesis o f N C A M and transport 
through thc Golg i apparatus to the cell membrane has bcen shown to bc a rapid 
phcnomcnon in cultured neurons, lasting only several minutes (Lyles et a l . , 
1984a). Thcse data explain thc absence or rclativcly low lcvels of N C A M 
observed immunocytochcmically in the cytoplasm compared with thc neuronal 
cell mcmbrane.Though in healthy adult nervous tissuc the N C A M synthetic 
machinery appcars to bc relatively silent, it is evident that external influcnces 
whieh may be provoked by traumatism can rapidly stimulate synthesis 
(Daniloffet a l . , 1986a). More recent immunocytochemical studies (DanilolTet 
a l . , 1986b) have confirmed that the adult N C A M staining pattern of chick 
nervous system reflccts that of thc Iate embryo (Thiery et a l . , 1982; Crossin ct 
aI.. 1985) except for a diminution in intensity.This rcduced N C A M immuno-
Iabeling in adult tissue is particularly striking in myclinated fibre tracts such as 
spinal cord and optie nerve. Some reports suggest that the down-rcgulation of 
N C A M during development Ieads to its complete suppression in tnature 
myclinated axons (Mirsky et a l . . 1986; Mar t in i and Schachner, 1988). A s 
alrcady pointcd out. caution in interpreting negative immunocytochemical 
data should bc exerciscd sincc the detection o f low antigen lcvels is much more 
dcpcndant on technical factors. Neverthelcss down rcgulation is confirmed by 
eomparative analysis of both N C A M protein and N C A M m R N A lcvels in 
adu l t sandyounganimals (Bocke t a l . . 1980; L i n n c m a n n e t a l . , 1985; Nybroec t 
a l . , 1986; Gennarini et a l . . 1986). It is likely that it is still present even on axons 
of C N S and P N S neurons in the adult though at much reduced levcls and may 
also bc associated with a slower turnover. In addition the reduced expression of 
N C A M in adult peripheral nerves seems also to be associated with changes in its 
topographical distribution on the axon surface: the membrane at nodes of 
Ranvicr appear to contain morc N C A M than is detectable on thc internodal 
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axon (Ricgcre t a l . . 1986).Thesc Inglih spcciali/.cd regions which prcdisposc 
the rapid saltatory conduction ol impulses in myelinatcd ncrves were shown 
several ycars previously(Langley, 1979) to be the si tesofhigh concentrationsof 
acidic carboxylated polyanions (which could in part include sialic acid 
containing glycoproteins such as N C A M ) . Histochemistry with rutlienium red 
(a former botanical stain for pectin, a carboxyl acid rich polyanion) results in 
staining not only of thc nodal axon membrane, but also the membrane of 
Schwann cclls, which havc subscqucntly becn shown to contain N C A M (sec 
below). 
N C A M has also bcen shown to be present intraaxonally at nodes of Ranvicr 
(Ricger ct a l . , 1986), thougli the function associatcd with such a distribution at 
present remains obscure.Thus. in nervous tissues. a degree ofcompartmen-
talisation of N C A M expression may occur in vivo after permanent stable 
interccllular relationships are established. In contrast, studies on ncurons in 
vitro (Negre-Aminou et a l . , 1988) show no differenccs in total N C A M 
membrane density bctween ecll bodies and neuritc Iikc extensions. This 
parallels the situation in vivo for non-myclinated fibrcs and may rcflect a lesser 
degrce of differentiation. 
4.3.2.2 N C A M Isoforms in Neurons 
In survcying thc literature on the nature of N C A M polypeptides expressed by 
neurons the reader is eonfronted by apparcnt contradictions. Many studies 
have bccn performed on neuronal cultures and it is oftcn difficult to cxtrapolatc 
from cultures to adult neurons for scvcral reasons. C c l l isolation and culture 
conditions may bc cxpccted to modify N C A M synthcsis sincc this has been 
shown to be sensitive to trauniatism influencing ccll contact relationships in 
vivt>. Tropliic factors may at lcast be partly responsible for such changes 
(Prentice et a l . , 1987). In addition most in vitro studics havc employed neurons 
from embryonic tissues in which the stable adult N C A M phenotype Iias not 
been attained. 
It is iniportant first to consider species diffcrcnccs in the rclativc expression 
of individual N C A M polypeptides. Birds appear to express all three N C A M 
forms but their relative amounts and dcvelopmental patterii arc different from 
those of rodents.Thc small surface domain peptide N C A M 120 is vcry wcakly 
expressed in embryonic chick brain (Cunningham. 1986) compared to that of 
rodents and then only in Iate development. Contradietory data on frog N C A M 
has been publislied. In one rcport (Suiishine et a l . . 1987) only N C A M 180 was 
detected while Levi et al. (1987) rcportcd that N C A M 140 was the first 
detectable form early during embryogenesis followcd by N C A M 180. The 
appearance of N C A M 120 was shown to be a rclativcly Iate devclopmental 
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event as in the ehicken. Frog is iinusual howcver in the expression by I iverotan 
N C A M of 160 k D different to the brain isoforms (Lev i et a l . , 1987). 
Analysis of tissue cxtracts from different anatomical regions of the C N S at 
different developmental times havc Icd toeonclusionson cell typc expression of 
different N C A M isoforms (Rougon et a l . . 1982; Chuong and Edelman. 1984). 
Different brain regions reflcet both developmental biosynthctic trends in 
different compartmcnts ofa given cell typc as wcll as the cel lularcomposit ion of 
thc tissuc at a given time. Sinee glial cclls also contain N C A M . though in lowcr 
amounts. tissue extracts corrcspond to a mixture of both neuronal and glial 
components. Dur ing C N S development neuronal proliferation and migration in 
general prccccd glial ccll multiplication and maturation. Thus total tissuc 
N C A M at Iater stages wil l rcflect a relatively greater contribution from glial 
cclls compared to neurons. It has been found in general that N C A M 120 Ievels 
inercase Iater than thosc of the other principal isoforms in dcvcloping brain. 
Analysis ofadult spinal cord white matterdemonstratcs elearly that anatomical 
regional differences can givc strong cliies concerniiig eell typc N C A M 
expression. S p i n a l e o r d c o n t a i n s r e l a t i v e l y l o w a m o u n t s o f N C A M 18()and 140 
and larger amounts of N C A M 120 (Chuong and Ede lman . 1984). Its N C A M 
composition may provide a better indicatioii ofastrocyte N C A M isoforms than 
neuronal forms. sincc this tissuc is composed mainly ofaxons and glial cclls and 
both axonal and oligodendrocyte N C A M is reprcsscd whcn fibres are 
myclinated. Both scts ofda ta suggest that both N C A M 180 and 140 are more 
typically neuronal than N C A M 120. The use of antibodies that spccifically 
recognize N C A M 180 in immunocytochemical studies of thc cerebellum 
indicates that this polypeptide is charactcristic of post-mitotic neurons 
(Pollerberg et a l . , 1985) and suggcsts that this polypeptide is topographically 
eompartmentalized. Higher concentrations of N C A M were found to exist at 
contact sites between cclls and it may bc eiiriehed on ecll extensions (Pollerberg 
et a l . . 1985; 1986). A t the present time it vvould be uiiwisc to gcneralizc from 
thesc findings, even though in a quitc different niodel, rcinforccmciit ol 
neuronal eliaracter which is accompanied by neunte outgrowth is also 
parallcled by higher N C A M 180 R N A Ievels and iiicreascd N C A M 180 
synthesis (Dol icr ty et a l . . 1988). 
The capacity of niature ncurons in situ to synthcsizc and axonally transport 
all tlircc N C A M forms has bcen dcmoiistrated for retinal ganglion neurons 
(Nvbroe et a l . . 1986) and this agrces with data showing in vitrt> translation ofa l l 
N C A M forms with ccrebellar granule cclls microsomes (i . e. post-mitotic 
ncurons). Some reportcd immunochemical data of peripheral ganglia culture 
extracts also suggest that all three forms can bc synthesized altliough 
N C A M 12()wasminor.whileotherstudiesfailed todetect N C A M L20(Nobleet 
a l . . 1985; Ly lese t a l . . I984a.b; Ke i lhauc rc t a l . , 1985; Nybroc et a l . . 1985). 
Such culturcd cclls may more closcly rescmble immature neurons. 
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4.3.2.3 "Embryonic" N C A M in Ncurons 
Rccent immunocytochemical data have demonstrated the pcrsistance of the 
carbohydrate polymcr of "embryonic" N C A M with an antibody against thc 
unusual highly sialylated N C A M (Roi igon et a l . . 1986) in isolated regions of 
adult rat brain (Aaron and Chessclet. 1989; Rougon et a l . . 1990) in contrast to 
the widely hcld opinion that the embryonic-adult conversion is complete beforc 
adulthood. 30 % of adult frog C N S N C A M is in the highly sialylated form 
(Sunshine et a l . . 1987). Regions wlicre high levcls of P S A persist may be 
associated with thc need for grcatcr plasticity of neuronal contacts, which is 
afforded by the Iower adhesive affinity of highly sialylated forms (Rutishauser 
et a l . . 1988). The relative immaturity of culturcd ncurons isolated from 
embrvonic or young animals cven wl icn maintained in culture for proloiiged 
periods is illustrated by the fact that the conversion to adult forms of N C A M is 
rarely observed (Negre-Aminou et a l . . 1988). emphasizing the daiigcr of 
extiapolatii ig from ciiltures to adult tissues. Sialylation has been studied in 
acellular systems using Iysates obtained from young and adult rats: sialylation 
ofbot l i N C A M 180 and 120 was observed with ccrcbellargranule cells. but thc 
N C A M 140 isoform did not appear to be sialylated in vitro (Breen et a l . , 1987. 
sce also Schlosshauer. 1989). 
4.3.3 Astrocytes 
Thc first report showing that astrocytes in situ express N C A M were made with 
monoclonal antibodies against BSP-2, before it was realized that this antigen 
was equivalent to N C A M (Langley et a l . . 1982a; H i r n et a l . , 1983).While 
clearcut evidence of immunolabeling was obtained on ccrebcllar tissue 
sections, curiously the same antibodies failed to i i i imii i iolabel cultured 
astrocytes. This may have bcen due to the relative immaturity of cultured 
astrocytes comparcd with their in situ counterparts. the relativcly low lcvcls of 
astrocytc N C A M compared to ncurons and thc relatively low affinity of the 
monoclonal antibodies cmployed at that time. More rcccnt immunocytochem-
ical data with polyclonal antibodies (Noble ct a l . . 1985) showcd that eulturcd 
astrocytes indeed contain N C A M but quantitative analysis of immunolabcled 
cultured astrocytes (van den Pol ct a l . , 1986) showcd that membrane density 
was 25 fold Iess than that found on cultured (immature) neurons. Neverthelcss. 
considerablc variation in N C A M density was notcd in ncurons of thc same 
culture. Iiiiniunoblot analysis ofcultured astrocytes (Nybroe et a l . . 1986; Noble 
et a l . . 1985)showed a predominancc of N C A M 140 with lower lcvels of N C A M 
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12().with littlc or no deteetable N C A M 180. A s suggestcd above for neurons. 
eell type characteristic N C A M isoforms can be dcduecd from total N C A M 
extracts from anatomical regions consisting mainly of one type of cell 
exprcssing N C A M . Opt ic nervc and spinal cord myclinated tracts contain no 
nerve cell bodies, axon levels of N C A M are relativcly low in thc adult and 
oligodendrocytes in vivo do not appear to cxpress signifieant quantities of 
N C A M . T h u s the relativcly high levels of N C A M 120 and low Ievcls of N C A M 
180 found in adult rat spinal cord and optic ncrvc (our unpublishcd data) may 
be assumcd to bc mainly duc to astrocytes. This agrees with the data from 
cultured astrocytes. but it may be argued that astrocytes in culture resemble 
*'rcactive" astrocytes. 
Furthcr indications that N C A M 120 is a predominant N C A M translation 
product in astrocytes arc obtained from studies of mixed neuronal and astrocytc 
cultures of Fricdlandcr et al . (1985) in which N C A M 120 synthcsis was found to 
be preferentially inhibitcd compared to other isoforms by inhibitors of cell 
proliferation which affeet mainly astrocytes in these cultures. 
Pituicytes are thc glial cells present in the neurohypophysis. Whi l c some 
morphological differcnccs are notable between these cclls and brain astrocytes. 
they resemble the latter with regard to the presence of G F A protcin. 
Immunoelcetron microscopy demonstrates that these cells. Iike brain astro-
cytes, also express N C A M (Fig. 4-5 and Langley et a l . . 1989a). Neurohypo-
physis has becn found to contain little N C A M 120 (Langley et a l . , 1989a); it is 
possible that all is contributed by the pituieytcs or that these cclls have a 
different N C A M polypeptidc phenotype than brain astrocytes. 
Section of peripheral nerve (Daniloff et a l . , 1986a) or optic nervc (our 
unpublishcd data) produec a marked up-regulation o f N C A M synthcsis which 
in peripheral nervc is associatcd with a rcturn to immature forms o f N C A M . In 
optic nerve the massive astrogliosis associated with axonal degcneration is 
accompanied by a considerable increase in immunostaining intensity with 
a n t i - N C A M antibodies. 
4.3.4 Oligodcndrocytes 
In contrast to astrocytes. no direct immunocytochemical evidencc in situ has 
been obtained of N C A M in oligodendrocytes. the other major brain glial cell 
type. Nevcrthclcss thc capacity of cultured oligodendrocytes to synthesize 
N C A M has been unambiguously demonstrated (Trotteret a l . . 1989; Bhat and 
Silberberg. 1985. 1988). which once more emphasizes thc danger of extrapo-
Iating from cultures to brain tissuc. Thc profilc of N C A M polypeptides 
expressed by cultured oligodendrocytes has been found to depend on their 
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degree of maturation. Oligodeiidrocyte maturation has been followed both in 
vivo and in vitro by the successivc appearance of thc glycolipid antigens 04 and 
01 (Trotter et a l . . 1989). Us ing thcse indices it was shown that immatiirc 
oligodendrocytes express both N C A M 140 and 120 while more mature cells 
express predominantly N C A M 120. In addition the N C A M in thcse cultures is 
highly polysialated demonstrating the relative immaturity ofthese cclls. //; vivo 
it is Iikely that the reduction of N C A M expression notcd in eulture continues 
further until it is almost completelv or totally represscd by thc time myelination 
occurs. 
4.3.5 Schwann Cclls 
Evcn though Schwann cells arc the peripheral nervous system myelinating 
counterparts of oligodendrocytes, marked diffcrences exist between thcm. 
Oligodendrocytes can myelinate many axons, while the Schwann cell can 
myelinate a single internode. Schwann cclls are surrounded by a bascment 
membrane in situ and their embryonic origin is the neural crest, while 
oligodendrocytes Iikc astrocytes arc derived from neural tube preeursor cells. 
Curiously, Schwann cells express proteins such as S-1()() which in thc C N S has 
becn cmployed as an astrocyte marker. Schwann cells Iike both oligodendro-
cytes and astrocytes have been shown to express N C A M in culture, but Iike the 
Iattcr continue to express it in vivo in normal adult tissues. In addition, lcvclsof 
N C A M in cultured Schwann cells are influenced by intcractions with ncurons 
(Seilheimeret a l . . 1989). //; vivo immunolabeling is intense vvhen Schwann cells 
surround unmyelinated fibres. but it has been reportcd that myelinating 
Schwann cells no Ionger contain N C A M (Mirsky et a l . , 1986; Covault and 
Sanes, 1986). It is likely that down rcgulation oecurs but low levcls appear to 
persist in peripheral nervcs at nodes of Ranvier (Rieger et a l . . 1986). 
Intcrcstingly, the H N K - I epitope has also been locali/.ed at these sitcs in optic 
nerve (Ffrcnch-Constant et a l . . 1986). A s is the case with other neural crest 
derivatives, the principal isoform present in Schwann cclls is N C A M 140. In 
cruslied or sectioned peripheral nervcs N C A M synthcsis dramatically increases 
and embryonic forms reappear (Dani lof fc t a l . . 1986a). Part of t l i i s incrcase is 
probably contributed by Schwann cells. 
4.3.6 Endocrine Cells 
The diffuse endocrine system cncompasses a wide dispersity ofei ther isolated 
cells o rcc l l eollectives situated in anatomically distant regions ofthe body. Cells 
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of this system differ radically in terms of thc naturc of their secretory products 
and their physiological function, but their classification as a common serics is 
due to data, aceumulated over several years, dcmonstrating many shared 
featurcs.Thcse include thcirgcncralsecretory naturc (endocrine not cxoerine), 
certain morphological eharacteristics (in partieular the presence ofdense corcd 
sceretory granulcs visible in the elcctron mieroseopc) and a number ot' 
bioehemical parameters (see also chapter 1). Pcarsc (1968) was thc originator 
of the conecpt of classifying neuroendocrine cells in a singlc series called 
A P U D celIs (aminc prccursor uptake and dccarboxylation). A n alternative 
terminology of ncurocndoerinc cells as paraneurons highlights similarities but 
also certain differcnccs between them and neurons (Fujita, 1977). Certain 
endocrine ccll typcs havc been widely uscd as modcls for thc study of secretory 
mechanisms, and as we have seen in chapter 2, parallels may cxist with 
meehanisms regulating secretion at synapses in the central nervous system. 
Since the original A P U D classification was proposcd for thesc cclls. data 
obtained with cxpcrimcntal approachcs unavailablc at that time have con-
firmed the common presence of "markcr" protcins in different cell typcs of this 
serics, which is one of thc principal motivations behind this book. The 
niLiltiplicity of common fcaturcs of A P U D cclls Icd Pcarsc (1969) to siiggest 
that all had a common embryonic (neural crest) origin. Subsequent advanccs in 
traiisplantation teehniques havc afforded the possibility of verifying this 
liypothcsis. It has frcquently bccn confirmed: chromaffin cclls of thc adrenal 
mcdulla may thus be vicwed as modified neural crcst derived sympathetic 
ncurons in which certain neuronal eharacteristics such as neurite formation and 
ncurofilament and synapsin expression arc supprcsscd. In addit ion. thc origin 
of the adenoliypohysis, classically taught in medieal schools to derivc from the 
eetoderm of the stomodcum (primitive mouth), has been shown to have a 
neural origin, sinee cells destined to form this endocrine tissuc are found in the 
neural ridge at early embryonic stages, but migrate away before formation of 
the neural crcst (Couly and L c Douar in . 1985. 1987).Thus fiiture Iiypophyseal 
cclls may be subject to neural inductivc influcnces before their arrival in the 
epithelial layer of the roof of the stomodeuni. Notable exceptioiis to this 
hypothcsis do howcver cxist. The same elegant transplantation teehniques 
demonstrating the neural origin of hypopliysis have failed to confirm a similar 
origin for the pancreatic islct endoerine cells which are derived from cclls 
situated in thc ducts (see chapter 1; L e Douar in . 1978;Teitelman et a l . . 1987; 
Teitclman and L e c 1987; Pcarse. 1983). 
4.3.6.1 Immunocytochemistry 
Thc existcncc of certain common properties between neurons and neuroen-
docrine cells promptcd us sevcral years ago to invcstigate whether thc same 
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adhcsive mechanisms between cells operatc in brain and the endocrine system. 
The prcscnce of N C A M was first tcstcd in adrenal medullary cells with thcir 
confirmed neural crcst origin (Langley and Aun i s , 1984) and latercxtended to a 
wider range of endocrine tissues, including thosc of non-neural origin and 
tumor cells (Langley et a l . . 1987, 1989a). 
The presence of N C A M in chromaffin cells of the adrenal mcdulla has bcen 
demonstrated or confirmed by light microscopy by sevcral laboratories 
(Jorgensen and Richter-Landsberg, 1983) and biosyntheticstudics show it to be 
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Fig. 4-4 Vibratome section of rat hypophysis immunoperoxidase labeled for 
N C A M . 
Note the very intense staining of the neural lobe (top), the discrete surface labeling of 
cells in the intermediate lobe (middlc) and the moderate surface labeling of anterior 
lobe cells (bottom). Bar = 20 um. 
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Fig. 4-5 Flcctroii micrograph of rat neurohypophysis immunostained for N C ' A M . 
illustrating the surfacc staining ol a pituicyte surrounded by neurosecretory cell, 
granule-containing, terminal swcllings.which arc also Iabcled on their surface. Section 
not counterstained. Bar = 1 um. 
synthesized in cultured rat chromaffin cells (Nybroc et a l . , 1986). Ultrastruc-
tural studies unequivocally show its membrane Iocalization on both endocrine 
cell types (both adrenergic and noradrenergic) in this tissue. Little or no 
immunoreaction product has been detected intraccllularly. which as Ior 
Purkinje cclls in the cerebeIlum, may be the consequence o fcombined rapid 
transport and inscrtion into the plasmalemma aftcr synthcsis and a relativcly 
slow turnover rate. Preeisc values on absolute amounts of N C A M in adrenal 
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mcdulla arc not available but in the adult rat. Ievels are much Iower than in 
cerebellum (unpublished obscrvations). Some of this is present on both 
unmyelinated nervc fibrcs and the Schwann cells surrounding thcm. 
When other endocrine tissucs were examined including the three lobcs of the 
pituitary gland, the pancreas. tumor cell lincs (Langley ct a l . . 19<S9a) and 
ccrtain human tumors (see below), an identical surface localization of N C A M 
was found immunocytoehemically (Figs. 4-4-4-7). However, both qualitative 
and quantitative differences bctwcen different endocrine tissucs have been 
found. For instancc. in addition to thc pronounced surface labeling of secretory 
cell processes, terminal swellings and nervc terminals constituting the neuroen-
docrine elemcnts of the neurohypophysis, extracellular staining was observed 
using polyclonal a n t i - N C A M antibodies (Langley et a l . , 1989a). Extracellular 
localization of this molecule has also bccn reported in muscle (Sanes et a l . . 
1986; Rieger et a l . . 1988). Sincc N C A M contains a heparin binding site (Cole 
and Glaser, 1986; Cole et a l . , 1986a,b) with a relative high affinity (Nybroc et 
a l . . 1989) capable ofbindingi t tocollagen fibrils by the intermediaryoflaminin, 
it is reasonable to suppose that any N C A M lost from the cell surface would 
adhere to neighbouring basemcnt membranc components.Wether tIie Ioss of 
Fig. 4-6 Vibratome section of rat pancreas through an islet of Langerhans Iabeled for 
N C A M . 
The surface labeling of all cclls in thc islct contrasts with the abscncc of staining in the 
exocrine pancreas. Bar = 20 um. 
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Fig. 4-7 Electron micrograph ol rat endocrine pancreatic cclls immunostained for 
N C A M . 
Thc immunoreaction isconfined to thc plasma membranes. Scction not counterstained. 
Bar = 1 um. 
N C A M from ccll surfaccs is a normal phcnomcnon in hcalthy tissue is not 
known though a solublc secreted form of N C A M with a M r 120 k D has been 
s h o w n t o c x i s t ( B o c k e t a l . , 1987). H o w c v e r , l e v e l s o f N C A M 12()areverylowin 
the neurohypophysis and at thc present time the molecular nature of N C A M 
found extraecllularly has not becn resolvcd. 
One of the striking features of the immunstaining pattern of rat pituitary 
gland scctions conccrns variations in labcling intensity found bctween the three 
lobes constituting this tissue (Fig . 4-4). The neural Iobe is thc most heavily 
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staincd and the anterior lobe is modcrately labeled, while intermediate lobe 
endocrine cclls appear vcry discretcly labeled at their surface (Langley ct a l . . 
L989a). Apparent differences of intensity of immunolabeling should always be 
treated with caution in immunocytochemistry. Similar differences wcrc how-
evcr observed on immunoblots when extracts from identical amounts of adeno-
and neurohypophysis were compared. It is. howcver. difficult to evaluate 
whether such overall differences in tissue concentrations reflect real differences 
in N C A M mcmbrane densitics in the two lobes, since their cellular composition 
differ radically: thc anterior Iobe of the hypophysis consists essentially of 
aggregatcs of cell bodies with few cell processes while the neurohypophysis. 
apart from a relatively small number of gliaI cells, which also express N C A M 
(Fig. 4-5), consists entirely ofce l l processes and terminals.Thus thc membranc 
surface area is much largeron the basis of tissue weight in the lattcrcompared to 
the former. 
Panereatic tissue is eharacterized by the absence of N C A M staining of 
cxocrine cells and the marked surface labeling of all endocrine cells of the islets 
of Langerhans, irrcspective of the nature of their secretory products (Figs. 4-6 
and 4-7).Several yearsago an N C A M related antigcn was found to be prcscnt in 
rat testis Iocalized on spcrmatids but not on mature spcrmatozoa (j0rgensen 
and M0l ler , 1983). O u r recent preliminary studies on rat testis have also shown 
that groups of endocrine cells (Leydig cells) situatcd between thc scminiferous 
tubules are immunorcactive with a n t i - N C A M sera. In addition. marked 
extracellular staining was observed in this tissuc. 
Molecular biological probes arc currcntly bcing uscd to examine lissuc 
distribution of the N C A M mcssage. A major advantage of such techniqucs is 
their potential to study expression of individual exons in thc transcript.Thus it 
is now possiblc to study not only the messagc for the major N C A M isoforms but 
also to detect the prcscnce and analyze tissue distribution of the minor exons 
recently discovered. Using S l nueleasc protection assays the prescncc of 
N C A M m R N A has been confirmed in adrenal gland. neuro- and adenohypo-
physis and pancreas (our unpublishcd results). 
4.3.6.2 N C A M Isoformsin EndocrineTissues 
Immunochemieal analysis of N C A M polypeptide profiles of brain and endo-
crine tissue extracts rcvealed unexpected differences (Fig . 4-8 and Langley et 
a l . . 1987. 1989a). Al though by immunocytochemistry with polyclonal anti-
N C A M antibodies very similar cellular staining pattcrns are obtained with 
brain and endocrine tissues, thc relative amounts of individual N C A M 
polypeptides in endocrine cells differ radically from those in brain: in addition 
one major exccption was found amongst the endocrine tissues studied. N C A M 
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140 is thc principal isoform expressed in rat adrenal gland. adenohypophysis 
and pancreatic islets but N C A M 180 is predominant in neurohypophysis. 
Cultured bovine adrenal medullary chromaffin cclls may express measurable 
amounts of N C A M 180 (our own unpublishcd results; see also Nybroe et a l . , 
1986) but this eould be due to the increased tendcncy of such cclls to express a 
neuronal phenotype. as illustrated by thc appcarancc of neurofilamcnt proteins 
in cultured chromaffin cells though thcsc are iindetcctable in vivo (Grant et a l . . 
1988). In addition. this could also be the result of species differences in the 
expression of N C A M 180 by endocrine cclls. Fcw data exist at the moment on 
intcrspccies N C A M polypeptide expression in endocrine cells. Analysis of 
human tissues indicate that N C A M 140 is thc predominant form present in 
adenohypophysis and endocrine Iung tumors (Aletscc-Ufreeht et a l . . 
199()b)." 
The neurohypophysis appcars to represent an cxccption to the idca that the 
endocrine N C A M phenotype is N C A M 140. A l l three major N C A M polypep-
tides are found in this tissue although N C A M 120 is a minor constituent.The 
fact that thc ccll processcs that form the bulk of this organ derive from 
pcrikarya situated in paraventricular and supraoptic nuclci of the hypothala-
mus. thus sharing similar embryonic origins with other central nervous system 
1 2 3 4 5 6 7 
Fig.4-8 Iiiiiiuinoblots showing N C A M isoforms in ccrcbellum (I). neurohypophysis 
(2). adenohypophysis (3), adrenal mcdulla (4). rat pheochromocytoma (5). pancreatic 
islets (6) and rat insulinoma cclls (7). 
Extracts ol rat tissues and cclls wcre resolved by polyacrylamide gcl elcctrophoresis. 
transferred to iiitroccllulose. and rcacted with polyclonal anli-NC'AM antibody. 
Immunorcactixc bands were visualized with radiolabeled protcin A and autoradiogra-
phy. Molecular masses (kD) arc indicated (from Aletsec-Ufrecht et al.. 1OSS); by 
permission. 
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ncurons. may bc a sufficient rcason to cxpcct that their N C A M profile should 
morc closcly rcsemble that of C N S neurons. Wc havc scen. however, that 
embryonic origin is not strictly detcrminant in N C A M expression.The structure 
ofthe neurohypophysis is quite different from that ofothercndocr inc organs in 
that it is composcd of ecll processcs that are very distant from their ccll bodics. 
Studies on cultured neurones subjccted to ageiits inducing neurite growth 
(Pollerbcrg et a l . , 1985, 1986) suggcst that some compartmentalization of 
N C A M 180. perliaps due to an interaction with thc cytoskeleton (Pollerberget 
a l . . 1987). may occur bctwccn cell body and ccll proccsses, the concentration 
beiiig greater on the latter. Tlius the higher levcls of N C A M 180 found in 
ncurohypoliysis may bc thc rcsult of such compartmentalization. In any case, 
thesc data show that all endocrine cclls are not idcntical with regard to N C A M 
polypeptides. and that somc may bctter suit the prcfix "neuro-" in this contcxt. 
It is interesting to notc that the N C A M f o r m that persists in adult endocrine 
cells is the form that is reported to bc firsfexprcssed by very carly embryos even 
bcforc neural induction occurs (Lev i et a l . , 1987; Jacobson and Rutishauser, 
1986) and that N C A M 180 is eonsidcred by some to be the more cliaracteristic 
form ofdifferentiatcd post-mitotic ncurons(Pollerbcrg et a l . . 1985. 1986). A s is 
rcvicwcd later. N C A M 140 is also thc form found in certain strictly non-neural 
cells. Endoerine cells may thus bc viewed as exprcssing morc primitive Iess 
characteristically neuronal N C A M forms. 
4.3.6.3 Eiidoeri i ic Tumors 
The PC12 cell l ine. derived from a rat adrenal medullary pheocliromocytoma. 
Iias providcd neurobiologists with a useful model for studying both endocrine 
ecll biology and neuronal diiferentiatioii and maturation. Sincc these cells also 
express N C A M . their response to nerve growth factor N G E in neurite 
outgrovvth formation Iias also provided the opportii i i i ty ol studying N C A M 
expression during such phenomeiion. Ccinflicting data have been published on 
the stimulatory effect o f N G F ( D o h e r t y ct a l . . 1988) or the absence ofan effect 
(Friedlander et a l . . 1986) on certain forms of N C A M in PC12 cc l l s .Thcsc 
differences may bc the rcsult of using different subliiies of these cells. N C A M is 
essentially Iocalizcd on the surface of PC12 cclls as has been found for other 
endocrine and neural cells. and N C A M 140 is the predominant tIiciugh not 
exclusivc isoform present. Walsh's group observed both inereased Ievels of 
N C A M 180 and N C A M m R N A of 7.2kb (the message considcrcd to ciicodc 
N C A M 180) after N G F treatment (Prentice et a l . , 1987). suggesting that this 
isoform may bc morc conccntratcd on neuritc-likc cxtcnsions. Elevated levels 
of this form have also been iiotcd in another experimental endocrine tumor. a 
158 4 Ncural Cell Adhesioii Moleeule 
Fig. 4-9 Cultured rat insulinoma (RIN A2) cells Iabeled for N C A M by immunofluo-
rescence. Notc the pronounced surface labeling. Bar = 20 um. 
rat insulinoma (Fig. 4-9), compared with their normal counterparts (Langleyet 
a l . . 1987). Rat insulinoma cclls in culture tend to produee thin cell process 
unlike normal pancreatic ß cclls although these are Iess pronounced than those 
of N G F treated PC12 cells.Thus increased N C A M 180 expression may not bc a 
directly related to the malignant transformation, but associatcd with cell 
morphological changes. 
It is interesting to notc that the expression of another C A M first idcntified in 
P C f 2 as N G F inducible largc external ( N I L E ) glycoprotein ( M c G u i r e et aI., 
1978) and subsequently shown to be equivalent to the cell adhesion molecule 
N g C A M o f c h i c k ( F r i e d l a n d e r e t a l . , 1986 )andL l i n roden t s (Boeke t a l . , 1985) 
parallels that of N C A M 180 (Pigott and Kcl ly , 1986): it too is upregulatcd after 
N G F treatmcnt. In fact the expression of L l and N C A M 180 in many tissues is 
similar and may in part be duc to an association between these two molecules 
(Thor ct a l . , 1986) particularly on cell processes. Antibodies against L l have 
been found to strongly stain neurohypophysis (Langley et a l . , 1989b;), which 
also contain high levels of N C A M 180: in contrast adenohypophysis and 
pancreatic islets are weakly or not at all stained for L l nor do they contain 
N C A M 180. Chromaffin cells of the adrenal medulla represent an enigma. 
since only 20% appear to express L l strongly in the rat adrenal which contains 
very little N C A M 180. 
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Two main classes of human endocrine tumors have becn recently studied with 
rcgard to their N C A M expression; Iung tumors and hypophyseal tumors.We 
havc studied the small ccll Iung carcinoma ( S C L C ) on ccll lines established 
Irom several paticnts (Fig. 4-10, Alctsee-Ufrecht et a l . , 1990a).Thesc cell lines 
grow best in suspension culture but can be grown on covcrslips. facilitating 
immunocytochcmistry.wherc thcy retain a rounded cell morphology and their 
endocrine phenotype as exemplified by thc presencc of synaptophysin and 
neuron specific cnolase. Immunoblot analysis has shown that N C A M 140 is the 
prcdominant if not cxclusive N C A M form expressed. Other Iung tumors 
examined ineluded mesotheliomas, squamous eell carcinomas (i . c. non-
endocrinc tumors) and "large cell carcinoma". N C A M was found only in the 
latter: it is Iikely that these tumors are derived from S C L C N C A M Ievels were 
found to vary betwcen different S C L C patients. and even between two lines 
derived from tumors of the samc patient at different times. Lcvels of othcr cell 
markers vverc also found to vary but in different directions. It can be eoncludcd 
that thc regulation of N C A M synthcsis varies during thc course of thc disease 
and that such regulation parallcls ncither that of vesicle or souble protcins. 
We have also recently examined human pituitary tumors for thc presencc of 
N C A M (Aietsce-Ufrecht et a l . , 199()b) including prolactinomas. growth 
hormonc producing adenomas. and inactive adenomas. which were each 
characterizcd on the basis of clinical fcatures, immunohistochemical data or 
Fig. 4-10 Cultured humansmallccll lungcarcinoma(SCLC)cellsimmunofluorescently 
Iabelcd for N C A M showing marked surface labeling. Bar = 20 um. 
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Fig. 4-11 Electron micrograph of human growth liormonc producing adenoma immu-
nostaincd for N C A M . illustrating the iiitense surface labeling ofthese cells. Section not 
counterstained. Bar = 1 um (from Aletsee-Ufrecht et al.. l990b, by permission ol 
Elsevier, Amsterdam). 
serum Iiornione analyscs. N C A M 140 was detectable on immunoblots of all but 
prolaetinomas. Highly sensitive immunocytochemical methods confirmed a 
surface Iocalization of N C A M in all these tumors (Fig.4-11) evcii in 
prolaetinomas, although staining intensity was much Iess in prolaetinomas, 
coiifirming rcduccd lcvels in this tumor. 
Thc prcsence of N C A M in certain human tumors may also bc responsible for 
the staining observed with othcr anti-tumor antibodies of prcvioiisly undctcr-
mined antigen spccificity. From a number of monoclonal antibodies dcvclopcd 
against a variety of tumors, somc have been shown to reeognizc thc N C A M 
molecule (Patel et a l . , 1989). In addition the staining of tumors with anti 
H N K - I (Leu7) antibodies (chapter 7; Wil l i son et a l . . 1986) eould be due to a 
subset of N C A M molcculcs earrying thc H N K - I carbohydrate liapten. 
4.3.7 Fibroblasts 
Fibroblasts represent a furtlier ambiguous class of cclls on which apparently 
contradictory data have bccn published. Ear l icr reports produced no evidence 
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o f N C A M in fibroblasts. Fibroblasts in normal peripheral nerve in endo-, pcri-
and epineiiral situations are N C A M negative in adult tissue and also at all 
developmental ages studied (Seilheimer and Sehaehner. 1988; Mart ini and 
Schachner, 1988; Seilheimer et a l . , 1989). Fibroblasts isolatcd from skin and 
brain havc not been found to contain N C A M . In contrast. immunocytochem-
istry demonstrates N C A M expression by fibroblast-likc cells which accumulate 
in nerve stumps alter crush Icsions or section of peripheral ncrves and by 
perisynaptic fibroblasts in dencrvated muscle (Gatchalian et a l . . 1989). 
Fibroblasts isolatcd from both peripheral nerve and skeletal muscle and 
subsequently maintained in culturc also have the capacity to express N C A M 
(Gatchalian et a l . . 1989).The isoform expressed is N C A M 140. which is thc 
same as that found in peripheral nerve Schwann cells. Mesenchymal cells 
possibly related to fibroblasts in regenerating newt Iimbs have also bcen found 
to be N C A M positive (Maier et a l . , 1986).The capacity to express N C A M may 
thus be confined to particular subsets of fibroblasts or bc induced either in 
culturc or in pathological situations in which increased N C A M syntliesis is 
known to occiir: N G F activity also incrcascs in peripheral nerves after 
injury. 
4.3.8 Muscle 
Thc considerablc number ol studies dcvotcd to both adult and developing 
skeletal muscle sincc thc initial discovery of N C A M in embryonic muscle 
(Griimet et a l . . 1982) have provided valuable iiisight into thc regulation ol 
N C A M synthesis and its molecular biology.Wc will not deal in detail liere with 
muscle and the rcadcr is referred to a reccnt rcview (Walsh. 1988) Ior a more 
detailed aiialysis. A bricfdiscussion I i o w e v c r o f N C A M in muscle is pertiiient in 
the context of its potential as a neural cell marker. It was the first tissue outside 
the nervous system in which N C A M expression was found to persist into 
adul thood.Whilc N C A M is detcctablc in all primitive gcrm eell laycrs in early 
embryos, defined tissue inductive cvcnts Icad either to its suppression or to its 
continued expression (Edelman. 1984). Dur ing skeletal muscle histogeiiesis. 
down-regulation of N C A M during myotiibe maturation and innervation is 
associated with a dramatic change in its Iocalization on thc surface membranc 
of the muscle ce l l .The wide distribution ovcr the cntire myotiibc surface is 
replaced in thc adult by rcstricted expression over specializcd contact regions. 
the neuromuscular junctions. This adult topographical distribution can bc 
rcverscd to that found in immature muscIe by dcncrvation. 
Analysis ofthe polvpeptide nature of muscle N C A M illustrates Iiow different 
tissues can process thcse molecules in specific ways. Initial immunoblot studies 
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on muscle Siiggcsted a molccular mass for this antigen similar to that of brain 
N C A M 140. Fiirther investigations showed that muscle N C A M m R N A 
contains an additional exon. not present in brain. encoding an amino aeid 
sei]iience unique to muscle, and it was siiggcstcd that thc isoform present in 
differentiated myotiibes is equivalent to a modified N C A M 12().whieh. Iike this 
brain isoform, is aneliored to the plasma membrane by phosphatidyl i i iositol 
(Moore et a l . . 19<S7). 
4.3.9 Othcr Non-Neural Tissues 
A rare but iiniisiially malignant kidney tumor (Wilms tumor) rcprcseiits a 
particularly interestingexample o f N C A M rc-cxpression in pathological tissue. 
N C A M is detectable during early development of thc kidney. but it is 
subscqucntly down-regulatcd and is absent from the adult gland (Roth ct a l . . 
1987). In Wilms tiinioiir N C A M has been found to be not only strongly 
expressed, but as the highly sialylated "embryonic" form (Roth et a l . . 1988). 
The malignant transformation may thus bc iiiterpretcd in terms o f a revcrsion 
ofthe normal differentiatioii and maturation process Icading to a cell with more 
primitive eharacteristics. Elevated levcls ol high P S A containing N C A M 
undoubtedly influences the contact relationships and "social bchav io i i i " of 
thesc cclls. propertics which many years ago Iiad bccn suggcsted to be l inked to 
ccll surfaec sialic acid content (Langley and Ambrose . 1964). 
N C A M has bccn detectable in a fcw other non-neural tissucs. Sevcral 
adhcsion molecules havc bccn fond in rodent intestinc with different distribii-
tions (Thor et a l . , 1986). N C A M appears to be confined to mesenchymal and 
Iieuroeetodermally derivcd parts of the intestine. In particiilar it was found to 
bc located in the oiiter muscle layers. not only in Auerbach's plexus but also in 
mesenchymal parts. and it was present in the submueosa, the miiscii laiis 
miicosa. the Iamina propria surrounding the crypts and in the inner part of v i l l i . 
Siirprisingly. all three N C A M isoforms were reportcd to bc present. thus 
reflecting the C N S patterii rather than that found in peripheral nervous or 
non-ncrvous tissues. Individiial N C A M containing ccllular elemcnts were 
uiifortunately not idcntified in this study. Thus it is not known if intestinal 
endocrine cclls contain N C A M . Some staining in the muscularis miicosa and in 
the Iamina propria may bc diie to neurons or their proecsscs. 
Chicken skin has bccn found to contain N C A M (Cluiong and Edelman. 
l985a,b) which is similar or identical to that of brain except in its polypeptide 
profile: only N C A M 140 is detectable in skin (Murray et a l . , 1986).This persists 
into adulthood and is subject to thc embryonic-adult post-translation modifi-
cation described for the brain antigen. It is associated with the morphogencsis 
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ot 'chickcn feathcrs, a process which continucs throughout adult I i fc A cyclic 
pattern of both N C A M and L C A M (equivalcnt to thc calcium dcpcndcnt cell 
adhcsion molecule E-eadherin) cxprcssion is found in growing and rcgcncrat-
ing feather buds. In addition to membranc expression, N C A M is also Iocated in 
certain extracellular regions aftcr cell disappearance. N C A M m R N A has also 
bcen dcteetcd by the blot hybridization technique in embryonic hcart, breast 
musele. gizzard. Iung and kidney (Murray et a l . . 1986). In non-neural tissucs 
N C A M 180 m R N A has becn only detectable in assoeiation with nervous 
elements such as the nervc plcxuscs in devcloping Iung and thc largc enteric 
gaiiglia ofgizzard. Most data siiggest that when N C A M is present in non-neural 
tissucs N C A M 140 is thc isoform generally found. 
4.4 Expression of N C A M During Development 
Attcmpts to rclatc N C A M function to tissue structure and in particular to tissuc 
inductive evcnts have strongly motivated studies of its expression throughout 
embryonic development. Major "decisions" which dctermine the course of 
Iiistogencsis are made relativcly carly in ernbryonic life. Radieai changes in 
tissuc Ievcls of ccll adhcsion molecules which cither stabilizc intcrccllular 
contacts or promote ccllular migration may bc cxpectcd to coincide with this 
period of intensc activity of ccl l sorting and reorganisation. The pattern of 
N C A M expression is indecd cxtremcly plastie during early embryonic Iife 
(Edelman. 1983. 1984b).This is also true in adult tissucs subject to inductive 
changes (Chuong and Edelman. 1985a.b). It is beyond thc scope ofthis chapter 
to review in detail such complcx changes in N C A M regulation during nervous 
tissue and endocrine tissue development. Readers are rcfcrrcd to the excellent 
studies by Edelman's group. In pioneering studicsTliiery and coworkers (1982) 
reported the very early appearance of N C A M in embryonic tissues. N C A M is 
detectable in all three primitive germ layers. thc endoderm, thc mesoderm and 
the cctoderiii , and Iias bccn shown to bc present in those regions concerned 
with primary dcvelopmental axes (neural plate, neural tube. notocliord. 
somitcs) and in thosc regions in which later induetive evcnts occur such as thc 
neural ercst. optie, otic and pharyngeal placodcs, cardiac mesoderm. meso-
nepliric primordium and Iimb buds.When tissuc inductive events occur, N C A M 
expression may bc cither supprcssed pcrmanently or tcmporarily or maintained 
according to thc nature of induction. 
A number of studies havc addressed the problcm of changing lcvels of 
N C A M during nervous tissuc development. Lcvels vary bctwccn different 
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brain regions or tissues during development (Boek et a l . . 1983; Linnemann et 
a l . . 1985). Levels are redueed more in myelinated traets than in regions 
containing eell bodies (Daniloff et a l . . 1986b). Cerebellar development is a 
relativcly Iate event comparcd with rat forebrain. occurring during thc first 
threc wccks of postnatal lifc. N C A M levels are low beforc birth but incrcase 
dramatically during thc pcriod of parallel fibre (granule eell axon) formation 
and synaptogenesis eorresponding to a period of dramatic incrcase of neuronal 
surface area (J0rgenscn and Honegger, 1983). Cerebcllar N C A M subsequently 
decrcases to a fairly constant levcl . This may be eorrelated with data from 
biosynthetic studies on cultures of rat brain cclls obtained at embryonic day 17 
and at postnatal day 25. which demonstratc a 50 % reduction in overall level 
(Nybroe et a l . . 1986). Analysis o f N C A M m R N A levcls show that the levcls of 
the transcription product arc reduccd during brain development three times 
morc than that of thc translation products (Gcnnarini et a l . . 1986).This may bc 
interpretcd in terms of a slowcr N C A M turnover as development proceeds or a 
h i g h e r N C A M m R N A s t a b i l i z a t i o n . A s l o w c r t u r n o v c r r a t c o f N C A M has becn 
suggestcd aftcr inscrtion into plasma membranes after axonal transport in the 
optic systcm (Garne rc t a l . . 1986). Interestingly. cvcn within thc eercbellum a 
differential distribution of individual N C A M polypeptides has been found 
during development (Pollerberg et a l . . l985) .Whi le N C A M is detectable by 
immunocytochemistry with polyelonal antibodies recognizing all N C A M 
polypeptides at carliest times in the gcrminativc Iaycr of the cerebellum, 
N C A M 180 is not detectable in this zonc. This polypeptide appears to be 
confined, in the molecular layer. to post-mitotie neurons. Regional differences 
have also been noted using specific probes capablc of distinguishing betwccn 
N C A M 180 and N C A M 140 mcssages (Murray et a l . . 1986).The N C A M 180 
mcssage has becn dcteeted as carly as the third day ofembryonic Iife in chick 
spinal cord but was not found in neuroepithelium. Al lhough N C A M 140 
mcssagc was detectable in embryonic heart. breast-muscIe. skin. gizzard Iung 
and kidney. N C A M 180 m R N A was found to be absent Irom these tissues and 
only detectable in tissues containing neural elements (such as the Iarge enteric 
ganglia in gizzard or thc nerve plcxuses in oesophagus and Iung buds) .Vcry 
rcccnt in situ hybridization studies confirm these earlier findings (Prieto et a l . . 
1989). 
A particularly relevant examplc of dcvelopmcntal N C A M up- and down-
regulation in thc context of this chapter is found in cclls which constitutc thc 
adrenal mcdulla. Thc endocrine chromaffin cells are dcr ivcd , as are sympa-
thetic ganglia. from N C A M positive precursors in the neural crcst (Thiery ct 
a l . . 1982).When thesc cclls inigrate away from the neural ercst towards their 
future site N C A M expression is supprcsscd. A t the same time substrate 
adhcsion molecules are upregulated (Duband ct a l . . 1986).Thc reaggregation 
of thesc cells during the histogcnesis of thc adrenal gland coincidcs with 
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rcncwcd exprcssion ol N C A M 140. and is accompanied by down-regulation of 
fibronectin receptors. These data have bcen iiiterpreted in terms of the 
stabilizing effect of N C A M on intcrcellular contacts. vvhieli would bc couiiter-
productive during the migration phase, but which are critical during formation 
of thc adrenal mcdulla. In addit ion, sincc the cortical cells surrounding the 
centrally situated groups of adrenal medullary chromaffin cells do not express 
N C A M . a meelianism of "cell sorting" may operatc in defining the particular 
tissue architecture of this endocrine gland (see Fricdlander et a l . . 1989). 
4.5 Post-Translational Developmental 
Modifications 
The dramatic modifications in the exprcssion of N C A M that occur during 
development or in post-traumatic or pathological situations undcrlined earlier 
can take a i iumbcr of different forms.We have sccn that tissuc lcvels of total 
N C A M , and accordingly membrane density, is dependant on endogenous 
environmental stimuli. Such factors may also diffcrentially influence the 
transcription of individual m R N A species codiiig for the different N C A M 
isoforms independently of each otiier. It is not yet known if thesc various 
N C A M m R N A s differ in stability or translation efficiency. In addition 
post-translational modifications represent a major aspect of these glycopro-
teins. N C A M is both phosphorylated and sulfated in its transit through the 
Ciolgi apparatus (Lyles et a l . , l984b). No significant alteratioiis in phosphory-
lation are thought to acconipany nervous tissuc development, and it vvould 
appear that they are uiilikely to havc major functional significance. Moreover, 
activatorsof protcin kinase C w h i c h is involved in thc phosphorylation of many 
proteins. stimulates thc synthesis ofcer ta in membcrs of the immunoglobulin 
supergene family but do not modify N C A M synthesis (Doherty et a l . , 1988). In 
contrast the Icvcl of sulfatioii dccreases during development (Lyles et a l . , 
19S4b; Linnemann ct a l . . 1985). 
Thc post-translational modification which Iias received most attention 
eoiieenis glyeosylation. Expression of the H N K - I carbohydrate epitope and 
more recently another carbohydrate epitope callcd L3 have been studied 
(Kruse et a l . , 1984. 1985; Kci l l i auere t a l . . 1985; Ki ic l ierere t a l . , 1987) but the 
degree of sialylation of N C A M Iias been investigated in most detail. From a 
functional viewpoint. sincc the sialic acid content profoundly affects thc 
adhesive binding eapacity of N C A M . such modifications assume as much 
importance as N C A M membrane density. Sialylation of N C A M is uniisual in as 
far as forms of N C A M with high sialic acid levcls (as much as 30% of thc 
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molecule) contain this sugar in the form of thc u-2.<S polysialic acid ( P S A . 
Cunningham et a l . . 1983; Finnc et a l . . 1983). A t thc very earliest stages of 
embryonic development P S A lcvels appear to bc low.Thcn N C A M with high 
P S A content is produced, and subsequently P S A content is reduced as 
development procccds but certain zones with high P S A N C A M pcrsist in the 
adult (Sunshine ct a l . . 1987; A a r o n and Chesselet, 1989; Rougon et a l . . 1990). 
Sinee the appearancc ofthe three principal N C A M isoforms is not simultaneoiis 
during development ( N C A M 12()appears somewhat latcr than thc othcr two) it 
is not clear if all forms are poly-sialylated to thc same dcgrcc. Data from 
explant cultures of mouse and chick tissues suggest that thc convcrsion from 
high to low P S A N C A M is not due to proccssingofthc embryonic into thc adult 
form, but by de novo synthesis o f N C A M with lower sialic acid content and that 
this is due to intraccllular rcgulation of sialyl transfcrase (Friedlander et a l . . 
1985). Morc r ccen t ly (Brecne ta l . , 1987. 1988)foundthatanendogenousGolgi 
sialytransfcrase was capablc of sialylating N C A M 180 and N C A M 120 in situ. 
though eiiriously obtained no evidencc of N C A M 140 sialylation under their 
conditions. In addition highest tissue activities of this enzymc coincide with 
highest tissuc lcvels of N C A M P S A . 
In pathological tissues increased P S A N C A M lcvels (Dani loffc t a l . , 1986a) 
has bccn Iinked to the proccss of ccllular reorganisation. In contrast in 
devcloping ccrebcllum no corrclation was found bctwccn rediietion in P S A 
levels and thc migratory status of cerebellar granule ncurons (Nagata and 
Schachncr. 1986). 
A t present no direct data cxist on N C A M sialylation in neuroendocrine 
tissucs. In the adult it is Iikely to be relatively Iow sinee immunoblots reveal thc 
prcscncc ofdiscrctc N C A M bands. Some data suggest that in the neurohypo-
physis P S A Icvcls may bc higher (Langley et a l . . 1989a). 
4.6 ConcIuding Remarks on N C A M as a 
Neuronal and Neuroendocrine Cell Marker 
Thc original concept that N C A M is confincd in the adult to neurons and 
moreover with restricted Iocalization to specializcd regions of the neuronal 
membranc has becn gradiialIy crodcd ovcr thc past fcw years. Clcarcut 
cvidencc has demonstrated its expression by othcr neural cclls in both P N S and 
C N S and also by endocrine cclls independant of whether their embryological 
origin is ncuroectodcrmal or not. In addition the prcsencc of N C A M in adult 
muscle and certain othcr non-nervous tissucs of adult chickcn including skin 
and Iung confirms thc wider than neural distribution of this molecule. The 
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ccllular expression ol N C A M cannot thus be taken as an absolute eriterion of 
neuronal charaeter. N C A M 140 may be regarded as thc more typical isoform of 
neuroendocrine cclls and may provide an additional parametcr to characterize 
putative neuroendocrine cclls in non-nervous tissues. For example the 
expression of N C A M 140 by S C L C contrasts with its absence in othcr Iung 
tumors such as mesotheliomas or adenomas. confirming the endocrine nature 
of this tumor. 
In contrast N C A M 180 appears to be more characteristie of post-mitotic 
mature neurones than of other neural cells in their terminally differentiated 
statc. Strictly non-ncural cells do not appear to express this isoform, although 
thc eapacity of paraneurons to synthesize N C A M 180 does not seem to be 
permancntly lost. A s has been shown for pheochromoeytoma PC12 cells, 
stiniuli which predispose differentiation towards a neuronal phenotype may 
up-rcgulate synthcsis of N C A M 180. In quantitative terms, howcver. thc 
expression of N C A M is heavily biased towards the nervous system. Levels 
found even in neural crest-dcrived tissues are much lower than those of thc 
C N S . In addition, levels o f N C A M have been found to vary between different 
typcs of endocrine tumor. For instancc. human prolaetinomas appear to 
contain Iess than growth hormone producing or inactive adcnomas of the 
hypophysis.This may itsclfbc of use to distinguish between tumors particularly 
if thc prolactinoma is inactive. 
Nevertheless it is clear that thc use of N C A M as a marker for neural and 
neuroendocrine cells sliould bc treated with caution. N o single marker protcin 
lulfills the erilcrion of absolute spccificity. Togctlicr with a battery of other 
marker protcins N C A M isoforms can aid cellular eharacterization and 
diagnosis of tumors. Polysialylation of N C A M polypeptides represents an 
unusual post-translational modification probably uiiique to members of this 
family of proteins. Its reappearance or continued prcsence in adult tissues 
secms to be associatcd with either altered intercellular contact phenomena 
Iollowing a pathological process or with the need to retain a higher degree of 
plastieity inccl lcontacts in normal tissucs. l t sprescnceinWilmstumorsuggests 
it would be a good marker in this tissue and prompts its seareh in other tumors. 
A rcecnt rcport (Moolcnaarc t a l . . 1990) showed the prcsence of l i igh levelsof 
N C A M sialylation in a ccll Iine derived from an endocrine Iung tumor. It is 
possible that high P S A N C A M forms may be gencrally associatcd with thc 
dediffcrcntiated state of maligiiantly transformed neural and neuroendocrine 
cells. 
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Part III 
Applications 

5 Neuron Specific Enolase as a Clinical 
Tool in Neurologie and Endocrine 
Disease 
Paul./. Marangos 
5.1 Introduction 
Thc eharacterization of cell specific proteins has becomc a viable strategy for 
elucidating the mechanisms involved in differentiated tissue and organ 
functions. The brain is probably the most differentiated of all organs and 
ecrtainly rcpresents thc most significant challenge for the molecular physi-
ologist with regard to the nature of its function.Theorctieally, it thc function of 
all thc protcins specific to a given cell typc were known then we would fully 
Linderstand how that ccll performs its specific tasks. This was in fact thc 
motivation for thc studies performed by Blake M o o r c and his collcagiies during 
the L960's when he utilized various methods of protein fractionation to 
clucidate thc soluble proteins specific to brain tissuc (Moore and MeGregor . 
I%5; Moore , 1973).Those pionecring studies Ied to thc description of two 
apparently novel brain proteins which Moore tcrmed thc 14-3-2 and thc S-1()() 
protein. There werc in fact a number of acidic. soluble protcins that only 
appeared in extracts of thc brain and were not readily detectcd in livcr and 
muscle extracts. 
In thc scveral years that followcd the initial description of thc 14-3-2 and 
S-1()() protcins it was shown by somewhat circumstantial evidence that 14-3-2 
was probably a neuronal component and that S-IOO was glial (Cicero et a l . , 
1972; Moorc . 1973; Cicero ct a l . . 1970). 
In the mid-7()'s it was further shown when specific antibodies to the 14-3-2 
protcins were utilizcd in immunocytochemical staining protocols that this 
protein was indeed highly localized to neurons and furthermore that it was 
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cytoplasmic (Pickcl et a l . . 1975).The protein at that time was redesignated as 
neuron specific protein or N S P (Marangos et a l . . 1978 Marangos and 
Zomzely-Neurath . 1976) sincc this was more descriptive in nature than 14-3-2. 
Shortly, thereafter it was further demonstrated that N S P was in fact a neuron 
specific form of the ubiquitous glycolytic enzyme enolase, at which time it was 
again re-named to neuron specific enolase or N S E (Boek and Dissing. 1975: 
Marangoset a l . . 1976: Fletcheret a l . . 1976). N S E hastherefore had a somcwhat 
confusing history over the years. To further complicate matters its structural 
components (dimeric protein) have given rise to yet another name for N S E . 
5.2 Structural and Functional Properties of NSE 
N S E has now bcen purified to cssentially homogeneity from a number of 
speeics including rat. cat and human brain (Marangos ct a l . . 1975; Scarna ct a l . . 
1982). A number of purification procedures have novv becn publishcd with a 
wide variation rcgarding the degree to whieh the final product had becn 
assesscd for purity (Marangos ct a l . . 1975; Solcr Fcdersppicl et a l . , 1987; Kel ler 
ct a l . . 1981) .Thes t ruc tu ra l fea tu resofNSEarc summar izedinTab. 5-1. L i k c 
enolascs from other tissucs. N S E is a dimcr which is composed of a subunit that 
is only synthesized in a restricted number of eell types (ncurons and 
neuroendocrine cells). Thc propcrties of the enolase subunit (gamma) are 
sufficicntly unique from that of the liver (alpha) or muscle (bcta) enzyme to 
warrant it being considered a separate and distinct gcne product (Marangos et 
a l . . 1977).Thc most convincing evidence derivcs from the fact that antibodies 
raiscd against the gamma subunit ( N S E ) do not reaet with either the Iivcr or 
muscle enzyme (Marangos et a l . . 1977). It has also been shown that antisera to 
the alpha subunit does not react with N S E . 
Tab. 5-1 Structural Properties ol Human Brain NSE. 
Molecular weight 
Isoelectric point 
Subunit composition 
Reactivity with anti-NSE serum 
Rcactivity with anti-liver enolase serum 
7,X.O()0 
5.0 
2 gamma 
(39.000) 
+ + + 
j 2 Siriiciiiral and Functional Fropcrtics of NSF 183 
Tab. 5-2 Conipaiison ol NSF and Livcr Enolase. 
Iunetional Properties NSE Liver Enolase 
K 1 M g + + 
Iemperature stability (55°C) 
Urea (3M) stabilit> 
C 'hloride stabilitx (().5M ) 
Substrate K 1.2 x K H 
2.4 x K H 
1.3 x K H 
6.1 x K H 
-
+ 
+ 
Moleeular biological studies involving thc cloning ot' the N S E gene now have 
supported previous protcin structural and immunological cvidencc that N S E is 
in fact a uiiiquc gene produet (Sakimura et a l . , 1985 a. b).These studics clearly 
show a differcncc in thc nucleotide sequence ofthe gamma gene relative to the 
alpha gene. It is thcrcfore clear that the N S E isoenzymc does in fact represent a 
considerable biological investment from thc cvolutionary perspective and that 
it is not siniply a cell specific isoenzyme that differs by a single dcrivatized 
amino acid residue. 
Sincc structure and function are generally related and the structure of N S E 
appears to be so different from that of the other enolases somc effort has becn 
expcnded to dcterminc whether N S E is functionally different from thc enolase 
isoenzymc present in livcr. Kinetical ly the neuronal enolase appears to bc quite 
similar to t hc l iverenzyme (Tab. 5-2) with some differences in thc affinity ofthe 
co-factor magnesium observcd.The standard kinetic comparison between the 
isocnzymes is rather unremarkable and difficult to ascribc any physiological 
significance to. Howevcr. the picture bccomcs somewhat more interesting 
vvlicn othcr paramcters such as stability towards temperaturc and iirea werc 
compared (Tab. 5-2). Here large differences wcrc observed with N S E being 
much morc stablc in these protoeols (Marangos et a l . 1978). The most 
interesting differences emerged when thc rcspectivc stabilities of N S E and liver 
enolase werc evaluated in the prcsencc of elevated halogen concentration. 
Chloride and bromide at mil l imolar levels dissociates and inactivatcs Iiver and 
yeast enolase (Marangos ct a l . 1978a) whereas N S E is much morc stablc 
towards these conditions. This finding is of considerable intercst sincc one of 
the relativcly unique aspects of neurons is that rather high levcls ofchloride can 
accumulate during periods of repcated depolarization. It tliercfore appears 
that N S E niiglit have evolved to dcal with this aspect of thc neuron;il milieu 
sincc non-ncuronal isoenzymes would bccome inactivated in neuronal cyto-
plasm Lindcr conditions of high functional activity. This would resiilt in an 
inhibition ofglycolysis at thc time when it is needcd most. i .c . during periods of 
high eiiergy requirements. 
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5.3 Cellular Localization of NSE 
Several groiips have reportcd on the preparation ofboth polyelonal (Marangos 
et a l . 1975b) and monoclonal antibodies to N S E (Seshi and B e l l , 1985).Thc 
quality of data from studies utilizing antibodies as immunocytochemical 
staining probes is critically dependant on the piirity of the N S E that is injcctcd 
into thc host animal and therefore the staining resiilts from different 
laboratories have varied. Cri ter ia such as lack of reactivity with non-neuronal 
enolase havc only been applied to a limited number of thc currently available 
antibodies (Marangos ct al , 1977). Nevertheless, the eonsensus is fairly 
compcll ing that N S E is highly localized to neuronal cytoplasm in mature 
nervous tissue (Schmechel et al , 1979; Schmechel and Marangos, 1983). 
Vir tual ly no glial staining is observed and consequcntly N S E is gradually 
becoming accepted as a gcncralized functional markcr for nerve cclls. There 
does appear to be a range of staining intensities where various neural subtypes 
are comparcd and this may retlect the state of functional activity of thc 
respective cclls. 
What makes N S E even more valuable as a neural ccll markcr is thc fact that it 
appears to only be present in differentiated neurons (Schmechel ct al , 1980; 
Whitehcad et al , 1982). Devclopmental studies have now clearly shown that 
undifferentiated nerve cells actually contain thc liver type enolase isoenzyme 
(alpha-alpha) (Schmechel et al , 1980) and that the N S E gamma subunit only 
appears aftcr functional synapse formations(Whitehead et al , 1982; Maxwel l et 
al , 1982). N S E therefore is not only usefiil as a general neural marker but also as 
an index of differcntiation and of eonsidcrable value to developmental 
neurobiologists. 
Radioimmunoassays for N S E have been dcvcloped in a number of labora-
tories (Parma et al , 1981; Soler Federsppiel et a l , 1987; Ka to et a l . 1981) in a 
coordinatcd fashion with the immunocytochemical protocols mentioned 
abovc.Thcsc procedures arc again only valuable when the antiscra employed 
arc highly specific and the antigen utilizcd to both immunize the rabbit or goat 
and as thc radioligand in thc assay is highly pure. Aga in as with the 
immunocytochemical studies thcre has been a considerable variation in the 
published Iiteraturc in this regard since a range of standards have bcen 
employed in assessing the specificity of the various assays. The most appro-
priate standard for R I A specificity assessment is the lack of reactivity with 
purified non-neuronal (Iivcr) enolase (Parma et a l . 1981). 
Through the utilization of both immunocytochemical and radioimmunolog-
ical tcehniques it has been shown that N S E or at least the gamma subunit of 
enolasc is present in a widc assortment of neuroendocrine cclls such as adrenal 
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Fig. 5-1 Paraffin section of human pancreas immunostained for NSE. Note the 
exclusive staining of the islet alls. 
medullary chromaffin cells, pineal cells, pancreatic islet cells (Fig. 5-1) and 
many other cclls of the A P U D classification (Pearse, 1976; Schmechel et a l . , 
1979). The neuroendocrine cells have somewhat lowcr lcvels of N S E than 
neurons and they also contain non-neural forms of enolase, both of which 
distinguish them from neurons which have all of thcir enolase in thc form of 
N S E . V i r t u a l l y all of the neuroendocrine. A P U D cell types that havc been 
evaluated contain N S E immunoreactivity which simply mcans they have thc 
gamma subunit. Since hybrid forms of enolase do cxist (Marangos et a l . , 1977) 
it is possible that the gamma subunit present in neuroendocrine cells is in thc 
form of the alpha-gamma hybrid. 
5.4 Clinical Applications of the NSE Methodology 
Since N S E is Iocalized in neurons and neuroendocrine cclls the potential exsits 
that it could bc uscd as a diagnostic probe for disease statcs characterized by 
pathologies involving thesc cell types. One would cxpect that in various 
neurological disorders such as strokc or neurodcgenerativc disease that N S E 
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levcls might accumulate in either cerebrospinal fluid (CSF) or perhaps even in 
seriim. For the pathologist, N S E immunocytochemistry might ;ilso be used for 
the typing o fcc l l s .Turnove ro f the neuro-cndoerinc cells ( A P U D o m a s ) might 
also bc expccted to result in elevated serum levcls of N S E . In fact all of the 
abovc approaches havc bccn exploited with the N S E methodology and each is 
summarized below. 
A s rcgards thc neurological diseases N S E Icvcls in C S F havc becn shown to 
be of value as an index of C N S damage post-strokc (Royds et a l . . 1981; May et 
a l . . 1984). Similar results, although rather preliminary in natiirc havc also bcen 
gcncrated in head trauma (Dauberschmidt et a l . . 1983). N S E determinations in 
thcsc paticnt populations may therefore in thc fiiture prove to be of some 
prognostic value. Efforts in the neurodcgcneration area have bcen somewhat 
morc frustrating in that clear corrcIations between N S E levcls and conditions 
such as Alzheimer ' s discase and amyotrophic Iatcrosclerosis have thus far 
provcn to be illusivc (unpublished data). It may bc that a temporal problem 
exists in thesc studics such that thc pathological insiilt may occur Iong (possibly 
months to ycars) bcforc the N S E sampling takes place. In this case it may provc 
quitc difficult to utilize scrum or C S F N S E levels as a diagnostic agent in the 
progressive neurodegcnerativc discase. 
Considerably more succcss has bccn obtained using serum N S E levcls 
diagnostically in various neuroendocrine cancers. Particularly scrum N S E 
levcls arc markcdly elevated in small ccll Iung cancer paticnts (Marangos and 
G o o d w i n . 1978; Johnson et a l . . 1984; Ar iyosh i et a l . . 1983) and in pediatric 
nciiroblastoma patients (Zeltzer et a l . . 1983; Zel tzcr et a l . , 1985). In both 
paticnt populations scrum N S E lcvels can bc elevated several hundredfold 
higher than controls and the levcls are eorrelatcd with the clinical course ofthe 
illness. In neither casc does the N S E elevation appear to represent an early 
detection marker for the illness but it may bc an carly detection marker for 
relapse in small eell Iung cancer patients (Johnson et a l . . 1984). It is therefore 
possible that seiial serum N S E determinations in patients experiencing 
remission may indicate thc relapse sooner and therefore make it possible to 
rcinstate salvage chemothcrapy sooner. Whether this wil l alter thc coursc and 
prognosis of small ccll Iung cancer remains to be secn. 
In pediatric neuroblastoma patients. serum N S E levels are eorrclated with 
survival time and in those paticnts below 1 year of age it was possible to 
discriminate bctwccn survival and deaths (Ze l tzcrc t a l . . 1985).Thc serum N S E 
assay is therefore ofeonsiderable use both diagnostically and prognostically in 
both of thcsc paticnt populations as well as in some other ncurocndrocrinc 
cancers where smaller studies have shown serum N S E elcvations (Prinz and 
Marangos. 1983: Wick et a l . . 1983). Obviously. it is necessary to have other 
diagnostic information to differentiate the various neuroendocrine cancers 
from each other. 
Tab. 5-3 Applications of NSE Methodology. 
5.5 References 1X7 
1) functional markcr Ior ncurons. neuroendocrine cells as an aid to tissue typing 
2) Index of neuronal maturation in developmental studies 
3) Diagnostic and prognostic tool (serum. cerebrospinal fluid) 
- stroke and he;td traum;t 
- neuroendocrine cancers 
- small cell Iung cancer 
- neuroblastonia 
N S E is therefore a rather interesting variant ofenolase that Iias provided us 
with not only a valuable marker for neurons (in brain) and neuro-endocrine 
cells (in the periphery) but also with a diagnostic tool that has already been 
shown to have considerable utility in a number ofc l in ica l situ;itions.Tab. 5-3 
sunimari/.es some of the applications of thc N S E methodology for basic 
researcliers. patliologists. and clinicians. It is therefore likely that N S E 
Iiistoehcmistry and serum R I A detcrmination wi l l beconie useful in the clinical 
vvorkup of various neuroendocrine neoplasms. 
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6 Diagnostic Value of Chromogranin A 
Measured in the Circulation 
Marwun A. Takiyyuddin, Juan A. Barbosa, RayJ. Hsiao, RobertJ. Parmer, 
and Daniel T. O'Connor 
6.1 Introduction 
Chromogranin A , a 48 K D acidicsoluble protein,was initially recognized as thc 
major soluble protein in the corc of thc adrenal medullary catccholamine 
storage vesicics. the chromaffin vcsicles (Fig . 6-1) (Smith and Winkler , 1967; 
Smith and Kirshner . 1967). Subsequentiy, chromogranin A immunoreactivity 
was demonstratcd in a wide variety of neuroendocrine secretory vesicles. 
including those in postganglionic sympathctic nerve endings and in virtually all 
normal polypeptide hormone producing tissucs (L loyd and Wi l son . 1983; 
O 'Connor , 1983; O 'Connore t a l . . 1983a; O ' C o n n o r a n d Frigon. 1984). A m o n g 
neuroendocrine tissucs. the adrenal mcdulla is the quantitatively major tissuc 
source o fchromogran in A (0*Connor. 1983). 
Al though thc primary structure of human chromogranin A has bcen 
determined ( K o n e c k i et a l . . 1987; Helman et a l . . 1988a). its pliysiologie rolc 
remains a matter of eonjecture. 
In 1984. we developed a radioimmunoassay for human chromogranin A 
( O ' C o n n o r and Bernstein. 1984). bascd on chromogranin A purified from 
catecholamine storage vesiclcsofhuman pheochromocytoma (O 'Connore t a l . . 
l984a).The assay utilizccl rabbit polyclonal antiscra (O 'Connorand Bernstein. 
1984).Wc have subsequcntly dcveloped scveral assay modifications to optimi/.e 
assay perforniance. including rapid immunoprecipitations (O 'Connor et a l . . 
1989) and thc use o f a monoclonal antibody agaiiist chromogranin A (Sobol et 
a l . . 1986). 
Human serum samples arc incubated with rabbit anti-human chromogranin 
A (first ant ibodv). and ' 1 T Iabcled human chromogranin A . lO,OOOcpm/tube. 
The solution is vortex-mixcd and allowed to incubate over night at 4 ° C . T h e 
192 6 Diagnostic ValiicofChromograninA 
Fig. 6-1 Transmission electron micrograph of a section of human pheochromocytoma. 
Thc electron dense core structurcs are chromaffin vcsicles. The freshly obtained 
operative tissue was fixcd, stained. and viewed as prcviously described (O'Connor and 
Frigon. 1984).Thc magnifieation is 6300 diameters. Rcprinted with permission from 
Ilypcriciision (Takiyyuddin et al., 1990b). 
Fig. 6-2 In vitro stability of human plasma chromogranin A immunoreactivity. (a) • 
Immunoreactivity during repcated freeze/thaw cycles (n = 6 samples). (b) Immuno-
reactivity before and after lyophilization plus water reconstitution (n = 7 samples). (c) 
Immunoreactivity alter prolonged incubation at 37°C. Rcprinted with permission Irom 
Hyperiension (Takiyyuddin et al.. l990b) and Clinical Chemistrv (O'Connor et al.. 
1989). 
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next day, normal rabbit serum (earriersecond antigen) is added, Iollovved by 
goat anti-rabbit gamma globiil in (seeond antibody), and the solution is 
vortcx-mixcd. Aqucous polyethylene glyeol is then addcd to preeipitate the 
immune eomplexes (leaving thc free antigen in solution). The solution is 
centrifuged at L500 x g for 20 minutcs, the supernate aspirated, and the 
radioactivity of the pellet is counted (O 'Connor ct a l . . 1989). 
Circulating chromogranin A immunoreactivity is remarkably stable to a 
variety of insults. including rcpeatcd freezing and thawing (Fig . 6-2a). 
Ivophilization followed by watcr reconstitution (Fig . 6-2b). and prolonged 
incubation at 3 7 ° C (Fig . 6-2c). 
Mcasuremcnt of circulating chromogranin A concentration by radioimmu-
noassay has emcrged as a potential probe of exocytotic sympathoadrenal 
activity in man (O 'Connor and Bernstein. 1984). as well as useful diagnostic 
adjunct in thc cvaluation of neuroendocrine neoplasia (O 'Connor and Deftos. 
1986; O 'Connor and Dcftos. 1987; O ' C o n n o r e t a l . . 1989). 
In the present chapter. we evaluate thc diagnostic value ofchromogranin A 
mcasiired in the eirculation under both physiologic and pathologic conditions. 
and parameters that influence circulating chromogranin A concentrations. 
6.2 Chromogranin A Release from the 
Sympathoadrenal System 
//; vitro, chromogranin A is corclcased with catecholamines from both adrenal 
chromaffin cclls and sympathctic ncrve endings. suggesting exocytosis as the 
mechanism ofcatecholaminc secretion (Sehneider et a l . . 1967; Smith et a l . . 
1970). 
In man. sclcctivc provocation of catccholamine secretion from cithcr the 
adrenal medulla or sympathctic neurons results in corelcase of chromogranin 
A . with consequent increments in plasma chromogranin A . The eorelcasc 
suggests exocytosis as thc mechanism of sympathoadrenal catccholamine 
secretion in vivo (Takiyyuddin et a l . . 199()a). 
Fig . 6-3 illustrates thc response ol plasma chromogranin A as well as 
catecholamines to sclcctivc adrenomedullary activation by insulin induced 
hypoglycemia in normal subjects. Following insulin administration, plasma 
epinephrine rosc 14 fold. peaking at 30 minutcs.while plasma chromogranin A 
rose 1.7 fold. peaking at 9(1 minutes. This temporal dissociation in the 
appcarance of plasma chromogranin A peak concentration (90-120 min) versus 
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plasma norepinephrine. Howevcr. thc increments in plasma chromogranin A 
attained during sympathoneuronal activation are modest compared with 
increments attained during adrenomedullary activation (1.2 foId vcrsus 1.7 
fold).This is eonsistent with the finding ot'97 foId Iess chromogranin A (ug/g) in 
sympathetic nerve endings relative to adrenal medulla (Takiyyuddin ct a l . . 
L990a). 
O n thc othcr hand. Iesscr dcgrees of adrenal medullary (caffeine ingestion) 
or sympathoneuronal (standing. smoking. Iow intensity cxercise) activation fail 
to perturb plasma chromogranin A despite significantly elcvating plasma 
cateeholamines (Takiyyuddin ct a l . . l990a). 
Thus. at extremes of sympathoadrenal aetivity, thc mechanism of catccho-
lamine secretion from thc adrenal medulla and sympathctic neurons appears to 
be, at least in part. exocytotic. 
6.3 Chromogranin A Release from other 
Endocrine Sites 
Chromogranin A immunoreactivity cxhibits a widc endocrine distribution, as 
rcvcaled by immunohistology. immunoblotting and radioimmunoassay (L loyd 
and Wi l son , 1983; O 'Connor , 1983; O C o n n o r e t a l . . 1983a; Cohn et a l . . 1984). 
Chromogranin A immunoreactivity has bccn dctccted in gut enterochromaffin, 
thyroid ealcitonin C. parathyroid chief, adrenal medullary chromaffin, pituitary 
(anterior > intermediatc > posterior), and endocrine pancreatic cclls. O n thc 
other hand. chromogranin A is not localizcd to tissucs with solcly exoerine 
function or to endocrine tissues producing only nonpeptide hormones ( O ' C o n -
nor. 1983; O ' C o n n o r e t a l . . 1983a. O ' C o n n o r e t a l . . I983b; O ' C o n n o r e t a l . . 
1984b). 
In man. Stimulation of normal human endocrine secretory cclls. other than 
adrenal medulla ( i .c . . anterior pituicytes, pancreatic islct cells, gut enterocn-
docrinc cclls, parathyroid chief celIs. and thyroid parafollicular C-cclls) with 
cell-typc selective secretagogucs. fails to inducc signifieant increments in 
plasma chromogranin A despite inducing measurable increments in thc 
concentrations of thc resident peptide hormones (O 'Connor et a l . . 1987). 
Hence. within the neuroendocrine system only Stimulation of thc adrenal 
medulla is likely to elcvatc plasma chromogranin A undcr physiologic 
circumstanccs (Takiyyuddin et a l . 199()b).This is eonsistent with the finding 
that thc adrenal medulla is the quantitatively major neuroendocrine tissue 
soLirce ofchromogranin A (O'Connor . 1983). 
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6.4 Parameters that Influence Circulating 
Chromogranin A Concentrations 
Thc souree of basal cireulating chromogranin A Ievels in man is still a matter of 
investigation. Basal circulating chromogranin A displays a significant ultradian 
or pulsatile rhytl im. peaking every 51 minutcs (Takiyyuddin et a l . . 1988). In 
man. somatostatin infusion suppresses basal circulating chromogranin A levcls, 
and diminishes the magnitude and freqiiency of pulsatile peaks. without 
altering plasma catecholamincs (Takiyyuddin et a l . . 1989). 
Plasma chromogranin A correlates significantly with serum creatinine 
concentration (p < ().()5)(Hsiao ct a l . . 1990a: O 'Connor et a l . . 1989). In 
patients with renal insiifficicney. plasma chromogranin A is markedly elevated, 
with the highest values attaincd in patients with end stage renal disease (Hsiao 
ct a l . , 1990a; O 'Connor et a l . . 1989).This suggcsts a major role for the kidneys 
in the removal ofchromogranin A immunoreactivity from circulation. Conse-
quently, knowledge of renal function is essential for proper iiiterpretation of 
changes in plasma chromogranin A changes. 
O n the other hand. plasma chromogranin A is elevated to a lesser degree in 
patients with hepatic disease, preciuding a major role for the Iiver in 
chromogranin A disposition (O 'Connor et a l . , 1989). 
Plasma chromogranin A is modestly but significantly elevated (mean. 1.4 
fold) in patients with essential hypertension, suggesting that there may bc an 
excess ofcxoeytotic sympathoadrenal activity in this disordcr (O 'Connor . 1985; 
Takiyyuddin et a l . . 199()b). Suppression of sympathctic outflow with guana-
bcnz. a centrally acting alpha 2 agonist. diminishes blood pressure and 
suppresses basal circulating chromogranin A levcls. suggcsting that the plasma 
chromogranin A basal elevation secii in essential hypertension is. at least in 
part. neural in origin (O 'Connor , 1985). Other antihypertensive tlierapies, 
including thc angiotensin converting enzyme inhibitor enalapril or thc 
bcta-blocker propranolol, lovver blood pressure without altering plasma 
chromogranin A (Takiyyuddin et a l . . 199()b). 
6.5 Chromogranin A as a Marker for 
Neuroendocrine Neoplasia 
Although no functional role for the chromogranins has been conclusively 
established. potcntial application of their measiiremcnt as diagnostic markers 
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for a varicty of neuroendocrine neoplasia has bccn presented in sevcral reports 
during rccent ycars. 
Chromogranin A immunoreactivity has been demonstratcd. by radioimmu-
noassay and immunoblott ing. in dense core secretory vcsiclcs in a varicty of 
polypeptide hormone producing tumors (L loyd and Wi l son . 1983; O 'Connor 
andDeftos, 1 9 8 6 ; 0 ' C o n n o r e t a l . , 1984a;Wei lerc ta l . . 1988) .ChromograninA 
may be exocytotically corcleased with the usual resident peptide hormone. 
suggcsting that mcasiiremcnt of plasma chromogranin A may be of valuc in the 
diagnosis of such tumors. 
lncleed. plasma chromogranin A is elevated in patients with phcochromo-
cytoma, aortic body tumor, carcinoid tumors (with the vcry highest plasma 
chromoganin A values observed), pancreatic islct cell tumors. medullary 
thyroid carcinoma and C-cell hyperplasia. and in a variety of pituitary tumors 
(O 'Connor and Deftos, 1986; Moattari et a l . , 1989). In these tumors. the 
diagnostic sensitivity and specificity of plasma chromogranin A measurement 
has bcen cstimated at 81 % and fOO%. respcctively (O 'Connor and Dcftos. 
1987). 
In pheochromocytoma, plasma chromogranin A is markedly elevated (10-20 
fold), suggesting that catccholamine secretion from the tumor is at lcast in part 
cxocytotic (O 'Connor and Bernstein, 1984; O 'Connor and Deftos, 1987; 
Takiyyuddine ta l . , 1990b). E l e v a t c d p l a s m a c h r o m o g r a n i n A ( > 112ng/ml)has 
a comparable sensitivity (83%) to. but greatcr specificity (96%) than plasma 
catecholamines in distinguishing pheochromocytoma patients from normals, or 
other hypcrtcnsivcs (unpublishcd work) . Fur thcrmorc, thc clevation in plasma 
chromogranin A eorrclatcs with tumor burden and catccholamine produetion 
by thc tumor, but docs not vary with agc, tumor location, or scx. In addit ion. 
drugs (clonidine, metoprolol . phentolaminc. tyramine) that are uscd in 
diagnosis or treatment of pheochromocytoma do not perturb plasma chromo-
granin A . and thus have Iittlc effect on the diagnostic accuracy ofchromogranin 
A for pheochromocytoma (unpublishcd work) . 
Plasma chromogranin A is elevated in patients with small eell Iung 
carcinoma. Furthcrmorc, plasma chromogranin A correlates with tumor 
burden, suggesting its potential use as a markcrofdiseasc activity (Sobol ct a l . . 
1986). 
Plasma chromogranin A is also elevated in most patients with Zol l inger-
Ell ison syndrome ( Z E S ) (Stabile et a l . . 1990). Chromogranin A level correlates 
with neither gastrin levels. the site and amount of the primary tumor. nor the 
prescnce or absenec of mctastasis (Stabile ct a l . . 1990). Intcrcstingly, plasma 
chromogranin A lcvels arc rcduced (by 66 %) by gastrectomy alone, suggesting 
the gastric cnteroendocrine cells as one source of plasma chromogranin A 
elevation (Stabile et a l . . 1990). 
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Wc initially found that plasma ehromogranin A w a s elevated in patients with 
primary hyperparathyroidism, with higher levels attained in patients with 
parathyroid hyperplasia versus patients with parathyroid adenoma (O 'Connor 
and Dcftos. 1986). However,we have reccntly found that plasma chromogranin 
A elevation in hyperparathyroidism is largely restricted to patients with familial 
multiple endocrine n e o p l a s i a ( M E N I) ,who also have Z E S (Nanesct a l . , 1989). 
Fur the rmorc following parathyroidectomy in patients with cither parathyroid 
adenoma or hyperplasia. plasma chromogranin A is reduced by 54 % , but only 
in patients with Z E S . T h i s suggests that parathyroid gland is not thc source of 
plasma chromogranin A elevation in this condit ion, but rather that hyperpa-
rathyroidism influenccs chromogranin A release from other tissues. possibly 
pancreatic islet cclls (Nanes et a l . , 1989) or stomach enteroendoerine cells 
(Stabile et a l . . 1990). 
Recently. plasma chromogranin A has been shown to be elevated in children 
with ncuroblastoma. and the elevation is greater in widcspread or metastatic 
than in loealizcd disease (Hsiao et a l . , 1990b). Furthermore, plasma chromo-
granin A concentration parallels discase stage and can bc, either alone or in 
combination with agc or disease stage, an effective prognostic index (Hsiao et 
a l . , 199()b). 
Plasma chromogranin A , on the other hand, is not secretcd by nonendocrine 
tumors or endocrine tumors not associated with dense core vesicles (O 'Connor 
and Deftos, 1986; O 'Connor et a i . , 1989). lntercstingly, chromogranin A 
m R N A expression has bcen detected in colon tissues with adenocarcinoma 
suggesting potential neuroendocrine lineage of some subscts of these tumors 
(Helman et a l . 1988b). 
In conclusion, mcasurcmcnt ofcirculat ing chromogranin A has emerged as a 
Liseful tool for the diagnosis and determination ofthe extent of neuroendocrine 
neoplasia. In addition, it has provided further insight into the mechanism of 
sympathoadrenal catccholamine secretion in man. 
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7 Markers for Neural and Endocrine 
Cells in Pathology 
Philipp U. Hcitz, Jiirgcn Roth, Christian Ztiher and Paul Koniniinotli 
7.1 Introduction 
T h c use ot' markers for thc pheiiotypic eharacterization of cells has yieldcd a 
wealth of information on number. types. distribution and function of normal 
and tumorous neuroendocrine cel ls .This knowlcdge enablcs the patliologist to 
analyze pathological phcnomena of neuroendocrine cells and tissues. i .c. 
hyperplasia and tumors with inore precision than ever. Markers are now 
cxtensivcly uscd in diagtiostie and experimcntal pathology. 
In diagnostic pathology the pathologist is very often confronted with thc 
qucstion of whether a given patient suffers from a tumor or from a different 
typc of lcsion. In prescncc of a tumor the next diagnostic stcps are 1) to define 
the phenotype ofthe tumor, 2) to define the biological behavior, 3) to dceide if 
the tumor is a primary or a metastasis and to localize the primary, and 4) to 
demonstrate the synthesis of secretory products. 
Histology. using conventional tinctorial stains. is sl i l l a very important 
technique in the diagnosis of lesions. However additional teeliniqucs. i .c. 
special t inctorial stains. elcctron microscopy. immunocytochemistry. in situ 
hybridization and polymerase cliain reactions are becoming increasingly 
important. Somc of these techniques arc at present widely uscd to define the 
phenotype. gradc ofdiffcrcntat ion, biological bchavior, and hctcrogeneity of 
tumor cells. 
A l l these techniques can bc useful in the biological analysis and diagnosis of 
lesions. especially oftumors, ifcarcfully selectcd and uscd propcrly. A t present 
immunocytochemistry is most widcly used for Ioealizing markers bccause ofthe 
possibility of establisliing eorrclations with biochemically demonstrable serum 
markers. and thc monitoring of the course of discase and/or the effect of 
therapy. It must however be born in mind that immunocytochemical techniques 
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arc mercly ablc to localizc epitopes on posttranslational products. Per se these 
methods allow neitherthe definition ofthe syntlietic activity ofthe eell . nor the 
ability of seerction of a givcn substance by the eell. In order to provide 
functionally significant results. immunocytochemical methods must bc coni-
bincd with investigations into the state and activity of reeeptors on the cell 
membrane. in situ hybridization and/or polymerase chain reaetion to definc the 
biosynthetie activity of the eell, and with assays determining the serum 
concentration of a givcn secretory product. Finally, the bioehemistry and site of 
the conversion of prc/prosccretory products into the final secretory product 
must bc elucidated (Roth et a l . , 1989). 
In medicine the eombincd findings of 1) thc symptoms presented by thc 
patient. 2) one orsevcral posttranslational products localized in inflammatory 
or, morc important. in tumor cclls. and 3) an elevated serum concentration of 
these products. is often sufficient for cstablishing a preeise diagnosis. The 
applieation of methods determining these phenomena has rcvolutionized the 
diagnosis of tumors. in particular thc diagnosis of Iymphomas and neuroendo-
crine tumors. 
In this short overview somc of the more important gcncral markers of the 
neuroendocrine phenotype of normal and tumor cclls (so called broad-
spcctrum niarkers) arc diseusscd. It is beyond thc scope of this short review to 
discuss thc iiumerous markers, i.e. hormones. considcrcd specific for the 
phenotype of thc various neuroendocrine cells. 
7.2 Neuroendocrine Tumors 
The terni neuroendocrine is used lierc to define the secretory products of the 
cells and tumors rather than their nature and embryological dcrivation. 
Neuroendocrine tumors occur in orgaiis known to secrcte neuroendocrine 
mcsseiigcrs and/or to contain cells displaying eharacteristics or activity typical 
o f the neuroendocrine phenotype (Heitz , 1987). 
Individual neuroendocrine tumor typcs arc uncommon but neuroendocrine 
tumors as a group are common. 
There are scvcral groups of markers characteristie of the neuroendocrine 
phenotype. including 1) thc prcsence of voltage dependent N a 1 and/or C a 1 ' 
channcls in thc cell membrane. 2) reeeptors for specific ligands, i.e. nerve 
growth faetor, 3) cytoskeletal proteins, 4) soluble proteins Iike neuron-specific 
enolase and protcin gene product ( P G P ) 9.5, 5) granule niatrix constituents. 
i.e. chromograiiiiis and epitope Leu-7. 6) secretory vesicle membranc consti-
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tuents, i.e. cytochrome B 561 or synaptophysin, and 7) amine biosynthetic 
enzymes. In a nearfuture additional markcrs. i.e. N C A M (Neural cell adhesion 
molecule). may provide new insights into the biology of neuroendocrine 
cells. 
Markers for cytoskelctal proteins. neuron-specific enolase, chromogranins. 
Leu-7. and synaptophysin are currently used for diagnosis and prccise 
classification of tumors. The localization and chcmistry of N C A M or N C A M 
polysialic acid wi l l probably soon be clarified in the various neuroendocrine 
cells and tumors. It is a promising additional marker of various typcs of 
neuroendocrine tumors (see below). 
Histology. using convcntional or special tinctorial stains, is a prcrequisite for 
the diagnosis of tumors, including neuroendocrine tumors.Thc morphology of 
the tumors, and mctastases thereof, is often characteristic, at Ieast in highly 
differentiated tumors.This picture bccomcs blurred in tumors ofa lesscrdegrec 
of phenotypic diffcrcntiation, especially in malignant tumors. Moreover, on the 
basis ofconventional histology it is not possible to reach a prccise functionally 
significant diagnosis, because by morphology alonc no conclusion ean be drawn 
as to the production of hormones by a given cell . In this situation the use of 
markers characteristic for the neuroendocrine phenotype of cells may bc 
helpful in reaching a diagnosis. or at least a differential diagnosis. 
Thc tumors often cause characteristic symptoms, or well defined syndromes 
by inappropriate hormone seeretioii .The concentration in the patient's scrum 
of many secretory products can be dctermined.The pathologist must therefore 
provide a specific and functionally significant diagnosis.Thc final cvidence for 
the production and secretion of a given substance ean bc provided only by the 
combined effort ofthe elinician, biochemist, and morphologist.This evidence is 
of paramount importancc forthe patient beeause some tumors arc of low grade 
malignancy, and can therefore bc treated succcssfully. using drugs with a 
specific action dircctcd against specific typcs of tumor cells and against cffccts 
ol secretory products on their target cclls. Evcn in thc presenec of mctastases 
the prognosis can be much better for a patient suffering from a neuroendocrine 
tumor than from other tumor types. 
7.3 Technical Prerequisites 
The quality of appropriatc tissue processing. including snap freezing or 
appropriate fixation. is of utmost importanee for the succcssful use of markers. 
It cannot bc ovcremphasizcd that routine fixation in buffered formaldehyde is 
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appropriate or at Icast sufficient for many reaetions. Deparatfinized seetions of 
formaldehyde-fixed tissuc can be briefly dipped into Bouin's fluid for obtaining 
optimal results with some antibodies. A number of antigens withstand Iow 
concentrations ofglutaraldehyde (0.1 to 1%) mixed with formaldehydc, or 
even postfixation with osmium tetroxide. Snap frcezing is nccessary for 
biochemical analysis of the tumor tissue and oftcn for reactions using in situ 
hybridization for visualizing m R N A . Howcver. routinely fixed and paralfin-
embcddcd tissue has bccn shown to be suited for successful localization of 
m R N A of N C A M (Roth et a l . , 1988a). O n the othcr hand. the polymerase 
chain reaction ( P C R ) is ofgreat promise beeause of the possible mill ionfold in 
sitit synthesis of a known primer even on conventionally fixed and stained 
tissue. 
Thc use of purified and specific antibodies and/or probcs is essential for 
obtaining rcliablc results. The importance of extensive testing for optimal 
reaction conditions. and the demonstration of thc spccificity of the reaction 
with every individual antibody or probe cannot be overstresscd. 
7.4 Significance of Neuroendocrine Markers 
Thc importance ofbroad-spectrum markers is to provide the pathologist with a 
clue to thc neuroendocrine phenotype of a tumor, if not prcviously rcvcalcd by 
eonventional histology. Using reactions for a range of markers, many tumors 
were shown to bc of the neuroendocrine phenotype, or at lcast to contain a 
variable number of cells bearing the neuroendocrine phenotype admixed with 
other tumor cells. 
Thc significance of thc general inarkers is their independence of hormone 
production by tumor cc l l s .Thcy arc therefore very valuable in the diagnosis of 
tumors not producing or sccrcting specific mcssengers. A s described below, thc 
general neuroendocrine markers can bc used in a second step of a diagnostic 
flow char t .Thc first step can consist of the gcneral eharacterization of a tumor 
usingcytokerat ins .vimentin and neurofilanient proteins. In thc thirdstep the 
prescnce of specific cell products. i.e. peptidc hormones can bc visualized. 
In the interpretation ofthe reactions it must be borii in niind that tlicrc are no 
absolute criteria for dcfining the phenotype of a given tumorccII on the basis of 
the combined occurrence ofvarious types ofcytoskeletal proteins. O n thc other 
hand thcre are tumors. not displaying furtlier neuroendocrine eharacteristics, 
which yicld reactions with one or several neuroendocrine markers. The 
differences t>htained in the reactions are therefore quantitative rather than 
qualitative although many tumors follow some general rules. 
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N o strict riiles can be established for the use of a certain number or set of 
reactions. A s mentioned above it must be the morphology which guides the 
pathologist in the eareful sclection of an appropriate set of reactions to be 
carried out. 
7.5 Diagnostic Algorithm 
In thc following thrce possible steps of a diagnostic flow chart are discussed. 
Thc last stcp, i .c . the visualization of specific cell markcrs. is discusscd only 
briefly bccausc it is bcyond the scope of this short revicw. 
7.5.1 First Stcp: General Markers 
A possible first step in characterizing a tumor is to use antibodies directed 
against epitopcs of cytoskcletal proteins. Many tumor cells of thc neuroendo-
crine phenotype contain cytokeratins, especially cytokeratins number 8 and 18 
(Höf ler et a l . , 1986). Ant ibodies directed against sclccted cytokeratins or 
directed against an cpitope common to many or all presently known 
cytokeratins may bc uscd (von Overbeck et a l . , 1985; Franke ct a l . , 1987).The 
reaction pattern of the cells may be pancytoplasmic, ccll membrane associatcd 
or paranuclear "dot-l ike".The lattcr pattcrn is characteristic, although by no 
means specific, for growth hormone producing pituitary adenomas and 
neuroendocrine carcinomas of the skin (Merkel cell tumors). 
It is st i iking that thc cells of tumors of the adrcnal medulla and paragan-
gliomas. steroid hormone producing tumors of the adrcnal cortex, testis and 
ovary. and melanocytes (normal or tumorous) contain only very rarely 
cytokeratins. Mclanocytcs and cells of pheochromocytomas or paragangliomas 
often contain vimentin. The massive vimentin content of endothelial and 
mesenchymal, and so-ealled sustcntacular cells may produce a vcry character-
istic alveolar Iike pattcrn in pheochromocytomas and similar tumors. 
It is vcry interesting that combinations of various cytoskelctal protcins may 
occur in neuroendocrine tumor cclls. Neurofilament proteins may occur in 
combination with cytokeratins in bronchial and intestinal carcinoid tumors and 
in bronchial neuroendocrine carcinomas. while vimentin and ncurofilaments 
often occur in the same tumor cells in pheochromocytomas or melanomas. In 
thc latter thcrc is morcover a characteristic combination of vimentin with thc 
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cytoplasmic protcin S-1()0. In thyroid tumors. cspccially in papillary thyroid 
carcinomas. cells containing either cytokeratin or vimentin often occur 
combined in the same tumor. 
7.5.2 Second Step: General or Broad-Spectrum 
Neuroendocrine Markers 
The second step of a possible diagnostic algorithm eomprises gencral or broad 
spectrum markers of the neuroendocrine phenotype, i.e. neuron-spccific 
enolase, synaptophysin, P G P 9.5, chromogranins. Leu-7. and N C A M as vvell as 
N C A M polysialic acid. 
Neuron-Specific Enolase (NSE) and Protein Gene Product 
( P G P ) 9.5 
This cytoplasmic enzyme, the chemistry of which is discussed in chapter 5 ol 
this volume. has bccn used extensively and successfully in morphologieal 
ana lys is (Tapiae ta l . . 1 9 8 1 ; D h i l l o n e t a l . , 1982a .b ;Oskamet a l . . 1985; Iwasc 
et a l . . 1986; Osborne et a l . . 1986). and as a serum marker Ior Ihe 
eharacterization of neuroendocrine tumors (Carney ct a l . . 1982; Prinz and 
Fig. 7-1 Strong cytoplasmic immunocytochemical reaction Ior synaptophysin in an 
insulinoma. Formaldehyde-fixetI. paraffin-embcdded tissue. Avidin-Biotiii-Complex 
technique, 125x. 
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Marangos, 1982;Zel tzerc ta l . . 1983). I n o u r c x p c r i c n c c N S E i s a u s c f i i l m a r k e r , 
providcd thc tissuc is rapidly and thoroughly fixcd and a good antibody directed 
aginast the gamma subunit (see chapter 5) is used. Nonspceific reactions oftcn 
occur in nccrotic or autolytic arcas.There is no detectable reaction for N S E in 
tumors of thc thyroid (cxcept medullary carcinoma) and in stcroid producing 
tumors. O n the other hand it must be born in mind that so-called N S E , i .c . thc 
gamma-gamma dimer of enolase, may occur in tumors not displaying othcr 
neuroendocrine eharacteristics. The occurrence of N S E has becn rcpeatedly 
dcscribed in solid and cystic ncoplasms of the pancreas, a tumor which may bc 
taken Ior an endocrine neoplasm on the basis of morphology alone. However. 
in our cxpcricnce all reactions for other neuroendocrine markcrs are consis-
tcntly negative in this tumor (Heitz et a l . , 1989). 
P G P 9 . 5 is a soluble protein originally isolated from neural tissue (Thompson 
et a l . . 1983). Its function is unknown. It has a widc distribution in ncrvcs 
(( iulbenkian ct a l . . 1987) and occurs in neuroendocrine tumors (Rodc et a l . , 
1985). In our cxpcricnce the marker is not as rcliable as others in tumors. 
Synaptophysin 
This specific component of membranes of prcsynaptic vcsicles apparently 
occurs in virtually all neurons (sec chapter 2) and in at lcast thc majority of 
normal and tumorous neuroendocrine cclls (Fig . 7-1). Its general use has becn 
hampered for some time because good and reliable and also specific antibodies 
were not commercially available. O n the other hand the tissuc must be very wcll 
preserved. i.e. Ireshly frozen or vvell fixed in formaldehydc and cmbedded in 
paraffin (Gould et a l . , 1986; 1987; Wiedenmann et a l . . 1986). Under thcsc 
conditions synaptophysin is a vcry reliable marker for almost all neuroendo-
crine tumor cclls. 
Chromogranins 
A s dcscribcd in a preceeding chaptcrof this volume. chromogranins are a group 
of acidic monomeric protcins of various sizcs. which form a major part of thc 
soluble proteins in secretory granules of many endocrine cells (Wilson and 
L loyd . 1984). Using specific and sensitive monoclonal antibodies chromogran-
ins havc bcen Ioealizcd in cells and tumors arising in the adrcnal medulla. 
endocrine pancreas, parathyroid glands. anterior pituitary gland and in thc 
thvroid (C-cells and medullary carcinomas). Focal staining may be observed in 
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Fig. 7-2 Neuroendocrine cclls in the mucosa o f a human appendix displaying a strong 
immunocytochemical reaction for chromogranin A . . 4()0x. Differential intcrference 
contrast optics. 
Merke l cell tumors, ncuroblastoma, and small cell carcinoma of the lung. O n 
the other hand therc is in general no chromogranin found in melanomas and 
naevi. Chromogranins could be localizcd in thc core of cytoplasmic secretory 
granulcs by immunoclcctron microscopy (Wilson and L l o y d . 1984; Ehrhart et 
a l . , 1986; Roth and Heitz , 1989). In addit ion. chromogranin A was shown to be 
secrctcd by at least some of the afore-mentioned tumors (scc chapter 3 and 6). 
The reaction for chromogranins is a useful adjunct in thc diagnosis ol 
neuroendocrine tumors yielding good results on formaldehydc-fixed and 
paraffin-embedded tissuc (Fig. 7-2). A condition sinc qua non is the prcscnce of 
a suffieicnt number of secretory granules containing chromogranin for 
detection by thc techniques presently uscd. It is therefore obvious that 
chromogranin is not a rcliable markcr for tumor cells of a low grade of 
differentiation, not producing granulcs. O n thc othcr hand chromogranin may 
be present in tumor cclls which can not bc shown to produce hormonal 
products. 
Leu-7 
Anti-Iymphocytc antibody Leu-7 ( H N K - I ) directed against a carbohydrate 
epitopc present on the cell surface of human natural ki l ler Iymphocytes ( A b o 
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and Ba lc l i . L981, A b o et a l . , 1982), on myelin-associated glycoprotein ( M A G ) 
(McGar ry ct a l . , L983, Tucker et a l . . 1984) and on certain ccll adhcsion 
molcculcs yields an intcnsc rcaction with normal and neoplastic adrenal 
medullary cells (Cail laud et a l . , 1984). The gene coding for the epitope is 
localizcd on human chromosome 11. Immunocytochemical studies and immii-
iioblot analysis showcd that this antibody apparently reacts with a carbohydrate 
moiety of a protcin (molecular weight 75 000 daltons) localized in thc matrix of 
chromaffin granules.The antibody was shown to rcact with a small pcrccntage 
of normal cclls of thc panercatie islets, the anterior pituitary. and endocrine 
cells of the gastrointestinal tract (Tischler et a l . , 1986).We found a reaction in 
tumor cclls of formaldehydc-fixcd, paraffin-embeddcd tissue of medullary 
thyroid carcinomas. pheochromocytomas. paragangliomas. cndoerine pan-
creatic tumors. and carcinoids of the stomach. duodenum. i lcum and rectum 
(unpublislied rcsults). It has been siiggested that Lcu-7 immunoreactivity may 
be a marker of specific subsets of secretory granules. Howevcr, thc Leu-7 
immunoreaetion is also obtained on the cell surface of small cell Iung cancer 
(Bunn et a l . . 1985).This may be due to the presence of Lcu-7 ( H N K - I ) on 
subsets of N C A M or related molecules (see chapter 4). 
Ncural Cel l Adhesion Molecule ( N C A M ) 
N C A M is a general calcium-independent cell adhesion molecule which serves 
as a homophilic Iigand niediatingcell-cell adhesion and affecting a widc variety 
ol different cellular events (Edelman, 1986; Rutishauser and Jcsscll , 1988; 
Rutishauser ct a l . . 1988).The N C A M polypeptides exist in various isoforms, 
thc 180 k D a . 140 k D a and 120 k D a polypeptides being most eommonly found 
(Nvbroe et a l . . 1988). T h c bioehcmistry, molecular biology and cellular 
distribution of N C A M is diseussed in chapter 4. Thc homophilic binding 
propcrties of N C A M arc modii latcd by diffcrential expression of homopoly-
mers of alpha 2.8-linked N-acetylnciiraminic acid. the so-callcd polysialie acid: 
the highly sialylated form of N C A M ( N C A M - H ) cxhibits rcduccd adhcsivc 
propcrties whcreas thc Iess sialylated N C A M ( N C A M - L ) proniotcs adhesion. 
Although N C A M is traiisicntly expressed in various early embryonic structurcs. 
the H - or L - form of N C A M is found prcdominantly in neurons and glial cells 
(Nybroe ct a l . . 1988), in striated muscle (Moore and Walsh, 1985), as well as in 
the adrenal mcdulla (Langley and Aun i s , 1984), pheochromocytoma cells P C 
12 (Margolis and Margol is , 1983), neuroblastoina cells (Livingstone ct a l . , 
1988) , anterior pituitary (Langley et a l . , 1987), panercatie islcts (Langley et a l . , 
1989) dcvcloping kidney (Roth et a l . , 1987, 1988a), and Wilms tumor (Roth et 
a l . . 1988 a. b).Various monoclonal and polyclonal N C A M antibodies havc been 
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demonstrated as useful for immunohistochemistry on native frozen sections or 
paraffin scctions of formaldchyde-fixcd tissuc. A mouse monoclonal IgG2a 
antibody recognizing polysialic acid typically found on N C A M - H (Frosch et a l . . 
1985) has becn shown to yicld excellcnt results on paraffin sections of routinely 
formaldehyde-fixcd and paraffin-cmbedded tissucs. 
It is at prcscnt obvious that N C A M - L and N C A M - H ean bc only auxiliary 
tools in the idcntification of neuroendocrine cells.The situation is complcx and 
far from bcing investigatcd in detail. In neural tumors thc N C A M - H may be 
prcvailing (Livingstone et a l . . 1988). and in our unpublished studies we found 
this to be also thc case for pituitary adcnomas. small cell Iung carcinoma. 
medullary thyroid carcinoma and immaturc teratomas. In all these instanccs 
the monoclonal anti-polysialic acid antibody gave unambiguous results and in 
the case of the immaturc tcratomas proved to bc a superior reagent as 
compared to other antibodies such as an t i -NSE. anti-chromogranin and 
anti-Sl(K). In our e.xpcriencc. polysialic acid is an cxeellent marker, providcd 
that structural prcscrvation of the tissue is good. In nccrotie or autolytic areas 
usually no reaction for polysialic acid is dcteetcd.This is in aecordanee with its 
well known structural fragility. Endocrine cc l l sof thc panercas and insulinomas 
appear to express only thc N C A M - L . Consequently, the polysialic acid 
antibody viclds no reaction, whereas positive immunostaining with N C A M 
antibodies can be observed. It is not yet clear, if thc differcntial expression of 
N C A M , N C A M - I L o r N C A M - L is related to the gradcofdiffcrcntiat ion and/or 
malignancy. Sincc N C A M is not a component ofendocrine secretory granules 
onc may cxpect to find it in tumors not producing hormones. 
7.5.3 Third Stcp: Specific Markers 
Peptides, glycoproteins. biogenic amines. catecholamines and. to a l imited 
extent. Steroid hormones may bc used as specific markcrs in a third step o f an 
algorithm dcsigncd Ior the preeise typing of neuroendocrine tumor cel ls .The 
immunocytochemical localization of these products. of ehromogranins and 
Leu-7 is based on thc fact that the intraccllular pathway of the substancc is 
regulated as well as directed. In a stcady state of the cell mctabolism, a 
post-Golgi pool of secretory products, precursors thcrcof. and substances 
contained in thc matrix of secretory granules exists.The secretory products can 
bc stored for several hours in granulcs (Kelly. 1985; Lauffer et a l . . 1985; 
Wickner and Lod i sh . 1985). and therefore a high concentration of secretory 
products and other substances contained in the granuIar matri.x is present in this 
post-Golgi compartment. 
The extensive usc of thesc markers has providcd thc ecll biologist and the 
pathologist with new insights into thc process of hormone biosynthesis. thc 
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secretion and the regulation thereof. and into the phenotypic lieterogeiieityof 
tumor cclls. 
In addition the usc ofthcse markers has revolutionized thc Classification and 
diagnosis of neuroendocrine tumors, i.e. tumors ofthe pituitary glaiid (Heitz et 
a l . . 1987). the lung. the gastrointestinal tract and the endocrine panercas 
(Klöppe l and Hc i t z . 1988). 
Thc eombined use of clinical . biochemical . and functional-morphological 
analysis of hormone secretion. biosynthesis at thc transcriptioiial. translational 
and post-translational lcvels, intraccllular transport and convcrsion of precur-
sors into the final secretory products. and of rcccptors wi l l undoubtcdly provide 
further exciting findings in the future. 
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